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Depersonalisation is a feeling of profound disconnection from oneself or surroundings including 
one’s body.  There is some conceptual overlap between symptoms of depersonalisation and 
those of psychotic disorders, however diagnostic protocols have precluded the diagnosis of 
depersonalisation disorder in the context of psychotic conditions considering the former better 
conceptualised as sequelae of the latter.  However there has been a recent interest in 
depersonalisation in psychosis, perhaps due to the common aetiological factors of trauma and 
anxiety.  In this context, we aimed to review the literature to determine the prevalence of 
depersonalisation symptoms and depersonalisation disorder in the context of psychosis.  
MEDLINE, PsycINFO and Web of Science were searched using standardised search terms in 
January 2016.  Sixteen studies were identified, involving 804 participants.  Rates of 
depersonalisation symptoms ranged between 33-100% and threshold for depersonalisation 
disorder was met in 3.5-54% of participants.  When present, depersonalisation symptoms were 
associated with more severe depression, anxiety and some psychotic symptomatology.  Studies 
included were at some risk of bias, particularly in sample selection and measurement of 
depersonalisation. While, further rigorous assessment of depersonalisation symptoms in the 
context of psychosis is required to address methodological concerns, these studies suggest that 
depersonalisation is present in those with psychotic symptoms and may represent a useful 
target for intervention.  
  




Dissociation is defined as ‘a disruption of and/or discontinuity in the normal integration of 
consciousness, memory, identity, emotion, perception, body representation, motor control and 
behaviour’ [1].  Defined in this way, dissociation is a broad term that incorporates a range of 
phenomena including normal, everyday experiences such as absorption and divided attention, 
more pathological symptoms such as depersonalisation and amnesia, to levels of impairment 
seen in diagnostic categories of Dissociative Amnesia and Depersonalisation Disorder (DPD).  
Using one term to cover such diverse phenomena has led to significant conceptual confusion 
and a lack of specificity in measurement [2-4] , leading several authors to distinguish two 
distinct forms of dissociation – detachment and compartmentalisation [2, 5].   
Compartmentalisation may be defined as: 
‘a deficit in the ability to deliberately control processes or actions that would normally be 
amenable to such control… the functions that are no longer amenable to deliberate 
control and the information associated with them are said to be ‘compartmentalised’’ [5], 
p5.  
In contrast, detachment may be defined as: 
‘a sense of separation (or ‘detachment’) from certain aspects of everyday experience, be it 
their body (as in out-of-body experiences), their sense of self (as in depersonalisation) or 
the external world (as in derealisation) [5], p5. 
Depersonalisation1 symptoms typify such detachment phenomena. The defining feature of 
depersonalisation symptoms is a sense of profound unreality. In contrast to 
compartmentalisation experiences, individuals who experience depersonalisation symptoms are 
‘present’ but experiencing a given situation as if from a distance.  Individuals may describe 
feeling as if they were living in a dream-like state or as if they were behind a glass wall [6]. 
Individuals may also experience emotional (both positive and negative affect) or physical 
numbing, cognitive disturbance (e.g., impaired memory and concentration, mind ‘emptiness’) or 
                                                          
1 Recently, the term ‘depersonalisation’ has been adopted as an umbrella term to cover symptoms of 
derealisation as evidence suggests a lack of clear distinction between the two [4]. As such, for purposes of 
simplicity ‘depersonalisation’ will be used to describe both depersonalisation and derealisation 
phenomena for the remainder of this paper. 
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physiological/perceptual disturbances (e.g., feelings of weightlessness, lack of sense of physical 
boundaries, watching themselves from a distance, loss of recognition of reflection and/or their 
own voice) [7, 6].   
Transient symptoms of depersonalisation are common in the general population [2] and may 
have an adaptive function [8, 7, 9]. However, for approximately 2% of the general population [2] 
the experiences are more persistent, frequent and associated with intense distress and 
functional impairment i.e., Depersonalisation Disorder (DPD).  While there are similarities (see 
below), depersonalisation symptoms are considered distinct from psychotic symptoms as the 
individual recognises that the experiences are not reality, rather they are able to acknowledge 
them as a subjective experience [2]. Indeed, current diagnostic protocols prohibit the diagnosis 
of DPD in the context of other psychiatric disorders, including psychotic conditions [1].  
 
Depersonalisation and psychosis  
Psychosis is a generic term used to describe symptoms or experiences where the individual 
experiences a distortion of reality, such as in the experience of hallucinations and/or delusions.  
Other psychotic symptoms include: negative symptoms such as affective flattening and a lack of 
motivation, cognitive and speech disturbances, and in some cases physical symptoms such as 
catatonia. Diagnoses that fall under the psychosis umbrella include Schizophrenia, Delusional 
Disorder and Schizoaffective Disorder [1]. A disturbance in the sense of self and one’s place in 
the world is central to phenomenological accounts of psychotic symptoms [10] and as such, 
there is a conceptual link to symptoms of depersonalisation [11, 12]. Indeed the discussion of 
the theoretical and conceptual association between depersonalisation, dissociation more 
broadly, and psychosis has a long history [13, 14].  For example, many have speculated as to 
whether auditory hallucinations are better conceptualised as dissociative or psychotic, as the 
individual experiencing hallucinations is experiencing some level of detachment from the 
outside world.  This idea has gained momentum amongst those studying the link between 
trauma and psychosis [15-17], where dissociation or depersonalisation is proposed as a 
psychological defence that protects the individual from extreme distress, while undermining 
their connection with the outside world and therefore impairing reality testing [18, 13].  
There are several such theories linking depersonalisation and psychosis.  Two extreme positions 
would propose that each symptom is a manifestation of the other.  For example, the most 
dominant theory, aligned with common diagnostic algorithms, would propose that 
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depersonalisation in the context of psychosis is merely a manifestation of the psychotic 
condition.  For example, some suggest that depersonalisation is part of the prodromal phase of 
schizophrenia spectrum conditions [19, 12]. Similarly, others assert that depersonalisation and 
psychotic symptoms are degrees of the same phenomenon, where a delusional interpretation 
of the depersonalisation experience is representative of a more profound disturbance [20].  At 
the other extreme, and as discussed above, some suggest that psychotic phenomenology are in 
fact dissociated aspects of the self and experience [21, 22, 13, 14].  
Alternative theories would fall somewhere in the middle of these two extreme positions. One 
view is that the two symptom clusters may simply co-exist as comorbid conditions [4].  Another 
related view is that they may be aetiologically linked. For example, there are clear overlaps 
between the cognitive models of depersonalisation and positive symptoms of psychosis [23, 6, 
24]. Both models emphasise risk and/or maintenance factors of trauma and heightened 
emotion and the role of negative and disturbing appraisals of experience [25, 26].  In this 
context, one way of explaining the link between the two is to consider depersonalisation as an 
‘anomalous’ experience in the development and maintenance of positive symptoms of 
psychosis (see Chapter 2 in this volume for a more detailed discussion).  Likewise, as discussed 
above, depersonalisation may be a cognitive process that undermines an individual’s contact 
with reality, thus conferring vulnerability to psychosis [18, 13].   
With the dominance of diagnostic approaches to psychiatric disorders, depersonalisation has 
been subsumed under the psychotic disorder. However, if one considers the possibility of 
depersonalisation symptoms as comorbid or aetiologically relevant in the 
maintenance/development of psychosis, it may be a useful and salient target for intervention 
[27]. In this context it is important to understand the prevalence of depersonalisation 
symptoms in those diagnosed with psychotic disorders.  
 
Prevalence of depersonalisation in psychosis 
There have been two relevant reviews of the literature.  In 2002, Hunter and colleagues [2] 
reviewed evidence for prevalence of depersonalisation symptoms in student, community and 
psychiatric samples.  Studies of transient symptoms of depersonalisation in student samples 
suggest lifetime prevalence rates of 26-70%, and 12 month prevalence of 46-70%.  Four large 
scale studies using standardised diagnostic criteria in the UK, USA and Canada suggest 
prevalence rates of DPD in approximately 2% in the general community, rising to approximately 
80% in those diagnosed with panic disorder. However, only three studies were identified that 
examined rates of DPD in psychosis. These studies suggested that rates of DPD appeared to be 
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affected by the severity or acuteness of presentation with higher rates amongst inpatients 
(36%) than outpatients (6.9%).  The review highlighted the limitations of the literature at the 
time, since many studies used non-standardised measures of depersonalisation or generalised 
measures of dissociation (i.e., the Dissociative Experiences Scale (DES) [3]) that do not 
distinguish between normative, detachment and compartmentalisation forms of dissociation.  
 
More recently, a review of dissociation and voice hearing found 31 studies published between 
1986 and 2014 [28]. The narrative review of the studies pointed to a positive relationship 
between dissociation and voice hearing and meta-analysis of 19 studies suggested a ‘robust’ 
effect size. Secondary analyses of different types of dissociation suggested depersonalisation 
has a significant and large effect.  However, the authors conceded that they did not aim to 
compare different types of dissociative experiences and suggest further investigations are 
needed in this area.  Additionally, the review did not include studies of other psychotic 
phenomena such as delusions.   
 
In this context, this review aimed to address the prevalence of depersonalisation symptoms and 
disorder in psychosis more generally.  The primary aim was to establish the prevalence of a) 
depersonalisation symptoms and b) Depersonalisation Disorder (DPD) amongst those with 
diagnosis of a psychotic disorder.  A secondary aim was to establish the association of 
depersonalisation and psychopathology (anxiety, depression, psychotic symptoms (i.e., 




1.3.1. Search strategy 
 
PsycINFO, OVID Medline and Web of Science databases were searched on 27 January 2015 and 
updated 2 January 2016.  Search terms for psychosis (Psychosis OR Schizop* OR hallucin* OR 
delus*) were combined with search terms for depersonalisation (Depersonalisation OR 
Depersonalization OR “Deperson* Disorder” OR Derealisation OR Derealization OR DPD OR 
Detachment) with an AND command. 
 
The reference lists of review papers were reviewed and key researchers in this area were 
contacted to find any other sources of information or unpublished research.  A citation search 
of key papers including [2] and [3] was conducted in January 2016.  
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1.3.2. Inclusion / exclusion criteria for studies  
 
Any type of study design (excluding case studies) that provided quantitative, published data on 
depersonalisation symptoms amongst adults with a psychosis (ICD/DSM criteria) diagnosis were 
included.  
Exclusion criteria for papers were as follows: 
- Studies examining ‘dissociation’ generally but did not publish or provide data on 
depersonalisation  
- Qualitative studies, case studies, and/or review papers  
- Studies where the main measure of depersonalisation was not a validated, standardised 
measure (e.g., Dissociative Experiences Scale (DES, [29, 30]) or Cambridge 
Depersonalisation Scale (CDS)) 
- Studies where the majority of participants were under 18 years of age (e.g., adolescent 
and child samples). 
If mixed diagnoses were present, authors were contacted to determine if they had raw data for 
just the psychosis sub-sample, if not, these studies were excluded. 
 
As the number of studies was expected to be low, studies were not excluded on basis of a poor 
quality assessment, rather, it was decided to provide commentary on how issues of quality may 
affect the interpretation of results.  
 
1.3.3. Selection process 
Papers from all three database searches were combined in Endnote and an automated 
duplicates search was conducted and duplicates removed.  The selection of papers was 
conducted over three main stages: 
- titles of papers were scanned for clearly irrelevant studies  
- abstracts were reviewed to exclude any further clearly irrelevant studies  
- the full paper of remaining studies were independently reviewed by two reviewers (SF 
and MA). Discrepancies between the two reviewers were discussed and resolved 
through discussion.   
 
1.3.4. Data extraction and analysis 
 
Data was extracted using a standardised form to capture a) aspects of the design that may 
influence interpretation of the results b) data on depersonalisation symptoms and DPD, and c) 
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any additional published data on the relationship of depersonalisation to distress or 
psychopathology.   
 
Depersonalisation Disorder (DPD) was considered present if indicated by one of two methods: 
the use of a diagnostic interview; and in studies that used the Cambridge Depersonalisation 
Scale (CDS, [3]) scores of greater than 70 were considered indicative of disorder. Other 
measures do not have an established clinical cut-off [2, 29-31] and so were not considered 
indicative of DPD but used for indications of depersonalisation symptom prevalence and 
intensity.  
 
Authors of studies were contacted at this stage to provide any additional data (e.g., for numbers 
of participants who scored over a diagnostic threshold or data specific to those with a psychotic 
diagnosis). 
 
1.3.5. Assessment of quality 
Several standardised tools are available to assess the quality of studies included in systematic 
reviews of randomised controlled trials; however, few have been developed to assess 
observational studies, and fewer still have been specifically designed with incidence or 
prevalence questions in mind [32].   The STROBE guidelines [33] are the most widely used and 
recommended [34] for observational studies. However, they were designed to improve the 
reporting of observational studies, and as such they are not a specific measure of quality [32]. 
 
In a review of quality assessment tools [32] five tools were identified that had been designed 
with prevalence/incidence studies in mind.  Based on their review of these studies, Shamliyan 
and colleagues did not recommend the use of any of the tools and subsequently designed and 
tested their own tool [35].  This tool specifically addresses issues of external and internal validity 
that are of particular relevance to questions of the current review.  However, it was anticipated 
that many studies included in the current review may not be specifically designed to assess 
prevalence/incidence but other clinical questions of interest. In this context, the Shamliyan tool 
[35] was adapted to remove aspects that would unfairly judge non-epidemiological papers (e.g., 
general population based sampling), to simplify scoring and to include other aspects deemed 
relevant from other measures [36, 33] such as the appropriateness of the design to the research 
question or hypotheses and description of study sample size. The final tool is shown in Appendix 
A with the original source of each item noted.  There are 14 items scored on a 0-2 scale with 
larger scores indicating greater quality (scores greater than 20 = high, 10-19 
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=acceptable/moderate, 0-9=unacceptable/poor) and less potential bias. Using the tool, all 
studies were independently rated by two reviewers (SF and MA).  Intra-class correlation 







The search process identified 1,211 potential studies, of which 16 were included in the review 
(see Figure 1). Agreement on the inclusion or exclusion of papers before discussion was 84%, all 
discrepancies were resolved after discussion. 
 
1.4.1. Study characteristics 
The 16 studies included 804 participants with psychosis (see Table 1 for a summary of their 
methodology).  The study samples were predominately male (average of 59%) and with an 
average age of 33 years.  Four studies recruited participants from community settings, two 
studies recruited from inpatient settings, four studies recruited from a mixture of inpatient and 
community settings and six did not specify or were unclear.  The studies were situated in 
various countries: one from Turkey, one from South Africa, two from UK, two from Italy, three 
from Germany and seven from Spain.   
 
All studies except one were cross-sectional. Most studies were explorative in nature and were 
designed to establish the intensity of dissociation/depersonalisation, examine and test the 
psychometric properties of measures of depersonalisation/dissociation, or to examine 
depersonalisation as a correlate or mediator of other variables.  Only one study had amongst its 
stated aims to assess prevalence of depersonalisation symptoms or disorder in psychosis. 
 
In terms of the measurement of depersonalisation, four different measures were found 
amongst the studies. Eight studies used the Cambridge Depersonalisation Scale (CDS [3]). The 
CDS [3] is a 29 item scale that measures the severity of trait depersonalisation symptoms over 
the preceding six months.  For each item, frequency (likert scale 0=never to 4=all the time) and 
duration (likert scale 1=few seconds to 6=more than a week) are collected; each item maximum 
is therefore 10. A total scale score is the sum of each item, with a maximum of 290.  Scores 
greater than 70 have been shown to reliably predict clinical diagnosis of DPD using DSM criteria.  
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Eleven studies used the Dissociative Experiences Scale (DES or DES-II, [29, 30]). The DES [30, 29] 
is a 28 item scale that measures the severity of trait dissociation symptoms across the lifespan. 
Items are rated on a scale of 0% to 100% and capture the extent of time that the individual 
experiences the dissociative symptom.  A total score is determined by calculating the average 
across the items (i.e., add all item scores and divide by 28). Analyses show good internal and 
test-retest reliability [29]. Three subscales absorption, amnesia and depersonalisation can be 
generated.  The Depersonalisation subscale is comprised of six items.  
 
Two studies used a state based measure (State Scale of Dissociation (SSD), [37]).  The SSD has 
56 items scored on a nine-point likert scale (from ‘not at all’ to ‘very much so’) capturing the 
extent to which respondents are experiencing the symptom at the time of completion of the 
measure.  Total score and subscale scores are calculated by the mean of items.  The 
Depersonalisation Subscale is comprised of eight items. Other subscales include identity 
alteration and amnesia.   
 
One study used the Dissociative Disorders Interview Schedule (DDIS [38]) which is a structured 
interview covering 131 items designed to establish the presence of dissociative disorders 
according to DSM criteria.  In addition two studies used DSM-IV criteria to establish the 
presence of DPD.   
 
  



































Figure 1: Summary of search process 
  
Potentially relevant citations identified after liberal 
screening of electronic databases, internet, reference 
checks (n= 1211) 
Irrelevant Citations excluded (n=1061) 
Studies excluded after evaluation of full text with 
reasons (n= 134) 
 
- Not psychosis (n=24) 
- Not DP/DR/Dissociation (n=25) 
- Non-clinical measure of psychosis (n=2) 
- Non standardized/validated measure of DP (n=32) 
- Dissociation only – not DP/DR (n=10) 
- Review/opinion (n=14) 
- Case study (n=6) 
- Duplicate (n=4) 
- Children (n=5) 
- Cannot find paper/conference abstract only (n=9) 
- Further data not available (n-=3) 
Relevant studies included in systematic review (n= 16) 
Studies retrieved for more detailed evaluation (n= 150) 
17 | P a g e  
 






Clinical setting & 





Psychosis DP Scores 
Proportion 




threshold for DPD 
Psychopathology 














Intensity: to investigate the 
occurrence of dissociative 
symptoms in patients with 
a schizophrenic disorder 
26 patients with 
schizophrenia 
spectrum disorder 
and 26 with BPD 
and 1056 healthy 
controls.  DES 
ICD-10; 
psychiatrist 
& 2 clinical 
supervisors 
DES mean: 1.40 
(SD=1.06) 
DES DP mean = 













Prevalence: To assess the 
presence of 
depersonalisation in 
patients with persecutory 
delusions and examine 
associations with levels of 
paranoia and worry 













19.8 - 50.5. 
Mean score as 
percent of 
maximum = 
31.7 47 (94%) 
Uncertain as not full 
scale 60% experienced 
10 symptoms regularly.  
BAI (r=0.51, p<0.01), 
PANSS Hallucinations 
(r=0.26, 0.07); PANSS 
positive (r=0.19, 
p=0.20); PANSS total 





and outpatients of 
psychiatric 







in Rome and 
Naples between 




Measures - factor analysis 
of Italian CDS 
47 schizophrenia; 67 
depression; 35 
anxiety CDS DSM-IV TR 
CDS: mean 
72.10 (SD= 
43.89) * 100%   * 23/47 = 48.9%   
BAI mean (17.34 (SD: 
11.74); PANSS-Positive 




mean 43.59 (SD: 
13.37); PANSS total 
mean 88.63 (SD: 
22.83); BDI mean 
22.38 (SD 12.71)  15 
  






Clinical setting & 





Psychosis DP Scores 
Proportion 





















then approach first 
degree relatives.  
Controls recruited 
from hospital flyers 
cross-
sectional 
Intensity & Prevalence:  to 
examine depersonalisation 
in schizophrenia spectrum, 











CDS: Mean frequency 
score 13 (IQR = 8-
20.3); Mean Duration 
score = 21 (IQR = 12-
36); Mean total  33 
(IQR= 20-60);  
Number of items with 
positive response = 10 
(IQR = 6-15) not reported 
21/174 = 
17% 
median and IQR 
PANSS scores - 
positive 13 (10-16); 
PANSS negative (14 
(10-18); PANSS 
general 27 (22-31); 
PANSS total score 53 
(44-63). No 












sampling 50 adult 
psychiatric patient 
with a history of 




Other: to explore 
concurrent associations 
between quantified 
dissociative states and 
quantitative 
electroencepholography 
parameters in psychiatric 
patients  
12 (24%) psychotic 
disorder; 18 (36%) 
dissociative/convers
ion disorders; 20 
(40%) mood and 
other disorders DES, SSD unclear 
* DES mean = 13.38 
(SD=6.69); DES-DP 
mean= 8.33 (SD=7.14) 
Correlate between 
SSD depersonalisation 
and DES total score 
r=0.730, p<0.01 
SSD mean = 0.68 
(SD=1.22); SSD - DP 




























Measures - Psychometric 
testing of SSD 
N=130 (67 patients 





Episode; 20 alcohol 
withdrawal. DES, SSD DSM-IV 
* DES mean =20.79 
(SD=20.02); DES-DP 
mean= 21.11 (SD= 
25.47).  
SSD mean =2.10 (SD = 
1.83); SSD-DP mean 








(77.8%) not reported not reported  14 
  





Clinical setting & 
recruitment Design 
Aims/Research 
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in two samples 
with psychotic 
disorders 
20 First episode 
schizophrenia and 
28 with multiple 
episodes of 
schizophrenia CDS, DES DSM-IV TR 
Total sample: CDS mean: 
= 40.58 (SD = 32.7);  
DES total = 22.01 (16.48) 
DES DP= 14.64 (SD = 
13.12) 
First episode: CDS mean: 
= 61.3 (SD=30.89);  
DES = 2.81 (14.24) 
DES DP= 21.0 (SD = 12.6) 
Multiple episode: CDS 
mean: = 25.53 
(SD=24.83);  
DES = 21.44 (18.41) 







24/28 (85.7%)  
* First episode 
= 8/20 (40%) 
Multiple 
episode =  
1/28 (3.5%) 
Total sample: PANSS 




First episode: PANSS 
positive = 22.25 
(SD=6.08); PANSS 
negative = 10.9 
(SD=4.71). 
Multiple episode: 
PANSS positive = 
24.0 (SD=7.82); 
PANSS negative = 
20.25 (SD=9.78). 16 
Migliorini et 






in two Italian 
regions. Recruitment 
92 in and 
outpatients referred 
to psychiatric 
services from within 
catchment area of 
500 000 in Rome 
between June 2010 
and July 2011 
cross 
sectional 
Measures - adapt 
and validate the 
Italian version of 
the CDS  
31 schizophrenia; 42 
Depressive disorder; 
19 anxiety disorder 
Criterion 
A and B 
DSM-IV 
TR; CDS 
and DES DSM-IV TR 
CDS mean = 80.45 (SD = 
42.35) 
DES mean= 23.11 (SD = 
16.30); DES - DP mean 
score = 27.19 (SD = 
18.95); DES Taxon = 










mean, SD, spearman 
correlation with CDS 
total: PANSS 
Positive 18.22 (SD 
6.51) r=0.21 (NS), 
PANSS Negative 
r=0.28 (NS), PANSS 
total score 88.96 
(SD 19.87) r 0.34, 
p<0.001, BDI 24.29 
(SD 13.14), r=0.51, 




Castillo et al, 
2006 [45].  
Spain 
Setting not specified: 
Patients from local 
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Spanish version of 
the CDS  








CDS mean = 43.16 (SD = 
37), median = 35; 
DES mean = 21.73 (SD = 
20), median = 16.6; DES-
DP = 18.37 (SD = 24), 







criteria.   
BDI mean: 12.32 (SD 
9), median 10; 
Hamilton anxiety 
scale mean 10.66 
(SD 6), median 10 18 
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no active symptoms 
for one year; 22 
patients with other 
clinical disorders 
(anxiety and mood); 
27 non-clinical 




delusions = 72.15 (95%CI 
56.62-87.67); 
Schizophrenia with 
delusions but no 
hallucinations: = 28.9 
(95%CI 17.5-40.30); 
patients diagnosed with 
schizophrenia but no 
active symptoms for one 
year = 18.36 (95%CI 
11.55-25.16) 




delusions but no 
hallucinations: 100%; 
patients diagnosed 
with schizophrenia but 
no active symptoms 
for one year: 89%. 















but no active 
symptoms for 
one year: 1/28 





predictor of PANSS 
hallucinations (Beta 
- 0.674, p=0.000) 16 
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Intensity: To study 
dissociative experiences 
and self-focussed attention 
by comparing patients with 
psychoses who suffer from 
auditory hallucinations, 
those who have recovered 
from auditory 
hallucinations, patients 
with psychosis but not 
auditory hallucinations and 
normal subjects 
68 participants: 17 
with active 
hallucinations; 16 
had hallucinations in 
the past; 18 
diagnosed with 
schizophrenia 




participants DES-II DSM-IV 
DES mean: 
active hallucinations = 
27.50;  
past hallucinations = 14.65  
no history of hallucinations 
= 9.19 
DES-DP mean: 
active hallucinations = 
36.24;  
past hallucinations = 6.45;  
no history of hallucinations 
= 1.75. 





33% of no 
history of 
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hallucinations (R 
















Other: to study the 
relationship between 
reported traumatic 
experiences in childhood 
and positive psychotic 
symptoms (with 
dissociative symptoms as a 
mediator). 




delusional disorder DES-II DSM-IV TR 
DES mean = 18.70 (SD = 
13.34) 
DES-DP mean = 18.09 (SD = 





















diagnosis.  178 
(63%) agreed to 
participate, after 
withdrawals the 














relationship of dissociation, 
childhood trauma and 
psychotic symptoms at 










German ICD-10  
DES mean T0= 19.2 
(SD=15), T1 = 14.1 
(SD=12.0); 
DES-DP mean at T0=18.1 
(SD=18.3); T1 = 13.3 
(SD=14.6);  
DES-Taxon T0 =15.1 
(SD=15.0), T1= 11.1 





predictor of DES at 
admission (F=3.66, 
p=0.17).  At T1 
sexual abuse was 
the best predictor of 
DES 17 
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associated with DP 
Quality 
Rating 








Other: Is there any 
relationship between the 
extent of dissociation and 
the predominant syndrome 
type of schizophrenia?  







DES mean = 
15.81 
(SD=10.55);  
DES-DP = 14.71 









r=-0.415, p< 0.01;  11 






of hospital, or 
neurology 




a 3 month study 




Intensity & correlates: to 
determine the clinical 
differences between 
dissociative identity 
disorder and comparison 
groups including 
schizophrenia 
20 with DID, 20 with 
panic disorder, 20 
with schizophrenia 







and DES DSM-IV 
DES mean = 15.6 
(SD =2.7) not reported 1 (5%) not collected 16 
 
Notes  
- where mixed samples with other clinical disorders, data presented is just for the schizophrenia spectrum group unless otherwise noted.  
* unpublished data received from author 
 
Abbreviations:  
BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; CDS: Cambridge Depersonalisation Scale; CI: confidence interval; DES: Dissociative Experiences Scale; DP: depersonalisation; DSM-IV: Diagnostic and Statistical 
Manual 4th edition; DID: Dissociative Identity Disorder; ICD-10: International Classification of Disease; IQR: inter-quartile range; PANSS: Positive and Negative Symptom Scale for Schizophrenia; r: correlational coefficient; R: R2 
Coefficient of Determination; SD: standard deviation; SSD State Scale of Dissociation;T0: Baseline; T1: time-point 1.  
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1.4.2. Quality of studies 
 
All studies were deemed to have used appropriate designs for their research questions. 
However, as the aims of this review were to address prevalence of depersonalisation in 
psychosis, studies were assessed according to criteria that provide estimates of the external and 
internal validity of data. With this caveat in mind, no studies were considered ‘high quality’ 
(greater than 20 – see Table 1 for total scores), but all studies were in the moderate or 
acceptable range, with some risk of poor generalisability and measurement error.  The ICC of 
0.907 indicated a high level of agreement between quality raters. 
 
Several studies [39, 43, 16, 46, 17, 47, 49] did not report the method of sampling used and all 
others [20, 40-42, 37, 44, 45, 48, 50] used convenience sampling. Two studies [43, 49] did not 
report their sampling frame, one study [41] attempted to recruit from the population of 
individuals with psychosis in the area and the remaining studies [20, 39, 40, 42, 37, 44, 45, 16, 
46, 17, 47, 48, 50] used local clinics lists or registers.  Likewise, few studies [43, 16, 17, 48] 
specifically recruited for or analysed different aspects of psychosis (either stage of illness or 
type or severity of psychotic symptoms). In this context, many of the studies have the possibility 
of selection biases.   Several studies [20, 39, 40, 42, 45, 16, 46, 17, 47, 48, 43] discussed the 
potential impact of such sampling and selection biases in their interpretation of the results but 
only one [20] adjusted for such issues in the analysis. Further, only two studies [48, 50] reported 
how they arrived at their final sample, both in terms of sample size determination and 
recruitment data such as the number of people who did not consent to be part of the research.  
In summary, all studies were deemed at risk of some bias.  
 
Ratings that addressed the internal validity of studies were fairly consistent across the studies.  
Nine of the sixteen studies [20, 39, 41, 44, 45, 16, 17, 47, 48, 43] confirmed the diagnosis of 
psychosis via interview with a clinician.  Similarly, all studies used a standardized and validated 
measure of depersonalisation and all except one [40] reported the depersonalisation data in a 
standardised manner. However, only three studies [44, 45, 50] confirmed participants’ self-
report of depersonalisation at a clinical interview, thus introducing the possibility of 
measurement error; particularly as items addressing depersonalisation experiences have been 
reported as particularly difficult for individuals with a psychosis diagnosis to interpret [48].  
 
In summary, the studies were deemed to be of moderate quality in addressing the question of 
prevalence of depersonalisation in psychosis. The main issues were the potential lack of 
generalisability of the samples and a lack of oversight in the assessment of depersonalisation.  
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1.4.3. Rates of depersonalisation symptoms in psychosis 
 
Ten studies provided data on the proportion of the sample who reported at least one symptom 
of depersonalisation.  The lowest percentage was found in a cross-sectional study of community 
outpatients with and without active hallucinations [17]. In this study, 33% of the participants 
who had an active diagnosis of a schizophrenia spectrum disorder but who had never 
experienced hallucinations reported at least one symptom of depersonalisation on the DES-DP 
subscale.  By contrast, 43% of participants with a past history of hallucinations and 100% of 
those with current hallucinations reported at least one depersonalisation symptom.  
Interestingly, a study by the same research group [47] using the CDS found that at least 89% of 
the sample reported at least one symptom of depersonalisation even amongst participants who 
had not experienced active symptoms of psychosis for at least one year.   
 
Four other studies [42, 41, 40, 43] reported that over 90% of their sample positively endorsed at 
least one symptom of depersonalisation.  None of these four studies distinguished rates of 
depersonalisation between active and remitted psychotic symptoms. Three of these studies 
used the CDS [41, 40, 43] and one the DES [42]. In two further studies that used the DES [16, 37] 
and one that used the CDS [44], between 60 and 70% of the sample reported at least one 
depersonalisation symptom.   
 
Two studies [40, 20] reported the average number of positively endorsed items on the CDS. In 
their study of inpatients and first-degree relatives, Gonzales-Torres and colleagues [20] 
reported that inpatients endorsed, on average, 10 items or symptoms of depersonalisation.  
Similarly Cernis and colleagues [40] reported that 60% of their sample reported experiencing at 
least 10 symptoms of depersonalisation regularly. 
 
Interestingly, two studies reported data on both a state based measure of depersonalisation 
(SSD-DP), and a trait based measure (CDS) and found some variation, suggesting that the 
experience of depersonalisation may not be constant. For example, Krueger and colleagues [42] 
found that 91.7% of participants from an academic hospital rated at least one symptom on the 
CDS compared to 58.3% on the state based measure - the SSD-DP.  Similarly, in an earlier study 
the same research group [37] found that amongst their mixed sample of inpatients and 
outpatients, 66% reported at least one symptom on the DES-DP compared to 78% on the state 
based measure – the SSD-DP. 
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In summary, the majority of studies found that over 60% of individuals with a diagnosis of a 
psychotic condition will report at least one symptom of depersonalisation. Additionally, in those 
who do experience depersonalisation, the majority experience multiple symptoms.  There is 
some suggestion from studies comparing state and trait measures of depersonalisation that 
experience of depersonalisation symptoms varies and is not constant within individuals.   
 
1.4.4. Intensity of depersonalisation symptoms in psychosis 
 
All 16 studies provided an indication of the intensity of depersonalisation.  Tables 2.1 and 2.2 
provide summary data from studies that used the CDS and DES respectively.  In studies that 
reported CDS data, mean scores ranged from 18.36 amongst participants with remitted 
psychotic symptoms to 80.45 amongst a mixed sample of inpatients and outpatients. Three 
studies [47, 44, 41] reported average scores amongst the sample that were above the clinical 
cut-off threshold for DPD (i.e., greater than 70).   
 
Table 2.1 Studies of intensity of depersonalisation using the CDS 
 
First author Frequency Duration Total 
Cernis 36.8 -  -  
Fagioli   72.10 
Gonzales 13 21 33 
Luque-Luque     -Total sample   40.6 
                            - First Episode   61.3 
                            - Multiple Episodes   25.5 
Migliorini   80.5 
Molina   43.2 
Perona-Garcelan 2011   53.9 
Perona-Garcelan 2012a – SCZ: AH & DELs   72.1 
                                           - SCZ: DELs, no AH   28.9 
                                           - SCZ in remission   18.4 
Notes: 
SCZ: schizophrenia; AH: auditory hallucinations; DELs: delusions 
 
Studies that used the DES reported total scores of between 1.1 and 23, which would be 
considered ‘low’ dissociation (scores higher than 30 are considered ‘high dissociation’ [29]).  
The scores on the DP subscale ranged from 0.99 amongst ‘remitted patients’ to 27.19.  Only one 
study measured depersonalisation at two time points.  Schafer and colleagues [48] measured 
depersonalisation using the DES at admission to an inpatient facility and then when considered 
‘stabilised’.  They found that scores on the DES-DP subscale and DES-total score dropped once 
psychotic symptoms had stabilised.  
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Table 2.2 Studies of intensity of depersonalisation using the DES 
 
First author DES-DP DES Total 
Brunner 0.99 1.14 
Krueger 2013 8.33 13.38 
Krueger 2002 21.11 20.70 
Luque-Luque                   - Total sample 14.64 22.01 
                                           - First Episode  21.0 2.81 
                                           - Multiple Episodes 10.1 21.44 
Migliorini 27.19 23.11 
Molina Costillo 18.37 21.73 
Perona-Garcelan 2008 - SCZ active hallucinations 36.24  
                                         - SCZ past hallucinations 6.45  
                                         - SCZ no hallucinations 1.75  
Perona-Garcelan 2012b 18.09  




Spritzer 14.71 15.81 
Yargic  15.6 
Notes:  
** T0: Time 0 - baseline/admission to inpatient facility; T1: Time 1 -  symptom stabilisation 
 
In summary, intensity of depersonalisation symptoms in psychosis may to vary according to the 
nature of psychotic symptoms.  Furthermore, studies using the DES report dissociation in the 
low range. There is no established characterisation of DES-DP or CDS scores, however, several 
studies reported CDS mean scores above the clinical cut-off.  These findings suggest different 
sensitivity amongst these two most frequently used measures of depersonalisation. 
 
 
1.4.5. Rates of DPD in psychosis 
 
Of the 16 included studies, 7 (44%) provided an estimate of the number of participants who met 
criteria for DPD.  For the studies that did not provide an estimate, eight studies used either the 
DES or other measures with no established cut-off for likely DPD and one study [40] did not use 
the full CDS and therefore could not provide an estimate of those exceeding the total score of 
70. Two studies [45, 46] used the CDS but did not report those exceeding the threshold and did 
not have this data available.  
 
Two studies [44, 45] used DSM-IV interview schedules and found that no participant also met 
the criteria for DPD, however this is because the DSM states that DPD cannot be diagnosed in 
the context of another disorder such as a psychotic disorder.  One other study [50] using the 
Dissociative Disorder Interview Schedule (DDIS) found 1/20 participant (5%) met criteria for 
DPD. 
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For the eight studies that used the CDS, five provided estimates of those meeting clinical cutoff 
for DPD (i.e., scoring higher than 70 on the CDS).  Rates of DPD in these studies varied from 
3.5% to 54%.  The five studies were based in Spain and Italy and used a mixture of inpatient and 
outpatient participants. The two Italian studies [44, 41] were designed to test aspects of the 
psychometric properties of the CDS. Both studies used similar methodology and a mixture of 
inpatient and outpatients, and reported rates of 49% [41] and 54% [44].  The three Spanish 
studies had quite different methodologies and aims.  One study [43] examined the differences 
in depersonalisation in a sample of inpatients once stabilised, and distinguished between those 
that were presenting with a first episode of psychosis compared to those with multiple 
episodes.  The rates of DPD were higher amongst the first episode sample (40%) compared to 
those with multiple episodes (3.5%). Another Spanish study [20] examined rates of 
depersonalisation in an inpatient sample once stabilised.  They found that 17% of participants 
scored over 70 on the CDS.  The third Spanish study [47] examined depersonalisation in a 
sample of outpatients diagnosed with a psychotic disorder with various symptom profiles.  
Overall, 23% scored over the 70 threshold on the CDS, however there were marked differences 
in the percentage who scored above the cut-off according to their symptom profile. The 
number scoring above cut-off were as follows: 3.5% of patients with a psychosis diagnosis who 
were considered to be in remission; 10% of those with current experience of delusions but no 
hallucinations; and 52% of those with current hallucinations and delusions.  
 
In summary, between 3.5% and 54% of those with a diagnosis of a psychotic disorder may meet 
threshold for DPD.  The prevalence of DPD appears to be related to both the stage of illness 
(i.e., first episode compared to more established disorder) and presence of active symptoms 
versus remitted psychotic symptoms.  Additionally, there may be a differential prevalence 
according to type of psychotic symptoms with higher rates of DPD amongst those experiencing 
hallucinations compared to delusions. However, as so few studies have examined these 
questions, the findings need replication.  
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1.4.6. Association with psychopathology 
 
Twelve studies provided data on the association between depersonalisation and other 
psychopathology.  
Association with depression and anxiety 
The association between depersonalisation and anxiety in psychosis was reported by four 
studies with community samples [45, 44, 41, 40]. Three studies used the Beck Anxiety Inventory 
(BAI) [51] and one used the Hamilton Anxiety Scale (from the Hamilton Anxiety and Depression 
Scales; HADS) [52].  There was a moderate correlation (ranging from r=0.37 [44] to r=0.51 [40]) 
between measures of anxiety and depersonalisation amongst those with a diagnosed psychotic 
disorder.  Levels of anxiety were in the mild (HADS = 10.66[45]) to moderate range (BAI = 19.54 
[44]).  
 
The association between depersonalisation and depression was reported by three studies [45, 
44, 41], all of which used the Beck Depression Inventory (BDI) [53, 54].  All three studies were 
explorations of the psychometric properties of the CDS amongst psychiatric outpatients and 
inpatients.  Two studies based in Italy reported moderate levels of depression amongst patients 
diagnosed with psychotic conditions who were also experiencing depersonalisation (BDI mean 
22.38 (SD 12.71) [41] and BDI mean 24.29 (SD 13.14) [44]).  One other study [45] based in Spain 
reported minimal levels of depression in their sample (BDI mean: 12.32 (SD 9).  One study [44] 
reported a moderate/strong correlation between depersonalisation and scores on the BDI 
(r=0.51, p=0.01)).  
 
Association with psychosis severity 
Eleven studies reported on the association between depersonalisation and psychosis severity.  
Two studies [47, 17] examined the extent to which depersonalisation would predict severity of 
hallucinations in multiple regression analyses.  They found that depersonalisation was, in fact, 
the only significant predictor of the hallucination score on the Positive and Negative Symptoms 
Scale (PANSS [55]) (other discarded predictors were total DES score, other subscales of DES, 
measures of self-consciousness, metacognition, and absorption).   
 
Four studies reported correlations ranging from r=0.26 (not significant) to r=0.71 (p<0.01) 
between different measures of hallucinations severity and depersonalisation. For example, in 
their study of depersonalisation in individuals with delusions, Cernis and colleagues [40] 
reported a non-significant correlation of r=0.26, between the CDS frequency score and PANSS 
29 | P a g e  
 
hallucinations.  Three other studies reported moderate to strong correlations between 
depersonalisation and hallucinations as measured by the PANSS.  Spitzer and colleagues [49] 
studied 27 German patients with positive and negative symptoms. They reported a correlation 
of 0.65 between the PANSS hallucination item and the DES-DP subscale.  Perona-Garcelan and 
colleagues [46] studied the relationship between self-focused attention, depersonalisation and 
positive symptoms amongst 59 outpatients in Spain. They reported a correlation of 0.50 
between PANSS-hallucinations and the CDS total score.  A study the following year by the same 
research group [16] examined the relationship between reported traumatic experiences in 
childhood and positive psychotic symptoms (with dissociative symptoms as a mediator) in 
community rehabilitation centre patients.  They reported a strong correlation (r=0.71) between 
PANSS-hallucinations and the DES-DP subscale.  By contrast, findings regarding the association 
between PANSS delusion item and depersonalisation were inconsistent. The Spitzer and 
colleagues’ study described above [49] found no statistically significant relationship between 
the two variables, while the two studies from the Spanish group [46, 16] found weak/moderate 
correlations.  
 
Moderate correlations (r=0.34 to r=0.57) were found between the total score on the PANSS and 
depersonalisation by two studies [44, 40].  The same two studies reported non-significant 
correlations between the PANSS-positive symptom subscale and depersonalisation. One study 
reported a non-significant correlation with a negative symptom of the PANSS and 
depersonalisation [44]. 
 
The severity of psychosis as measured by the PANSS [55] was reported by three studies [44, 41, 
20] to be in the mild to moderately ill range [56]. However, none of these studies compared the 




This systematic review aimed to establish the prevalence rates, intensity and correlates of 
depersonalisation in the context of a psychotic disorder.  Sixteen studies involving 804 
participants provided data.   
 
The first aim was to determine the prevalence of depersonalisation symptoms in those with a 
diagnosis of a psychotic disorder.  Between 33 and 100% of individuals with psychosis report at 
least one experience of depersonalisation.  It appears that higher percentages may be found in 
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those with active psychotic symptoms.  Further, there is some indication that the majority of 
those reporting depersonalisation symptoms will report 10 or more symptoms, though only two 
studies to date have reported such data and so this finding requires replication.  Intensity scores 
on measures of depersonalisation in the included studies were consistent with previous findings 
in the literature (see [29]). As with prevalence of depersonalisation symptoms, stage of illness 
and presence of active psychotic symptoms may have an effect on intensity as those in earlier 
stages of illness [43] and those with more active phase symptoms of psychosis [47] report a 
greater intensity of depersonalisation.   
 
Several studies provided data on the influence of temporal factors and other psychopathology 
on the prevalence and intensity of depersonalisation symptoms.  For example, Schafer and 
colleagues [48] suggested that the relative prevalence of depersonalisation symptoms was 
affected by mental state, with a decrease in self-reported symptoms once psychotic symptoms 
were stabilised.  Similarly, Perona-Garcelan and colleagues [16] found that prevalence of 
depersonalisation symptoms differed amongst those with active symptoms and those in 
remission. It is possible that, as some authors have suggested [48], that those with active 
symptoms of psychosis may have difficulty interpreting the content of depersonalisation 
questions due to attentional, memory and other cognitive deficits.  Additionally, there is some 
concern about conceptual overlap between measures of depersonalisation and psychotic 
symptoms, for example, the DES includes an item about hearing voices.  Considering the lack of 
clinical review of the self-reported depersonalisation symptoms, it is not possible from this 
review to determine if the high rates of depersonalisation symptoms are a result of 
measurement error, and perhaps better conceived of as an artifact of the psychotic disorder. 
However, it is also possible the link between mental state and high rates of depersonalisation 
symptoms is evidence of the aetiological relationship between the two symptoms – i.e., that 
presence of depersonalisation creates more distress leading to increased positive symptoms, 
and vice versa. This proposition requires further empirical investigation, through a 
phenomenological, longitudinal investigation of the content of the symptoms.  Interestingly, 
and notwithstanding the significant concern regarding measurement, there is emerging 
evidence that depersonalisation symptoms may exist independently to the psychosis. For 
example, in the Perona-Garcelan study mentioned above [16] a group of ‘remitted’ patients 
continued to report at least one symptom of depersonalisation despite having no active 
psychotic symptoms for at least one year [47].  This is consistent with the proposition that 
depersonalisation tends to persist [30, 48, 4] beyond the active phase of other disorders. 
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The second aim was to determine the rates of DPD.  When using strict diagnostic protocols, 
three studies found that no participants with a psychotic disorder also met criteria for DPD, but 
this was an artefact of the diagnostic rules precluding the diagnosis of DPD in the context of 
another psychiatric diagnosis. When using the symptom based measure of the CDS the rates of 
DPD ranged from 3.5% to 54%.  This high level of DPD in psychosis is a similar finding to 
previous reviews [28, 2] and suggests that rates of DPD are much higher in individuals with 
psychotic experiences than in the general population.  
 
Finally, we aimed to explore the association between depersonalisation, anxiety, depression 
and psychotic symptoms.  There was a moderate correlation between depersonalisation and 
both anxiety and depression.  Furthermore, there was a moderate correlation between 
depersonalisation and hallucinations and/or overall psychotic symptoms. In this context, it is 
safe to presume that if depersonalisation is present in the context of psychosis, there will be 
more distress and more severe symptomatology.   
 
1.5.1. Implications of findings 
 
Research implications 
The question regarding the relationship between depersonalisation and psychosis remains and 
further research is required.  Longitudinal research is required to chart the course of 
depersonalisation and psychosis in a representative sample.  For example, do depersonalisation 
symptoms attenuate when psychotic symptoms remit and/or do they persist as some authors 
have suggested [48, 30]? Stage of psychosis may also be important; for example, the finding of 
higher rates of DPD in the earlier stages of psychosis, compared to those with multiple 
episodes, requires replication.  It would be an interesting area for further research, and help to 
answer the question of measurement error, to compare the phenomenology of psychotic and 
depersonalisation symptoms within individuals at such different stages of illness.  A 
phenomenological study of both psychotic and depersonalisation experiences would also be 
interesting to disentangle the relationship between the two phenomena. For example, if 
someone is experiencing depersonalisation and psychosis, would their psychotic symptoms 
always be directly linked with the depersonalisation, for example through a delusional 
interpretation, or may they exist as two separate, comorbid symptoms?  
 
In terms of treatment protocols, typically, clinicians would target psychotic symptomatology 
and/or distress, however, it would be an interesting avenue for further research to determine if 
direct targeting of the depersonalisation led to improvements in psychotic symptoms.  Freeman 
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[27] recently called for a different approach to devising treatments in psychosis and has had 
some success in targeting potential etiological factors such as worry and sleep difficulties; 
depersonalisation as an ‘anomalous experience’ [11, 19] may be one such factor. There is 
currently limited evidence for the efficacy of treatments for depersonalisation however, 
cognitive behavioural approaches are promising [57]. Our research group is currently 
undertaking a feasibility study for brief cognitive behavioural therapy for depersonalisation in 
psychosis (see Chapter 2 in this volume). Should this prove feasible, a further avenue may be to 
compare the efficacy of treatments targeting depersonalisation and those targeting 
hallucinations/psychosis in patients who have both experiences.  
 
All studies in the review are potentially subject to measurement error as none reported they 
used a clinical interview to clarify participant responses to questionnaires assessing 
depersonalisation.  In future research, assessment of depersonalisation in psychosis should use 
standardized, self-report questionnaires only in conjunction with a clinical interview with a 
clinician familiar with both psychosis and depersonalisation, to ensure participants’ 
understanding of the items is adequate.  
 
Clinical implications 
Considering the research suggests that between 3.5 and 54% of those with active symptoms of 
psychosis may also meet criteria for DPD, clinicians should consider routine screening for 
depersonalisation in their clinics.  Formulations that ignore potentially distressing 
depersonalisation experiences may miss an opportunity for intervention. Furthermore, the 
finding that depersonalisation is positively correlated with psychotic symptoms and measures of 
distress (anxiety and depression), suggests that there may be some benefit in directly targeting 
depersonalisation, though this requires further research to determine effective treatments.   
  





Limitations of the review  
This review only looked at depersonalisation and not other forms of dissociation.  Some studies 
were excluded that looked at dissociation as a broad concept and did not specifically report on 
depersonalisation (and/or authors did not respond to requests for data if potentially available – 
e.g., through use of the DES scale).  This was an a priori decision however it is possible that 
other manifestations of dissociation in psychosis may be prominent and may influence outcome 
in psychosis. Future reviews could consider prevalence of detachment and 
compartmentalization separately to give a fuller picture of the prevalence of dissociation in 
psychosis.  Several studies were excluded due to using non-standardised and validated measure 
of depersonalisation including symptom checklists that had one or two items assessing the 
presence of depersonalisation.  This was an a priori decision to reduce or control measurement 
error as much as feasible, however, it is possible that it may have omitted relevant forms of 
depersonalisation.  
 
Limitations of the studies  
The majority of studies were not designed to measure the prevalence of depersonalisation 
symptoms and disorder in psychosis.  In this context, sampling was the main limitation of the 
studies and it is possible that such selection biases may have influenced the findings of this 
review. Further, few studies sampled or analysed participants at different stages of illness 
and/or symptom profiles. The studies that did examine these differences in their sample all 
found statistically significant differences [47, 17, 58]. In this context, studies that provided 
estimates of the sample as a whole may not be reliable.  
 
The other major limitation of the studies was the potential for measurement error in the 
depersonalisation estimates due to the lack of use of ‘gold standard’ diagnostic schedules or 
interview clarification of self-report measures. As discussed, the concepts addressed in 
depersonalisation may be difficult to understand and may be interpreted differently by different 
individuals [20, 59, 48]. Additionally, there is some conceptual overlap with psychosis is the 
items on depersonalisation scales. As stated, the DES includes an item regarding auditory 
hallucinations.  The CDS also has items that are closely aligned with positive and negative 
psychotic symptoms such as ‘my favourite activities are no longer enjoyable‘ and ‘I have the 
feeling of having no thoughts at all, so that when I speak it feels as if my words were being 
uttered by an automaton’. In their development of the DES, Carlson and Putnam [29] stipulated 
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that participants’ responses to the questions should be clarified. An additional concern is that 
each of the measures used by the studies had different time scales of interest. For example, the 
DES asks about experiences in adulthood, compared with the CDS which stipulates only 
experiences in the last six months. In this context, findings from this review must be interpreted 
with caution and further research using rigorous assessment of depersonalisation symptoms by 




Depersonalisation is common in psychosis with 3.5-54% of those with active psychotic 
symptoms meeting threshold for Depersonalisation Disorder.  When present, depersonalisation 
symptoms are associated with increased distress and more severe psychotic symptoms. Further 
research is required to disentangle the relationship between the two phenomena; however, the 
evidence from this review suggests that there is variation in both experiences that is not 
accounted for in the other. This finding is consistent with the theory that the two disorders may 
be related but are distinguishable [4, 37] and suggest the need for routine screening and the 
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Recent research suggests that depersonalisation symptoms may be prevalent in those with 
current psychosis symptoms, and, when present, these symptoms are associated with 
increased impairment. We aimed to establish if a brief, six session treatment protocol 
adapted from a Cognitive-Behavioural model of Depersonalisation Disorder was feasible to 
deliver as well as acceptable to participants who also had current psychotic symptoms.  A 
single-blind, randomised controlled trial with a treatment as usual control condition was 
used to examine our research aims.  Feasibility and acceptability estimates examined 
included rates of referral, acceptance, eligibility, consent, satisfaction and improved 
skills/knowledge to manage depersonalisation. Over a 10 month period, 21 individuals were 
recruited to the trial.  Data suggest that the intervention was feasible to deliver and highly 
acceptable to participants. Preliminary clinical data suggest decrease in mean scores of 
depersonalisation, anxiety and depression though further, appropriately powered analyses 
are required before any definitive statement can be made. Overall the data suggest that a 
larger-scale trial is warranted and recommendations for this trial are made.  
  




Psychosis is a general term covering a range of symptoms including delusions, hallucinations, 
cognitive disturbances and negative symptoms. Approximately four in 1000 people are 
diagnosed with a psychotic condition in the UK [60], with similar prevalence found in other 
countries [61], at an estimated cost of £2 billion cost to the UK National Health Service each 
year [62].  The main treatment for psychotic conditions remains medication focused, 
however, leading clinicians and academics have bemoaned the lack of progress and relative 
efficacy of these treatment protocols [63, 64].  Psychological approaches to psychosis have 
shown some benefit and are now part of national treatment guidance [65]. In such guidance, 
Cognitive Behavioural Therapy for Psychosis (CBTp), along with Family Intervention 
approaches, are the main treatments of choice.  Recent meta-analyses of CBTp suggest a 
small effect size [66], however, there has been impassioned debate as to how to measure 
the impact of CBTp [67, 68].  One particular concern is whether as an overall reduction on 
measures of positive symptoms should be the focus, or whether distress or other factors 
would be more appropriate target of treatment [68].  Notwithstanding this debate, there is 
some consensus further work is needed in understanding the components of interventions 
that will achieve the best outcomes for individuals diagnosed with psychotic conditions. 
  
One approach, the ‘causal-interventionalist’ [69], has been proposed to improve the impact 
of CBTp by focusing on the factors and processes associated with the aetiology and 
maintenance of psychotic symptoms.  The approach is based on cognitive models of 
psychosis [70, 71] which propose that in predisposed individuals, stressful events can lead to 
cognitive dysfunction and anomalous experiences. However, unlike general stress-
vulnerability models, cognitive models further specify that it is the maladaptive appraisal of 
such experiences, influenced by heightened emotion and cognitive biases and processes that 
are influential in the development of distressing positive psychotic symptoms.  A number of 
recent studies have demonstrated that brief interventions targeting processes such as 
worry, are efficacious in reducing both the targeted factor and psychotic symptoms such as 
persecutory delusions [72].  A further application of the causal-interventionalist approach 
would be to target anomalous experiences.  In their description of anomalous experiences, 
Garety and colleagues [70] describe experiences of “heightened perception, actions 
experienced as unintended, thoughts appearing to be broadcast” (p.190).  One type of 
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anomalous experience, which is relatively common in the psychotic prodrome [73], is 
depersonalisation.  
 
Depersonalisation is a sense of profound unreality and detachment of oneself and/or the 
external environment so that it appears changed, empty, remote, or lifeless [74, 6, 7, 9].  
Individuals commonly report affective disturbances such as emotional numbing, cognitive 
disturbances such as mind ‘emptiness’ and impaired concentration, and 
physiological/perceptual disturbance such as loss of a sense of body weight and seeing 
objects as flat and two dimensional [6]. These experiences are not psychotic inasmuch as 
individuals retain an awareness that these are subjective phenomena that do not reflect 
reality [6].  These experiences can range from brief transient phenomena to chronic 
distressing symptoms which cause functional impairment and as such are diagnosable as 
Depersonalisation Disorder (DPD) (if the symptoms of depersonalisation do not occur 
exclusively in the course of another psychiatric condition or due to the effects of a substance 
or organic condition [1]). 
 
Transient symptoms of depersonalisation are found in between 26 and 74% of the general 
population and between 31 and 66% at the time of a traumatic event [2]. Symptoms of 
depersonalisation are part of the diagnostic criteria of some psychiatric disorders such as 
panic and post-traumatic stress disorder [1] with prevalence rates as high as 82.6% in panic 
disorder reported [2].  It is estimated that approximately 2% of the general population meet 
the criteria for DPD [2], though some suggest that it is under-detected [74, 7].  Recent 
studies suggest that symptoms of depersonalisation may also be prevalent in psychosis and 
that some individuals may also meet threshold for DPD, if one disregards the exclusionary 
criteria regarding occurrence in another psychiatric condition.  For example, a recent 
systematic review (see Chapter 1 in this volume) found 16 studies that have investigated 
depersonalisation symptoms in those with a diagnosis of a psychotic disorder, and reported 
prevalence rates of depersonalisation symptoms of between 33 and 100% (e.g., [17, 47]). 
Additionally, the threshold for DPD (using a standardised questionnaire) was met by 
between 3.5 and 54% of those with current psychotic symptoms (e.g., [44, 47]).  In the few 
studies that investigated the impact of depersonalisation, there was a positive correlation 
between depersonalisation and positive symptoms of psychosis (e.g., [75]).  
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There has been a long history of debate as to whether depersonalisation and psychosis are 
the same, related or distinct experiences [76]. There are similarities between the symptoms 
of both disorders, for example, both may involve a change in the way the individual 
perceives themselves, their identity and the world around them– what some theorists have 
referred to as a ‘disorder of the self’ [10].  Further, there is a well-established body of 
research that illustrates common aetiological pathways between the two. Individuals with a 
diagnosis of a psychotic disorder have a disproportionate experience of trauma [77-81], as is 
in the case in those who experience dissociative disorders [7, 9]. Similarly, the role of 
heightened emotional experiences, in particular anxiety, have been implicated in both 
psychosis [72, 25, 70] and depersonalisation [6, 82, 26].  To distinguish between the two, for 
a symptom to be considered depersonalisation, ‘reality testing’ must remain intact.  Further, 
as stated above, diagnostic algorithms, such as that found in the DSM [1] have stipulated 
that DPD should not be diagnosed in those with a current diagnosis of a psychotic condition. 
The inference is that depersonalisation symptoms and associated distress in the context of 
psychotic symptoms would be better conceptualised and treated as a psychotic symptom.  
In this context, the diagnosis and psychological formulation of depersonalisation and DPD is 
generally lost as it is subsumed under the diagnosis of a psychotic disorder.  
 
However, as stated above, a depersonalisation symptom may be aetiologically related to the 
psychosis as an anomalous experience [73, 11, 83].  For example, an individual may 
experience a typical depersonalisation symptom of feeling as though part of their body did 
not belong to them. The associated distress and cognitive biases in individuals vulnerable to 
psychosis may lead the person to appraise this unusual perceptual experience as evidence 
that someone or something is persecuting them or taking over their body.  Such a 
threatening appraisal is in turn likely to lead to heightened distress and maladaptive ‘safety’ 
behaviours (such as hypervigilance), thus creating a ‘vicious cycle’ which serves to 
exacerbate and maintain the depersonalisation phenomena, in addition to potentially 
strengthening the conviction in the psychotic appraisal.  
 
An alternative explanation for the relationship between the two symptoms is that they may 
co-exist as two separate experiences or comorbid conditions. In the above example, the 
individual may feel as if part of their body did not belong to them, however the dominant 
psychotic symptom may be feeling paranoid about people on the street saying negative 
things about them, comments that are unrelated to the unusual feelings in their body. In this 
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context, the symptoms are not conceptually overlapping but may influence each other by 
creating heightened emotion (particularly anxiety) in the individual and increase attentional 
biases such as hypervigilance and symptom monitoring. 
 
Both of these propositions (i.e., depersonalisation as an anomalous experience in pathway 
to positive symptoms of psychosis and/or comorbidity), would suggest that targeting the 
depersonalisation symptoms directly may positively influence the depersonalisation, 
psychotic symptoms, and associated distress.  However, perhaps due to the diagnostic 
overshadowing of psychosis, we are not aware of any published studies of interventions 
targeting depersonalisation in such a way, despite the availability of psychologically-based 
treatments, such as CBT for depersonalisation (see [84] for a review). 
 
The cognitive model of DPD [6] emphasises the role of catastrophic appraisals of the 
depersonalisation experiences. Such appraisals led to heightened emotional states and 
efforts to control, creating a maintenance cycle similar to that found in panic disorder. These 
cognitive processes have been empirically validated [82] and an open study of Cognitive 
Behavioural Therapy for DPD [84], found scores on depersonalisation measures were 
significantly reduced and one third of participants no longer met criteria for DPD, at end of 
therapy and at six month follow-up. 
  
There are similarities between the cognitive models of depersonalisation and psychosis, for 
example, both models stipulate the role of heightened emotion and appraisals of ‘odd’ or 
‘anomalous’ experiences as key parts of the aetiology and maintenance of distress.   In this 
context, we sought to develop a brief, six session CBT protocol specifically focusing on 
depersonalisation symptoms in those with current positive symptoms of psychosis.  
 
We sought to address the following research questions: 
- Is it feasible to deliver a brief course (six sessions) of CBT that directly targets 
depersonalisation in those with current psychotic symptoms? 
- Is such a course of treatment acceptable to participants? 
 
2.3. Methodology 
The detailed protocol for this project has been submitted for publication (see Appendix B), 
and a summary is provided below. The ethical components of this feasibility study were 
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approved by the NRES Committee London - Camberwell St Giles on 25 February 2015 
(reference number 15/LO/0081 – see Appendix C).  The trial is registered on 




A single-blinded (researcher blinded) randomised controlled, feasibility trial with a 
treatment as usual (TAU) control condition was used. Assessments were conducted at 




Participants were included if they were adults (aged 18-75), had active psychotic symptoms 
(scores greater than zero on either scale of PSYRATS [85]), significant depersonalisation 
symptoms that met threshold for DPD (i.e., a score of greater than 70 on the Cambridge 
Depersonalisation Scale (CDS) [86]) and gave informed consent.  Participants were excluded 
if they: were currently engaged in CBT or psychotherapy in another setting; did not have 
capacity to provide informed consent; did not have sufficient English proficiency to engage 
in CBT; and/or had a primary diagnosis of intellectual disability, head injury, substance 




Research and community mental health clinic registers in the local mental health trust were 
screened for participants who had reported active symptoms of psychosis; it was not 
possible to screen directly for experience of depersonalisation as it is not regularly recorded 
in patient records.  Local clinical teams were also approached and asked to refer to the trial. 
Identified potential participants were sent a letter of invitation, followed by a phone call a 
week later made by the first author. Willing potential participants were screened via 
interview to determine if they met the eligibility criteria.  If eligible, they were invited to 
provide informed consent and participate in a baseline interview, after which they were 
randomly assigned to either the intervention and TAU group or TAU only control group. An 
online randomisation program with randomly permuted block sizes was used to ensure 
equal allocation to the two groups. Ten weeks after randomisation, participants were invited 
to a follow-up interview with a researcher blinded to their allocation.  Strategies to maintain 
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blinding of the researcher included the first author conducting randomisation and contacting 
participants directly, holding participant materials in a separate work space, conducting 
intervention sessions (where possible) in separate work space and reminding intervention 




The intervention involved six sessions of Cognitive Behavioural Therapy (CBT) focussing on 
symptoms of, and distress associated with, depersonalisation. Session content was based on 
the protocol developed for DPD [87, 84] and modified for delivery in the context of 
psychosis.  Individual formulations made links between positive symptoms of psychosis, 
anxiety and depersonalisation, but the focus was on depersonalisation symptoms 
specifically, with the rationale that a reduction in depersonalisation would, in turn, lead to 
an improvement in psychosis symptoms.  The intervention aimed to reduce distress through 
psychoeducation, developing a shared formulation of current and past triggers and 
maintenance cycles, and installing strategies that targeted cognitive, behavioural and 
emotional factors involved in the maintenance of the DPD (see Box 1). The intervention 
components listed did not necessarily map on to individual sessions, rather sessions covered 
factors determined by the individual formulation of the participant.  The intervention was 
delivered by the first author (a clinical psychologist in training) under the clinical supervision 
of the author of CBT model for DPD (EH). Supervision was weekly and covered the process 
and delivery of the intervention and problem solving any impasses.  During the intervention 
period, competence in CBT and fidelity to the DPD protocol were assessed by EH using audio 
recordings of sessions.  
 
Treatment as usual control condition 
For most participants, TAU involved regular contact with a care coordinator, medication and 
regular reviews with a psychiatrist as provided for under the Care Programme Approach 
(CPA; [88]).  
 
2.3.4. Data collection 
 
Demographic and relevant clinical data were collected at baseline.  Feasibility of trial 
recruitment was assessed by monitoring rates of referral, contact with potential 
participants, acceptance of screening offer, eligibility and consent.  The feasibility of 
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delivering the intervention was assessed by monitoring the rates of completion of six 
sessions of therapy, completion of homework tasks given in each session, and the average 
number of weeks taken to complete six sessions.  Therapist competence and fidelity were 
assessed by EH using a random selection of 10% of intervention session recordings using a 
standardised CBT adherence measure [89] and a specifically designed fidelity measure for 
DPD protocol (See Appendix D).  Feasibility of data collection was assessed by: monitoring 
the rate of data attrition; the number of weeks to obtain outcome data; and the 
maintenance of blinding.   
 
 




The acceptability of the intervention was monitored by participant ratings on a five-point 
Likert scale on a range of parameters [90, 91] including expectations of progress (from ‘a lot 
of progress’ to ‘things to get a lot worse’), satisfaction (‘very satisfied’ to ‘very dissatisfied’), 
the extent to which they gained new knowledge/skills (‘strongly agree’ to ‘strongly 
disagree’) and the relationship to the therapist including aspects of competence, support 
and warmth and friendliness (‘very much’ to ‘not at all’).  In addition, acceptability was 
further assessed by asking open ended questions about the most helpful and unhelpful 
aspects of the intervention.  
 
Box 1: components of CBT intervention for depersonalisation disorder in psychosis 
Psycho-education / shared formulation  
• Psycho-education about depersonalisation 
• individualised CBT shared formulations for current pattern of depersonalisation 
• rationale for keeping a depersonalisation diary for homework 
• example of depersonalisation diary completion 
• assessing factors which influence fluctuations in severity  
 
Behavioural  
• Planning and testing impact of environmental / behavioural changes to manipulate 
and manage depersonalisation symptoms 
 
Emotion regulation  
• Examining the role of emotions associated with depersonalisation 
• Identifying anxiety/ distress management strategies 
• Psycho-education about grounding strategies and practice of these 
 
Cognitive  
• Identifying and exploring unhelpful thoughts about depersonalisation 
• Cognitive restructuring  - Reviewing the evidence for and against unhelpful 
depersonalisation related thoughts 
 
Thinking processing  
• Role of attention in maintaining depersonalisation 
• Reducing hyper-vigilance / symptom monitoring / checking behaviours 
• Acceptance and mindfulness approaches to depersonalisation 
 
Review and relapse prevention 
• Summary of what has been learnt from the sessions 
• Depersonalisation action plan 
After each session, participants were given a small ‘homework’ task to practice 
techniques introduced in the session and the monitor symptoms using a diary.  
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Data on psychopathology were collected at baseline and follow-up interview using the 
following standardised measures: 
- Cambridge Depersonalisation Scale (CDS) [86].  The CDS is a 29 item scale that 
measures the severity of trait depersonalisation symptoms over the preceding six 
months.  For each item, frequency (Likert scale 0=never to 4=all the time) and 
duration (Likert scale 1=few seconds to 6=more than a week) are collected; each 
item maximum is therefore 10. A total scale score is the sum of each item, with a 
maximum of 290.  Scores greater than 70 have been shown to reliably predict 
clinical diagnosis of DPD using DSM criteria. In order to measure change, the 
wording of the trait CDS was changed to measure the severity of depersonalisation 
symptoms over the preceding month.  A factor analysis of the CDS [92] identified 
four likely factors:  
o Alienation from surroundings which includes items such as ‘I feel strange, as 
if I were not real or as if I were cut off from the world’, ‘my surroundings feel 
detached or unreal…’, and ‘what I see looks ‘flat’ or ‘lifeless’, as if looking at 
a picture’;  
o Emotional Numbing which includes items such as ‘when I weep or laugh, I do 
not seem to feel any emotions at all’, ‘I find myself not feeling any affection 
towards my family and close friends’, ‘I have the feeling of not having any 
thoughts at all…’ and ‘the smell/flavour of things no longer gives me a 
feeling of pleasure or dislike’; 
o Anomalous subjective recall which includes items such as ‘I feel detached 
from memories of things that have happened to me…’, ‘it seems as if things 
that I have recently done had taken place a long time ago…’, and ‘when in a 
new situation, it feels as if I have been through it before’;  
o Anomalous Body Experiences which includes items such as: ‘I have a feeling 
of being outside my body’, and ‘whilst doing something I have the feeling of 
being a ‘detached observer’ of myself.’ 
- The level of distress, preoccupation, impairment and understanding of 
depersonalisation symptoms was also collected using items derived from PSYRATS 
(see below). 
- The Psychotic Symptom Rating Scale (PSYRATS; [85]).  The PSYRATS was used to 
monitor changes in psychotic symptomatology between baseline assessment and 
outcome interview.  The PSYRATS consists of two subscales measuring the presence 
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and typology, beliefs/conviction, distress and disruption associated with auditory 
hallucinations and delusions.  The auditory hallucination (AH) subscale has 11 items 
and the delusions (D) subscale has six items.  All items are scored between 0 and 4. 
For example, for item 1 in the AH scale 0=voices are not present to 4= voices are 
present continuously. The maximum score for the AH and D subscales are 44 and 24 
respectively.  
- Beck Depression Inventory (BDI; [93]). The BDI-II is a 21 item self-report scale, rated 
on a 4 point Likert scale (0= symptom not present to 3 = symptom present with 
significant distress/impairment) measuring common symptoms of depression.  Total 
scores range from 0 to 63.  Total scores of less than 13 indicate minimal depression, 
scores 14-19 indicate mild depression, scores 20-28 indicated moderate depression 
and scores above 29 indicate severe depression.  
- Beck Anxiety Inventory (BAI; [94]). The BAI is a 21 item self-report scale with the 
same scoring as the BDI. Total scores are interpreted as follows: 0-9 indicates 
minimal anxiety; 10-16 indicates mild anxiety; 17-29 indicates moderate anxiety; and 
30-63 indicates severe anxiety.  
- Post-traumatic Diagnosis Scale (PDS, [95]). The PDS has 49 items including a checklist 
of potentially traumatising events and an indication of the distress, intrusive 
thoughts, avoidance and hyperarousal in the last month.   There is a total score 
ranging from 0 to 51 with 1-10 considered ‘mild’, 11-20 ‘moderate’, 21-35 ‘moderate 
to severe’ and greater than 36 ‘severe’.  
- Structured clinical interview for DSM-IV dissociative disorders (SCID-D)[96] is a 
structured clinical interview using DSM criteria for DPD.  It includes nine items 
addressing the presence and frequency of common depersonalisation symptoms, 
the duration and frequency of the most severe instance of depersonalisation, 
functional impairment, distress and exclusionary criteria such as: not the result of 
drugs, organic issues and does not occur exclusively in the context of other 
psychiatric condition such as psychosis. 
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2.3.5. Analysis  
 
As this is a feasibility study and the aim was to provide estimates of key parameters for a 
future trial rather than to be powered to detect statistically significant differences, an a 
priori power calculation was not conducted [97]. Instead, we aimed to recruit sufficient 
participants to provide reasonable estimates of study parameters.   Based on the feasibility 
and time allocated to this work, it was aimed to recruit 30 participants.  A recently 
completed research study (Emma Davies, unpublished manuscript) recruiting people from 
the same pools as proposed for this trial suggested that approximately 50% of participants 
reporting depersonalisation experiences met criteria for DPD. Assuming 50% of those 
screened would meet the eligibility criteria, we anticipated needing to screen 60 participants 
to obtain our target sample. In order to screen 60 participants, we anticipated: needing to 
make an initial contact attempt with 160, 100 of whom would be contactable (i.e., a 60% 
contact rate); and that 60% of those contacted would accept the offer of screening for 
eligibility screening (i.e., 60% acceptance rate). These anticipated rates of contact and 
acceptance corresponded to 16 intial contact attempts, 10 actual contacts and six screening 
interviews per month.  
 
Analyses were primarily descriptive.  Descriptions of continuous data, including clinical data 
and sample characteristics, were analysed using mean, standard deviations (SD), median and 
Interquartile Range (IQR). Frequencies and proportions were used to analyse categorical 
clinical or demographic variables.  
 
Feasibility of trial procedures were assessed using proportions and their estimated 95% 
confidence intervals (CIs) for rates of: referral (number of referrals divided by total 
approached); contact (number of contacts made divided by total approached); acceptance 
(number agreeing to be screened divided by number approached); eligibility (number of 
eligible participants divided by number screened and number approached); consent 
(number consented divided by number approached); therapy and homework completion 
(number completing the full six sessions of the intervention divided by number of 
participants in the intervention group; average number of treatment sessions attended; and 
number completing all homework tasks divided by number of participants in the 
intervention group); average number of weeks taken to complete the intervention; data 
attrition (proportion of follow-up assessments completed); and maintenance of blinding 
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(incidences of unblinding of researcher divided by number of follow-up assessments). 
Therapist competence was presented as proportion (the total score divided by applicable 
items) with estimated 95% confidence intervals for the CBT adherence and DPD fidelity 
measures. Acceptability of trial procedures was assessed using proportions and their 
estimated 95% confidence intervals for rates of expectations and actual progress 
(proportion rating at each point on Likert scale) and satisfaction with therapy, therapist and 
tasks (proportion rating at each point on Likert scale).  Data from open-ended questions 
regarding the most helpful and least helpful aspects of the intervention were collated and 
grouped according to themes. 
 
To inform a sample size calculation for a future trial, the population variance of the CDS at 
baseline was determined using the upper 80th nonparametric bootstrap percentile of 
confidence intervals around the estimates [98]. An estimate of effect size was set at the 
difference between the intervention and control groups’ median change scores on the CDS 
at follow-up.  
2.4. Results 
 
A total of 21 participants were eligible and consented to the trial. Eleven were randomised 
to the intervention group, and 10 to the control group. The demographic characteristics of 
the sample are shown in Table 1 and the recruitment process is illustrated by the CONSORT 
diagram in Figure 1.  There were some demographic differences between the two groups, 
which is likely to be due to the low sample size.  For example, there were more males (71%) 
than females overall, with a greater imbalance in the intervention group (82%) than in the 
control group (60%). Similarly there were more White British in the intervention group (64%) 
than in the control group (40%).  There was a similar distribution between the groups in 
terms of age, marital status and other characteristics. Interestingly, the vast majority (95%) 
had received psychological therapy in the past.   
 
All participants met DSM criteria for DPD (not including the criterion regarding occurrence 
during another disorder). The mean total score on the CDS for the overall sample was 103.8 
(SD 32.7), over the clinical cut-off of 70. The mean scores on the PSYRATS-AH and PSYRATS-D 
for the overall sample at baseline were 24.7 (SD 13.7) and 13.3 (SD: 8.1), which is 
comparable to those presenting to a local psychological therapies service in terms of 
auditory hallucinations, but lower in terms of delusions [99]. The mean scores for BAI and 
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BDI were 33.1 (SD: 12.3) and 35.5 (SD: 11.5) indicating severe levels of both anxiety and 
depression.  In terms of the PDS, distress score for the sample at baseline were 23.5 (SD: 
14.9) indicating moderate levels of post-traumatic distress.  
 
Table 1 – Demographic characteristics of the sample at baseline 






Gender (n, %) Male 9, 81.8 6, 60.0 15, 71.4 
 Female 2, 18.2 4, 40.0 6, 28.6 
Age (mean, sd)  42.6 (14.0) 38.2 (12.1) 40.5 (13.0) 
Ethnicity (n,%) White British 7, 63.6 4, 40.0 11, 52.4 
 Black/Black British 1, 9.1 3, 30.0 4, 19.1 
 Asian/Asian British 1, 9.1 1, 10.0 2, 9.5 
 White European/White Other 1, 9.1 1, 10.0 2, 9.5 
 Mixed 1, 9.1 1, 10.0 2, 9.5 
Marital status (n,%) Married/Civil partnership 1, 9.1 1, 10.0 2, 9.5 
 Co-habiting 1, 9.1 2, 20.0 3, 14.3 
 Divorced 2, 18.2 0, 0 2, 9.5 
 Single 7, 63.6 7, 70.0 14, 66.7 
Level of education (n,%) None 3, 27.3 1, 10.0 4, 19.1 
 GCSEs/level 2 3, 27.3 5, 50.0 8, 38.1 
 A-Levels 2, 18.5 2, 20.0 4, 19.1 
 Diploma or higher 3, 27.3 2, 20.2 5, 23.8 
Clinical diagnosis (n,%) Schizophrenia 8, 72.7 8, 80.0 16, 76.2 
 Bipolar   2, 18.2 0, 0 2, 9.5 
 Depression with psychotic 
symptoms 
1, 9.1 2, 20.0 3, 14.3 
Age at first: (mean, sd) depersonalisation symptoms 18.3 (12.8) 21.0 (11.8) 19.5 (13.1) 
 psychosis symptoms 24.2 (10.3) 25.7 (9.9) 24.8 (121) 
 contact with mental health 
services 
26.2 (11.0) 27.2 (9.7) 26.6 (10.2) 
Duration (years) of: 
(mean, sd) 
Depersonalisation symptoms 24.4 (17.7) 17.2 (14.1) 20.9 (16.1) 
Psychosis symptoms 18.5 (15.2) 13.5 (10.2) 16.1 (13.0) 
Previous psychological 
therapy (n,%) 
Yes 11, 100 9, 90.0 20, 95.2 
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*Other category includes – unable to consent (n=6), currently engaging in therapy (n=3), needing an interpreter (n=1), 
unable to speak (laryngectomy) (n=1).  
  
Sent letter of invitation (n=229) 
Allocated to intervention (n=11) 
- Received allocated intervention (n=9) 
- Did not receive intervention (n=2) 
o Physical illness/hospitalisation (n=1) 
o Declined CBT intervention (n=1) 
 
Assessed for eligibility (n=100) 
Not assessed (n=129) 
- Not contactable (n=66) 
- Declined to be screened (n=63) 
Excluded (n=79) 
- No DPD  (n=57) 
- No current psychotic symptoms 
(n=10) 
- Other (n=11)* 
- Eligible but declined (n=1) 
Randomised (n=21) 
Allocated to control (n=10) 
- Received allocated intervention (n=10) 
- Did not receive intervention (n=0) 
 
Lost to follow-up (n=1) 
 
Lost to follow-up (n=1) 
 
Analysed (n=11) 
- Excluded from analysis (n=0) 
Analysed (n=10) 
- Excluded from analysis (n=0) 
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Over a period of 10 months (between April 2015 and January 2016), an attempt was made 
to contact 229 individuals to offer them the opportunity to participate in the trial. At the end 
of the recruitment period, 21 (9.2% of those contacted) individuals had consented.  The 
overall recruitment statistics for the trial are summarised in Table 2.   
 
Table 2 Feasibility estimates of recruitment 













Initial contact attempts (letters) 229 
   
No response 66 28.8 (23.3 – 35.0) 
  
Total contacted 163 71.2 (65.0-76.7) 
  
Declined screening 63 27.5 (22.1-33.6) 38.7   (31.5-46.3) 
 
Screened 100 43.7 (37.4-50.1) 61.3   (53.7-68.5) 
 
   Not eligible – Total 78 34.1 (28.2-40.4) 47.9   (40.3-55.5) 78.0   (68.9-85.0) 
     Not eligible – Depersonalisation 57 24.9 (19.7-30.8) 35.0   (28.1-42.6) 57.0   (47.2-66.3) 
     Not eligible – Psychosis 10 4.4   (2.4-7.8) 6.1     (3.4 – 10.9) 10.0   (5.5-17.4) 
     Not eligible – Other 11 4.8   (2.7-8.4) 6.7     (3.8 – 11.7) 11.0   (6.3-18.6) 
   Eligible but declined  1 0.4   (0.08-0.02) 0.6     (0.1 – 3.4) 1.0     (0.1-5.5) 
   Eligible and consented 21 9.2   (6.1-13.6) 12.9   (8.6 – 18.9) 21.0   (14.2-29.9) 
 
2.4.1. Feasibility estimates of recruitment (rate of referrals, contact, acceptance and 
eligibility)  
 
Of the 229 attempted contacts, 24 individuals were referrals from clinicians in the local 
mental health trust, making the proportion of referred participants 10.5% (95% CI: 7.1-15.1).  
Of these referrals: 22 were contacted (91.7% (95% CI: 74.2-97.7)), 18 accepted the offer of 
screening (75.0% (95% CI: 55.1-88.0)); 10 were eligible (41.7% (95% CI 24.7-61.2)); and 9 
consented (37.5%, (95% CI 21.2-57.3)).  
 
The remaining 205 individuals were found from research registers (i.e., they had given their 
permission for researchers to approach them).  The contact rate was 71.2% (i.e., 163 of 229 
attempted contacts – see Table 2 for confidence intervals), at an average of 16.3 per month 
over the course of recruitment.  Of those who were contacted, 63 (38.7%) declined the offer 
to be screened.  Reasons for declining screening included: not wanting to participate in 
research generally (n=16); not having the time, including concerns that the research was too 
much of a commitment in terms of number of sessions (n=14); being too unwell (n=5); not 
interested (no further reason given) (n=28); and not enough remuneration offered for the 
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assessments (n=1).  In this context, 100 individuals agreed to be screened for the trial 
making the acceptance rate of 61.3%, and an average screening rate of 10 per month. 
 
The number of individuals meeting the eligibility criteria was lower than expected.  Of the 
100 individuals who agreed to be screened, 22 met the eligibility criteria.  The most common 
reason for not meeting eligibility criteria was having no current depersonalisation 
phenomena or not meeting clinical threshold on the CDS (n=57, 57%).  Other reasons for not 
meeting eligibility criteria were: having no current experience of psychotic symptoms (n=10); 
currently engaging in therapy (n=3); not able to provide informed consent (intellectual 
disability or too mentally unwell; n=6); and language difficulties (n=2). 
 
With one exception, all of those who were eligible for the study agreed to participate, 
making a consent rate of 95.5% (95% CI: 78.2-99.2).  The one individual who was eligible but 
declined participation (a referral) was put on a waiting list for a specialist clinic and decided 
it was preferable to wait for this support rather than engage in brief therapy as part of the 
trial.  
 
In summary, the rates of contact (71.2%) and acceptance of screening (61.3%) were within 
expected ranges, but the 22% rate of eligibility was much lower than the expected 50%. In 
this context, the overall recruitment rate and number was lower than projected and the 
sample target was reduced to 20 individuals midway through the recruitment period.   
 
2.4.2. Feasibility and acceptability estimates regarding the delivery of the intervention 
 
Eleven participants were randomised to receive the intervention.  Of these, nine (81.8%, 
95% CI: 52.3-94.8) participants completed the full six sessions.  Two participants did not 
complete the full six sessions, making a ‘drop-out’ rate of 18.2% (95% CI: 5.1-47.7). Of those 
who did not complete: one attended two sessions before declining further sessions citing a 
difficulty with the cognitive behavioural therapy approach; one individual attended one 
session before declining further sessions due to high levels of anxiety regarding leaving the 
home (home visits were also declined).  For the nine participants who completed the 
intervention, the six sessions were delivered over an average of 8.3 weeks (maximum 
allowed was 10).  
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Sessions were delivered in outpatient clinics near to the home of the participant for all 
participants with two exceptions.  Two participants found leaving the home too difficult due 
to high levels of anxiety, and therefore sessions were conducted at these participants’ 
homes.  
 
Homework tasks were given at the end of each session and completion was noted at the 
beginning of the next session.  Five participants completed all five homework tasks (no 
homework monitored after the final session) giving 100% completion amongst 55.5% (95% 
CI: 26.7-81.1) of the intervention sample.  The average completion was 4, giving an overall 
homework completion rate of 80% (95% CI: 37.5-96.4).  
 
Therapist competence was rated using a random selection of 10% of recorded sessions. The 
average item rating on the CBT competence measure was 5.2/6, making a competence rate 
of 86.4% (95% CI: 82.2-89.6). The average item rating on the DPD fidelity tool was 5.1/6, 
making a fidelity rate of 85.9% (95% CI: 81.7-91.8). 
 
2.4.3. Components of the intervention delivered. 
 
There were six potential components or topic areas to be covered in the intervention (see 
Box 1). For the nine individuals who completed the intervention, an average of four topic 
areas were covered.  Two participants received all six components of the intervention. All 
nine participants received the psychoeducation and formulation, emotional focus and the 
review/relapse prevention components. The least frequent area covered was cognitive focus 
including identifying and working with thoughts about depersonalisation (n=3), followed by 
behavioural focus (n=5) and cognitive processes (n=7).  The focus of the sessions and 
components covered were determined by the individual formulation of the participant and 
their progress through the focal areas. For example, one participant, with a complex history 
of abuse had some difficulty managing emotions and it was therefore decided to focus on 
the formulation and managing emotion components with this participant.  Two example 
shared formulations are shown in Appendices E and F. 
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2.4.4. Acceptability of the intervention 
 
At follow-up interview, participants who had completed the intervention (n=9) were asked 
about their expectations for progress at the beginning of therapy.  Fifty-six percent (95% CI: 
26.7-81.3) reported that they had expected to make ‘no progress’ and the remaining 44% 
(95% CI: 18.8-73.3) reported that they had expected to make a ‘little progress’.  In terms of 
their impressions of actual progress made, six participants (66.7%, 95% CI: 35.4-87.9) 
reported that they made ‘a lot of progress’, one participant (11.1%, 95% CI: 1.9-43.5) had 
made ‘a little progress’, and two participants (22.2%, 95% CI: 6.3-54.7) thought they had 
made ‘no progress’.  Regarding their expectations for the future, six participants (66.7%, 95% 
CI: 35.4-87.9 ) expected to make ‘a lot of progress’, one participant (11.1%, 95% CI: 1.9-43.5) 
expected to make ‘a little progress’, one (11.1%, 95% CI: 1.9-43.5) expected to make ‘no 
progress’ and one (11.1%, 95% CI: 1.9-43.5) expected ‘things to get a little worse’.  
 
In terms of satisfaction with the therapy, six participants (66.7%, 95% CI: 35.4-87.9) reported 
they were ‘very satisfied’, two reported they were ‘satisfied’ (22.2%, 95% CI: 6.3-54.7) and 
one (11.1%, 95% CI: 1.9-43.5) reported they were ‘indifferent’. All participants (100%, 95% 
CI: 70.9-100) reported that the therapist understood their problems ‘very well’.  There were 
high levels of confidence in the therapist with eight participants (88.9%, 95% CI: 56.5-98.1) 
stating they could trust the therapist ‘a lot’ and one participant (11.1%, 95% CI: 1.9-43.5) 
reporting ‘a little’.  Homework tasks were rated as ‘very helpful’ by seven participants 
(77.8%, 95% CI: 45.3-93.7) and ‘slightly helpful’ by two participants (22.2%, 95% CI: 6.3-54.).  
 
Specific questions and responses about new skills and knowledge about depersonalisation 
are shown in Table 3 and suggest that the majority of the recipients of the intervention 
either ‘agreed’ or ‘strongly agreed’ that they had gained new knowledge and skills.  
However, three ‘disagreed’ or were ‘unsure’ that they had more control over their 
experiencing of depersonalisation. 
 
The therapeutic relationship was rated highly by all intervention recipients.  All nine 
recipients (100%) agreed ‘very much’ that the therapist was ‘sympathetic and caring’, 
‘competent’, ‘warm and friendly’, ‘supporting and encouraging’ and all participants (100%) 
disagreed ‘very much’ that the therapist was ‘not possible to get along with’.  
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In terms of the most helpful aspects of the intervention, there were a range of responses 
and some participants stated more than one aspect. The most frequent category of 
responses was ‘coping strategies to manage mood and worry’ (n=5) about the 
depersonalisation.  
 
For example,  
“It was really helpful for depersonalisation and mood/anxiety. I’m not worried about 
the feeling in my hands anymore. I have no more panic and I’m feeling a lot better. I 
have learned a lot. I used to have panic attacks, but not anymore. None in the 10 
weeks, when I used to have three a week.” 
 
Three participants stated that the most helpful aspect of the therapy was the relationship 
with the therapist. For example,  
“I was getting somewhere. I could trust someone. I told [the therapist] things that I 
hadn't told others. [The therapist] was very sympathetic and a good listener.” 
 
Three participants stated that learning about maintenance cycles, triggers and having these 
aspects drawn out for them was the most helpful aspect of the intervention.  One 
participant said the therapy was not long enough to determine the most helpful aspects.  
 
Participants were also asked about the least helpful aspects of the intervention.  Four 
participants (44.4%, 95% CI: 18.8-73.3) could not think of anything that was not helpful. Four 
participants (44.4%) stated that six sessions was not long enough. One participant (11.1%, 
95% CI: 1.9-43.5) said it would have been helpful to see notes from another patient with 
similar difficulties and to read how they had recovered.  Interestingly, three (33.3%, 95% CI: 
12.1-64.6) participants reported that six sessions felt about right to address 
depersonalisation, however, all three wanted to continue engaging in therapy to address 
further issues including self-esteem and trauma.  
 
The one intervention participant who declined further sessions after the first session but did 
attend the follow-up interview rated the intervention highly but stated that the: 
“Timing meant journeys were too stressful. I would have liked to continue but travel was 
too hard. I was too worried at the time about getting home to concentrate on sessions.” 
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Table 3. New skills and knowledge about depersonalisation 
 n, %, 95% CI: 
Through therapy I gained:  Strongly agree Agree Unsure Disagree Strongly 
disagree 
A better understanding of how my 
depersonalisation developed 
5, 55.6 (22.2-88,9) 3, 33.3 (10.0-66.7) 1, 11.1 (0.0-40.0) -  -  
A better understanding of what 
keeps my depersonalisation going 
5, 55.6 (22.2-88.9( 2, 22.2 (0.0-50.0) 2, 22.2 (0.0-50.0) - - 
A better understanding of my 
experiences generally  
5, 55.6 (22.2-88.9) 3, 33.3 (10.0-66.7) - 1, 11.1 (0.0-33.3) - 
Techniques or methods to cope 
with my depersonalisation 
6, 66.7 (20.1-100.0) 2, 22.2 (0.0-50.0) - 1, 11.1 (0.0-33.3) - 
Better control over my 
depersonalisation 
5, 55.6 (20.0-88.9) 1, 11.1 (0.0-33.3) 1, 11.1 (0.0-37.5) 2, 22.2 (0-50.0) - 
A greater ability to cope with my 
moods and anxiety 
4, 44.4 (12.5-77.8) 3, 33.3 (10.0-66.7) 1, 11.1 (0.0-33.3) 1, 11.1 (0.0-33.3) - 
A better understanding of my 
thoughts and how to manage 
them 
5, 55.6 (20.0-88.9) 4, 44.4 (12.5-77.8) - - - 
A better understanding of how I 
think and how to manage that.  
4, 44.4 (12.5-77.8) 3, 33.3 (10.0-66.7) 1, 11.1 (0.0-33.3) 1, 11.1 (0.0-33.3) - 
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2.4.5. Feasibility estimates of data collection 
 
Follow-up assessments were attended by 19 of the 21 participants making an outcome rate 
of 90.4 (95% CI: 71.1-97.4).  There was equal attrition between the two groups.  One 
participant from the intervention group who declined further sessions of the intervention 
after attending two also declined further contact with the research study.  One participant 
from the control group did not attend an arranged follow-up interview and could not be 
reached within the study period.  Follow-up interviews were conducted on average 11.6 
weeks after randomisation (range 9.3-16.9).  
 
Blinding of the research assistant was maintained in 17 of the 19 (87.5%, 95% CI: 68.6-97.1) 
follow-up interviews conducted.  In one incident, the participant themselves told the 
research assistant of their group allocation at follow-up interview.  In the other incident, an 
individual who was randomised to the intervention group attended the research assistant’s 
office for the first intervention session by mistake.   
 
2.4.6. Clinical Outcome data 
 
Summary statistics for clinical outcomes are shown in Table 4.  With such a small sample size 
it was not possible to test for statistical differences between or within the groups; however, 
several patterns can be noted. The mean total score on the CDS was higher in the 
intervention group compared to the control group at baseline.  However, at the end of 
intervention assessment, the mean total score in the intervention group had reduced. In 
contrast, the mean total score in the control group had increased.  A similar pattern was 
observed in the other clinical outcomes. With the exception of the PDS, all other mean 
scores of outcomes reduced in the intervention group at follow-up.  In the control group, 
with the exception of PSYRATS-D scale which decreased slightly, all other mean scores on 
the outcomes stayed approximately the same.  
 
2.4.7. Phenomenology of depersonalisation in psychosis. 
 
Table 5 provides a summary of the phenomenology of the depersonalisation symptoms and 
response to therapy in the intervention group. The table shows the two most frequently 
experienced CDS factors for each participant. The most common factor endorsed (n=8) was 
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Alienation from surroundings, followed by Emotional Numbing (n=6), Anomalous Subjective 
Recall (n=4) and Anomalous Body Experiences (n=2). 
 
In all but three of the 11 participants, depersonalisation symptoms were separate to the 
content of delusions or other psychotic symptoms. When separate or distinct from 
delusional content, participants were able to describe their depersonalisation experiences 
‘as if’ and therefore would meet DSM-V criteria for DPD, comorbid with their psychotic 
disorder (excluding the criterion that precludes diagnosis in the context of a psychotic 
disorder).  In contrast, for those participants where there was a link between their 
depersonalisation and psychotic symptoms, the depersonalisation experience was 
explained, at least partly, by a delusional interpretation.  For example, one participant for 
whom items addressing Anomalous Body Experiences were amongst the most frequently 
endorsed, had a firm belief that his body was, in fact, irrevocably changed.  
 
A reduction in CDS total score was observed in all but one of the participant who completed 
the intervention, and the mean change score was 22.5 (95% CI -0.24 – 43.9). In six of the 
nine (66.7%) participants CDS total scores dropped below the clinical cut-off at follow-up.  By 
comparison, in the control group, a reduction in CDS total score was observed in 5 of the 9 
participants (55%) for whom follow-up data were available, with an average change score of 
8.9 (95% CI -37.4-18.1); three participants’ scores (33.3%) dropped below the clinical cut-off 
for DPD  on the CDS.  
 
It is of note that the three intervention participants who still met threshold for DPD at 
follow-up experienced their depersonalisation symptoms frequently (see Table 5), and two 
of the three had a link between the depersonalisation symptom and their psychotic 
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Table 4. Summary of clinical data in the two groups at baseline and follow-up 









 Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) 
CDS total score 98.3 (24.5) 90.0 (80.5-115) 108.2 (65.2) 82.0 (61.5-167.0) 108.8 (39.3) 97 (80-141) 89.2 (52.6) 71.5 (42.4-149.0) 
PSYRATS-AH 25.0 (13.7) 31.5 (18-34.2) 24.7 (11.9) 27.0 (17.0-34.0) 24.4 (14.5) 29 (12-75) 17.5 (16.5) 18.0 (0.0 – 33.5) 
PSYRATS-D 11.1 (9.8) 15.0 (0 – 19.5) 7.6 (8.3) 4.0   (0.0- 16.5) 15.3 (5.9) 17 (12-20) 12.0 (7.8) 12.0 (4.5-19.5) 
BAI 28.2 (12.5) 28.0 (18.0-39.0) 28.4 (13.8) 32.0 (18.5-38.0) 37.5 (10.7) 36.0 (34.0-43.0) 29.4 (18.5) 29.5 (12.7-41.7) 
BDI 31.6 (14.9) 33.5 (16.7-44.7) 32.3 (15.6) 27.0 (17.5-47.0) 35.5 (11.5) 34.0 (24.0-48.0) 29.1 (19.6) 27.5 (10.5-48.0) 
PDS distress 22.6 (16.8) 24.0 (6.7-40.7) 23.7 (12.7) 28.0 (14.5-34.0) 24.4 (13.8) 28.0 (16.0-35.0) 31.0 (10.5) 29.5 (24.5-39.5) 
 
Abbreviations: AH: auditory hallucinations; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; D: delusions; CDS: Cambridge Depersonalisation Scale; IQR: interquartile range; PDS: Post-traumatic 
Diagnostic Scale; PSYRATS: Psychotic Symptom Rating Scale; SD: standard deviation. 
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Table 5 Typology of depersonalisation experiences and response in intervention group participants at follow-up 
ID Psychosis Depersonalisation factor^ (frequency 
at baseline) 
DP linked to 
psychosis* 
 
Trauma DPD! Change 
in CDS 
Change in Depersonalisation: Change in 
PSYRATS: 
Change in 
    Total  Distress Preocc- Impair- AH  D  BAI BDI PDS 
1 AH & D Alienation (100%) 
Anomalous body (83%) 
Yes No Yes -30 -1 0 0 4 2 -1 -4 n/a 
2 AH & D Anomalous subjective recall (55%) 
Alienation (50%) 
No CSA No -56 -2 -1 -1 0 -5 -11 6 -5 
3 AH & D Alienation (100%) 
Anomalous subjective recall (80%) 
Yes CSA+ Yes 21 0 2 0 -1 1 16 5 21 
4 D Alienation (50%) 
Anomalous subjective recall (40%) 
No War No -36 -3 -3 -1 n/a -4 -17 -15 -24 
5 AH & D Alienation (81%) 
Emotional numbing (38%) 
No No No -46 -2 -2 -1 -7 n/a -21 -31 n/a 
6 D Anomalous body (58%) 
Alienation (56%) 
No CSA No -36 -3 -3 -1 n/a 0 -17 -16 -24 
7 AH & D Emotional Numbing (67%) 
Anomalous subjective recall (60%) 
No No Yes -15 -1 -1 1 0 0 -28 -16 8 
8 D Alienation (94%) 
Emotional numbing (83%) 
Yes No No -68 -1 -2 -1 n/a -8 0 0 -1 
9 D Emotional numbing (75%) 
Alienation (56%) 
No No No -31 -1 1 -1 n/a 0 -4 -2 11 
10** D Emotional numbing (67%) 
Alienation (56%) 
No No Yes 46 -2 -2 1 n/a 0 12 9 -9 
11**# AH & D Alienation (69%) 
Emotional numbing (54%) 
No CSA -          
Notes: 
^   DP experience summarised using Sierra et al [92] factor analysis which generated four factors: ‘anomalous body experience’, ‘emotional numbing’, ‘anomalous subjective recall’, ‘alienation from surroundings’.  
Two most frequently endorsed factors presented for each participant. Percentage = average frequency of experience – 100% = all the time; 50%= half of the time. 
*   DP linked to psychosis when there was a delusional interpretation of the depersonalisation symptom;   ** Did not complete the intervention;  #Lost to follow-up;  ! DPD: threshold met for DPD (using CDS cut-off). 
Change scores (-) denotes a decrease in score at follow-up  
Abbreviations: AH: auditory hallucinations; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; D: delusions; CDS: Cambridge Depersonalisation Scale; CSA – childhood sexual abuse; CSA+ - child hood 
sexual abuse plus neglect and physical violence; DP: Depersonalisation; DPD: Depersonalisation Disorder; impair: CDS impairment score; PDS: Post-traumatic Diagnostic Scale; preocc: CDS preoccupation score; 
PSYRATS: Psychotic Symptom Rating Scale. 
Page 61 of 128 
2.4.8. Estimate of sample size 
 
To determine the likely sample size for a future trial, the upper 80% confidence interval of the 
standard deviation of CDS total score at baseline was used (i.e., 49.4). We are not aware of 
other studies using the CDS to measure change. In this context, we decided to use the 
difference in median change scores on the CDS between the two groups at follow-up as an 
estimate of effect size.  The median change score in the intervention group was 30.5 and 7 in 
the control group, making a difference of 23.5.  To be conservative, we rounded down to 20. 
Dividing this change score by the upper 80% confidence interval of the CDS total standard 
deviation at baseline generates an estimate of Cohen’s d (effect size) of 0.40. Using these 
metrics, a total sample of 200 (100 in each group) would be able to detect such a change in 
CDS total scores with 80% power, using a two group t-test with a 0.05 two sided significance 
level.   
 
To obtain such a sample, using the overall consented rate for the study (i.e., 9.6% (95% CI: 6.1-
13.6)), approximately 2, 083 (range 1,470-3,278) individuals would need to be approached (if 
using the same methodology).  However, if using a referral based system, the estimate of 
eligibility rate would be approximately 37.5 (range 21.2-57.3), making an initial contact 




This paper describes the feasibility and acceptability of a novel, brief, six session intervention 
for DPD in the context of current psychotic symptoms.  To the authors’ knowledge, this is the 
first study of such an intervention.  The findings suggest that this intervention is both feasible 
to deliver and acceptable to participants.  The study was not powered nor designed to examine 
clinical effect, however, there is some suggestion of a positive impact of the intervention, with 
66% of those receiving the intervention no longer meeting threshold for DPD at follow-up, 
compared to 33% in the control group.  Reductions were also observed on other measures of 
interest including psychotic symptoms, depression and anxiety.   
 
Regarding the feasibility of recruitment, contact and acceptance (of screening) rates were 
within expected ranges. Furthermore, only one eligible participant did not provide consent 
suggesting a high level of interest in the intervention amongst those meeting criteria.  
However, the eligibility rate of 22% of people screened, was substantially lower than the 
expected rate of 50%.  A recent systematic review (Chapter 1 in this volume) found four 
studies that used the same methodology (i.e., CDS threshold) to determine the presence of 
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DPD in those with current psychotic symptoms.  In these four studies, the rate of DPD varied 
between 3.5% and 54%; however questions were raised about the validity of such findings 
since none of the studies used a clinical interview to clarify the participants’ self-reported 
depersonalisation symptoms on the CDS.  Several authors [100, 101] have suggested that 
individuals who are experiencing current psychotic symptoms may have difficulty 
understanding the questions regarding depersonalisation symptoms, and thus may over-report 
their experience of such symptoms. In contrast, this study administered the CDS as part of a 
clinical interview, and all responses were explored and clarified to determine if the participant 
understood the item and that their responses were relevant. It is possible that this rigorous 
methodology may provide a closer estimate of the prevalence of DPD comorbidity in 
psychosis; however, this finding needs to be replicated.  If this is an accurate representation, 
approximately one in five individuals may have a true comorbid condition that could benefit 
from formulation and treatment.  However, as depersonalisation symptoms are not routinely 
noted in clinical records, in this study initial contact attempts were made to individuals who 
had notes suggesting they had current psychotic symptoms only.  Based on the consent 
estimates found in this study, using this broad recruitment strategy, a future trial would need 
to contact up to 16 individuals to recruit one (using the lower confidence interval for consent 
rate). Furthermore, considering the estimated sample size of 200 individuals required to detect 
a moderate effect size in a future trial, this is likely to render a future trial extremely onerous if 
the same methodology is used. In contrast, the consent rate amongst referrals from clinicians 
was much higher and would make recruitment more feasible.  In summary, consent rates (i.e., 
those who accepted screening, were eligible and gave consent to participate), and therefore 
the feasibility of recruitment to a future trial, could be improved if routine assessments of 
depersonalisation were completed at entry to clinics and thus facilitating more targeted 
recruitment efforts (i.e., referral based).  
 
Overall the intervention was highly acceptable to participants.  Only two individuals dropped 
out of treatment: one due to not finding the CBT approach helpful and another due to high 
levels of anxiety preventing him from attending and accepting home visits.  For all other 
participants, six sessions were completed and homework compliance was high.  Overall, 
responses from the participants who completed the intervention suggest a high level of 
satisfaction with the intervention including: actual and expected future progress; developing 
new skills and knowledge about depersonalisation symptoms; and the delivery of the 
intervention by the therapist.   Participants who expressed some concerns were those who 
remained above diagnostic threshold for DPD. Understandably, such participants were unsure 
of the practical impact of the intervention, but rated the therapist highly and expressed a 
desire to continue with the intervention beyond the six sessions.   
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The study was not powered nor designed to measure treatment response or effect size, 
however, the summary data presented were promising.  Most individuals receiving the 
intervention had reduced scores on depersonalisation and dropped below the diagnostic 
threshold for DPD.  This is similar to the finding from the open study of CBT for DPD [84] where 
one third of participants no longer met the criteria for DPD at the end of therapy.  Those who 
remained above diagnostic threshold at follow-up were, in the majority of cases, those 
participants where there was a link between the depersonalisation and psychotic symptoms, 
most typically through a delusional interpretation of the depersonalisation symptom (for 
example, my body has reduced density) and who had very high initial scores on the CDS.  Such 
individuals may represent a more severe subgroup that require more intensive treatment; 
something that warrants further investigation.   
 
Most individuals in the intervention group also had reduced scores on measures of anxiety and 
depression, supporting the link between depersonalisation and distress [87, 26].  There were 
some reductions on scores of psychotic symptoms amongst some participants, but overall 
there appeared to be little effect.  In this context, these data do not provide support for one of 
the hypothesised links between depersonalisation and psychosis symptoms (i.e., 
depersonalisation as an anomalous experience in the aetiology of psychosis). Rather these 
data provide some support for the second proposal – that they are comorbid conditions. 
However, longer follow-up and larger sample sizes are required to clarify these potential 
relationships.   
 
The most frequent comment regarding unhelpful aspects of the intervention was that the 
intervention did not last long enough.  While the outcomes were promising at 10 weeks 
follow-up, it is not possible to speculate about the impact of the intervention at longer follow-
up periods.  It is possible that six sessions were sufficient to introduce participants to a greater 
understanding about depersonalisation as well as learning strategies to help them manage 
their depersonalisation symptoms, but was not sufficient to embed change.  For example, one 
third of the intervention participants were either unsure or disagreed that they had more 
control over their depersonalisation symptoms.  Additionally, for those participants where 
there was a direct link between the depersonalisation and psychotic symptoms, it was clear 
from the therapist’s perspective that six sessions were insufficient and all three participants 
remarked as such at follow-up interview. In the six-session protocol we were unable to 
complete the latter phases of intervention in the majority of cases due to the need for slower 
pace of therapy in the context of psychosis. Interestingly, three participants said that six 
sessions was the right amount of time for them to focus on depersonalisation but they wished 
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the sessions could continue to address other issues (for example, response to childhood 
trauma or low self-esteem, issues that may have been identified as a maintenance factor in the 
formulation of depersonalisation).  Six sessions and other ‘low-intensity’ CBTp interventions 
show some promising effects [102].  These data suggest that this protocol of six sessions 
targeting depersonalisation may also be a useful module that perhaps acts as a precursor to 
further CBTp interventions or increases access to therapeutic support for some individuals; 
however, those with more complex needs may understandably benefit from further sessions. 
 
In summary, the findings were mixed regarding the acceptability of the length of intervention. 
For approximately one third of participants, six sessions was sufficient to address 
depersonalisation and two thirds of participants no longer met criteria for DPD. However, for 
some the work uncovered other potential intervention targets and for another third, six 
sessions was insufficient to make an acceptable impact on their experience of 
depersonalisation.    
 
2.5.1. Implications for research  
 
The data from this study show that brief CBT for depersonalisation disorder in psychosis is 
feasible to deliver and highly acceptable to participants.  Furthermore, while the study was not 
powered or designed to detect treatment effects, the reduction in scores in the intervention 
group, suggests the approach may be beneficial and warrants further investigation.  In this 
context, a pilot trial with sufficient power should be considered. 
 
The finding that those with a link between psychosis and depersonalisation symptoms 
remained above diagnostic threshold at follow-up suggests that these individuals may 
represent a subtype of individuals who require more in-depth treatment.  Equally, it may be 
that the depersonalisation experiences are better considered more psychotic in nature, and 
treatment approaches devised for psychosis may be more appropriate.  Further research is 
needed to examine the phenomenology of depersonalisation and psychosis to determine if 
there are subgroups that have a differential response to treatment.  
 
2.5.2. Implications for clinical practice 
 
The use of diagnostic algorithm in the context of psychosis and depersonalisation symptoms 
that stipulates that depersonalisation should not be diagnosed in the context of the presence 
of other disorders, may limit the identification of distress associated with depersonalisation 
and miss a useful (and possibly effective) target for intervention.  This study shows that 
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consideration of depersonalisation symptoms is highly acceptable to participants with 
comorbid psychotic symptoms and there is a suggestion of a positive treatment effect.  While 
further investigation is required before any treatment recommendations are made, the data 
from this study suggest that clinicians should consider the routine assessment of 
depersonalisation in those with psychotic symptoms and to provide some psycho-education 
about these experiences when present.  Such routine assessment may also help to clarify the 
true prevalence of DPD comorbidity in psychosis and facilitate attempts to recruit for a larger 




The lower than expected eligibility rate resulted in not meeting the original recruitment target 
of 30. The feasibility and acceptability estimates had large confidence intervals creating 
difficulty in estimating parameters for future trials.  The smaller sample size also resulted in 
the intervention and control groups having different characteristics at baseline. For example, 
there was a larger proportion of males and White British participants, and slightly higher CDS 
scores, in the intervention group than in the control group.  
 
Recruitment in most cases came from research registers in the local NHS trust.  While all 
participants were still involved with local mental health teams, it is possible that individuals 
who agree to participate in research may differ from those found more generally in community 
mental health teams. In this context, the external generalisability of these data may be 
compromised.  For example, it was interesting that such a high proportion of participants had 
received previous psychological therapy.  It is unlikely that this is representative of the wider 
population as rates of psychological treatment in the local trust are approximately 10-30%.  In 
this context, the group participating had previous experience of therapy (mostly CBT) and 
therefore were familiar with some of the concepts introduced, which may have influenced the 
response to the intervention.  For individuals without prior experience of CBT, it is likely that 
more sessions would be necessary to introduce such concepts.  
 
The suggestion of some effect of the intervention found in these data should be interpreted 
with extreme caution since the trial was not powered to test for effect of intervention.  
Furthermore, the follow-up period of 10 weeks is comparatively short and future efforts to test 
the intervention should include a longer follow-up to ascertain any effect of the intervention in 
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2.5.4. Recommendations for future trial 
 
Considering the data from the current study, there are three specific recommendations for a 
future trial.  
1. In order to facilitate recruitment and build the evidence base for a future trial, it is 
recommended that routine screening for depersonalisation is conducted.  If this were 
in place, it is likely that referrals and initial contact attempts for potential recruits 
could be more targeted to those who are likely to meet criteria for DPD.  
2. A longer follow-up period, in addition to an immediate assessment at the end of 
intervention period, is required to determine if there are sustained/mid-range effects 
of the intervention beyond the very short term.  Furthermore, an assessment of the 
specific strategies used by intervention participants (i.e., emotional, cognitive, 
behaviour, thought processing) and their relationship to outcome would facilitate the 
tailoring of the intervention and provide indication of the mechanism of action of the 
intervention.  
3. It may be necessary to extend the intervention beyond six sessions, particularly for 
those with no prior experience of therapy and those with a link between psychosis and 





This paper provides the first account of delivering a brief CBT intervention for 
depersonalisation disorder in psychosis.   The intervention was feasible to deliver and 
acceptable to participants. Depersonalisation symptoms were not directly linked to psychotic 
symptoms in the majority of participants suggesting that DPD can exist as a comorbid 
condition alongside psychosis.  There is some suggestion of a positive effect on scores of 
depersonalisation, anxiety and depression though further, appropriately powered analyses are 
required before any definitive statement can be made. Overall the data suggest that a larger-
scale trial is warranted and recommendations for this trial are made.    
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3.1. Abstract 
 
The presence of cognitive deficits in individuals diagnosed with psychotic disorders is well 
established. Typical deficits include problems with memory, attention, executive functioning 
and processing speed.  These deficits are thought to precede the onset of psychotic disorder, 
however the evidence for further decline is less clear.  Cognitive functioning may be influenced 
by many factors including psychiatric, medical, psychological and social factors. This report 
presents the findings of a study of the cognitive functioning of inpatients on the Fitzmary II 
ward, a national specialist unit for the treatment of refractory psychotic illnesses, often in the 
context of co-morbid physical health problems. The specific objectives of the study were to 
establish the: level of cognitive impairment amongst the inpatients on the Fitzmary II ward; 
feasibility of administering a neuropsychological test battery; acceptability of 
neuropsychological assessment from perspective of patients; and usefulness of 
neuropsychological assessment data in the planning of service delivery.  Fifteen inpatients 
were invited to participate in the assessment. There was a 90% acceptance rate.  All but three 
of the participants completed the full assessment, representing a completion rate of 77%.  The 
results indicate significant decline at the time of the assessment compared to estimates of 
premorbid functioning. Areas of particular difficulty were tests of attention and memory; 
visuospatial performance was a relative strength.  The assessment was acceptable to the 
inpatients, most of whom said they enjoyed the experience.  Professionals expressed some 
reservations about the usefulness of individual assessments. In summary, the assessment was 
feasible to deliver and acceptable to participants. Tests indicate significant levels of decline 
from estimates of premorbid levels, however, professionals reported that individual 
assessments were of limited clinical use.  Recommendations for future assessments included 
paired assessments and a dedicated professional to provide consultancy to the ward. 
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3.2. Introduction 
 
Cognitive deficits are noted in most, but not all, individuals diagnosed with a psychotic 
disorder [103, 104].  When present, research suggests common deficits include problems with 
memory, attention, executive function and processing speed [105, 104]. Typically those with a 
diagnosis of schizophrenia perform up to two standard deviations below average, and also 
below those with a diagnosis of other psychotic disorders such as an affective psychosis [103, 
106, 107].  The experience of cognitive difficulties in those with psychotic disorders has been 
associated with a sense of loss, shame and fear of the future [108], which may in turn lead to 
further impairments in cognitive performance.  Cognitive impairment has also been strongly 
linked with outcomes such as employment, independent living, quality of life [109, 104], 
dependency on services (see [105]), and may influence the capacity to learn new skills at the 
centre of rehabilitation programs and/or psychological therapies [105]. In this context, it is 
important to understand an individual’s level of cognitive functioning in order to be able to 
tailor treatment plans.  
 
The neuro-degeneration hypothesis of schizophrenia [110] and other psychotic disorders 
proposes that difficulties in cognitive functioning pre-date the onset of disorder, and that 
those with the more severe positive or negative symptoms may have had lower premorbid IQs 
and less ‘cognitive reserve’ to deal with the onset and impact of the disorder [111].  Various 
longitudinal and cohort studies provide relatively robust evidence of premorbid cognitive 
difficulties and potential further decline during the onset or early stages of the disorder [111, 
112, 105] however, there is inconsistent evidence regarding the long-term progression of 
cognitive difficulties in schizophrenia [113, 114, 105].  Studies addressing the question of 
progressive decline have been limited by methodological problems, such as cross sectional 
designs, small sample sizes and cohort effects.  However, recent longitudinal studies provide 
some evidence for the existence of cognitive decline in psychotic disorders. For example, in a 
longitudinal study over 33 years of 43 individuals diagnosed with schizophrenia and matched 
controls [114], deficits were identified in those with schizophrenia in verbal intelligence, non-
verbal abstract reasoning and problem solving skills at baseline.  There was no further decline 
in verbal intelligence over the 33 year period, however, there was evidence of further decline 
in non-verbal reasoning and problem-solving abilities, beyond that which was exhibited in the 
matched healthy controls [114]. Additionally, a 13 year prospective study of adolescents 
diagnosed with schizophrenia compared to those diagnosed with ADHD and healthy controls, 
suggests that beyond the initial deficits noted at onset, schizophrenia is associated with further 
decline in verbal memory and a lack of improvement (or ‘arrest) in attention and processing 
speed.   
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The extent to which these deficits represent true neuro-degeneration is unclear due to the 
number of other factors typically present in psychotic disorders which may influence, interact 
with or be the result of cognitive impairment.  For example, if the positive psychotic symptoms 
were successfully treated, would the cognitive deficits remain?  In addition to positive 
symptoms of psychosis, other psychological processes such as depression, anxiety or learned 
helplessness may influence performance on cognitive assessments.  Further, it is well 
established that individuals with psychotic disorders have a high prevalence of physical 
illnesses such as diabetes and high blood pressure and are at risk of premature death from 
such disorders [115]. Furthermore, the social context for individuals with psychotic disorders 
may exert an influence.  For example, it is well known that individuals with psychotic disorders 
are amongst the most socially isolated individuals in our communities [116] and social isolation 
can negatively affect cognitive function [117].  In this context, understanding the cognitive 
profile of individuals with psychotic disorders is extremely complex.   
 
The Fitzmary II ward is a National Specialist inpatient unit that provides specialist treatment 
and assessment of individuals who may present with one or many of the complexities 
discussed above. Those admitted to the Fitzmary II ward may have persistent psychotic 
symptoms, poor response or tolerance to common pharmacological treatments, co-morbid 
medical conditions that complicate treatment and/or mild learning disabilities.  The multi-
disciplinary staff on the Fitzmary II ward provide a range of interventions including innovative 
pharmacological, psychological, occupational therapies and nursing treatments.  
Understanding the individual cognitive profile of patients might facilitate more highly 
specialised individual treatment plans which take into consideration the individual’s cognitive 
strengths and weaknesses, facilitating treatment success and independence. For example, an 
individual may have particular strengths in visual processing and memory. Tailoring 
psychological interventions using visual aids and tools may improve the individuals’ response 
to treatment. Further, an understanding of the overall cognitive profile of the patients on the 
ward may facilitate service planning, for example providing evidence for the need of a 
specialist memory clinic or staff training to facilitate systems and processes which build 
independence, confidence and self-efficacy in the context of cognitive difficulties.  
 
In this context, the aim of the project was to understand the level of cognitive functioning 
difficulties on a long-stay national specialist ward for psychosis (the Fitzmary II ward). The 
specific objectives were to establish the  
- level of cognitive impairment amongst the inpatients on the Fitzmary II ward;  
- feasibility of administering a neuropsychological test battery;  
- acceptability of neuropsychological testing from perspective of patients; 
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The Fitzmary II ward is a National Psychosis Unit specialising in persistent and treatment 
resistant psychotic disorders. Many of the inpatients have comorbid physical health concerns 
which add complexity to the treatment of their mental health problem. The ward has 23 beds, 
with an average stay between 6-9 months.  The ward has a routine assessment covering a 
detailed personal history, medical and psychiatric history and current functioning and 
symptoms, however, staff do not routinely conduct neuropsychological assessments.  
 
Approvals for this study were obtained from the Psychosis Clinical Academic Group (CAG) – see 




Participants were inpatients on the Fitzmary II Ward.  All inpatients, other than those for 
whom testing would not have been feasible (for example, hearing impairment or being acutely 
unwell), were invited to participate.  
 
3.3.3. Procedure and data collection 
 
Testing was conducted on five days between January and May 2014.  Two or three 
assessments were completed on each visit to the ward.  Inpatients were approached by their 
lead psychologist and invited to participate in the assessment.  Inpatients were told that 
participation was not compulsory and that there would be no impact on their treatment if they 
did not wish to participate.  The assessments were conducted in the psychology office or 
meeting room on the ward at a time that was convenient to the participant. Those who chose 
to participate were told that the assessment would cover their strengths and weaknesses in 
memory, concentration and attention and this information would be used to tailor their 
treatment.  The participant was informed that they could take breaks as required.   
 
After the assessment, a report was compiled and sent to the psychologist in charge of the 
participant’s care for review.  Once the report was finalised, the psychologist in charge of the 
participant’s care reported the findings to the multi-disciplinary team and to the participant 
themselves.  
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Three neuropsychological measures were administered to assess the level of cognitive 
impairment: the Repeatable Battery for Assessment of Neuropsychological Status (RBANS), 
Test of Premorbid Functioning (TOPF) and Trail Making Test.  
 
The Repeatable Battery for Assessment of Neuropsychological Status (RBANS) [118] 
The RBANS is a brief neurocognitive battery measuring immediate and delayed memory, 
attention, language, and visuospatial skills. The RBANS was specifically developed for use in 
inpatient wards as it is comparatively quick to administer (average administration time is 25 
minutes).  It was originally designed to assess dementia, but has since been used to assess 
cognitive functioning in many disorders.   
 
The reliability and validity of the RBANS has been tested in community and inpatient samples 
of individuals diagnosed with schizophrenia and other psychotic disorders and shown to be a 
reliable and valid measure of cognitive impairment in such groups and comparable to fuller 
batteries [119, 120, 109, 121].  Studies using the RBANS to test current cognitive function in 
individuals diagnosed with schizophrenia suggest that this patient group tend to score around 
two standard deviations below the mean, i.e., a Total Scale of Score of approximately 70 [109, 
106, 107], which is significantly lower than those diagnosed with Bipolar Affective Disorder and 
control groups, and possibly associated with the severity of positive and negative symptoms 
[107]. 
 
The RBANS generates a Total Scale Score and five index scores: Immediate memory; 
Visuospatial/constructional; Language; Attention; Delayed memory.  Each of the index scores 
are described briefly below. 
 
Immediate memory index 
This index is a measure of initial encoding and learning of complex and simple verbal 
information. Low scores on this index indicate difficulties with verbal learning. There are two 
subtests: Story Memory and List Leaning.  For Story Memory, participants are read a short 
passage encompassing 12 items regarding a fire. Participants are asked to repeat as much 
detail as they can remember and using the original words where possible. After the initial 
attempt to repeat the story, the story is read a second time and participants are invited to 
repeat it again, this is to allow for learning.  The maximum score for this task is 24.  For the List 
Learning subtask, participants are read a list of 10 unrelated words, and asked to repeat as 
many as they can remember.  The list is repeated 4 times allowing for learning.  The total score 
is therefore 40.  
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Visuospatial/constructional index 
This index is a measure of basic visuospatial perception and the ability to copy a design from a 
model.  Low scores on this index indicate difficulties with processing and using visuospatial 
information.  There are two subtests: Figure Copy and Line Orientation.  The Figure Copy 
involves a direct copy of a complex geometric figure.  There are 10 components of the figure. 
Participants are scored for accuracy and placement, yielding a total score for this subtask of 
20.   In the Line Orientation task, participants are shown 10 arrays of 13 lines. Each line 
originates from a common central point and varies through 180 degrees.  For each item, 
participants are shown two target lines and asked to identify which lines they correspond to 
within the array.  The total score for this task is 20 (10 items with two lines to match).  
Attention index 
This index is a measure of auditory registration, visual scanning and processing speed.  Low 
scores indicate difficulties with aspects of attention and speed of information processing. 
There are two subtests: Digit Span and Coding.  On Digit Span, participants are read a list of 
numbers (from two to nine digits) and asked to verbally repeat the numbers back in the same 
order.  On the Coding task, participants are provided a ‘key’ at the top of the page which 
matches simple symbols to digits.  Below the key, participants are given a grid with the 
symbols and asked to enter the corresponding digit; participants have 90 seconds to complete 
as many items as possible.  
Language index 
The language index is a measure of expressive language function.  There are two subtests: 
Semantic Fluency and Picture Naming. The Semantic Fluency test requires participants to name 
as many fruits and vegetables as possible within a 60 second period.  Picture Naming requires 
participants to recognise and name drawings of common objects such as a sailing boat.  
Delayed Memory Index 
This index is a measure of delayed recall and recognition. The tests on this index require 
participants to recall and recognise material from the Story Memory and List Learning subtasks 
of the Immediate Memory Index and the Figure Copy subtask from the Visuospatial index.  Low 
scores indicate difficulties with recognition and retrieval of information from long term 
memory stores. 
Total Scale Index 
The raw scores on subtests are scaled together to create index scores. The Total Scale Index is 
a composite of all the indexes within the battery. The Total Scale Index score is a good 
indicator of the general cognitive functioning of the participant.  Low scores on this index 
strongly suggest general cognitive impairment. 
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The Test of Premorbid Functioning (TOPF) [122] 
The TOPF is reading test, designed to estimate an individual’s level of intellectual functioning 
before the onset of illness or injury.  It is a list of 70 words that the participant is required to 
read out loud.  The test is discontinued after five consecutive mispronunciations.  Total scores 
can be used to estimate premorbid ability compared to other scales such as FSIQ generated 
from the Weschler Adult Intelligence Scale.  
 
Trail Making Test (TMT) [123] 
The TMT is a test of executive functioning. It consists of two timed trials. The first trial involves 
the participant linking numbers, this is a test of processing speed.  The second trial involves 
linking numbers and letters in order, but switching between the two, for example, 1, A, 2, B, 3, 
C, 4, D... . This second trial assesses visual attention and task shifting.  The score for each trial is 
the amount of time taken to complete the task. Scores on the TMT for individuals diagnosed 
with schizophrenia show associations with psychotic symptomatology, and with other 
cognitive factors such as working memory, psychomotor speed and executive function [124].  
 
3.3.4. Process measures of feasibility and acceptability 
 
To assess the feasibility and acceptability of such assessments, process data were collected 
including:  
- the number of assessment refusals 
- the time and number of sessions taken to complete the assessment 
- acceptability of the assessment for service users was measured by a short 
questionnaire that was completed at the end of the assessment (see Appendix C)  
- acceptability and usefulness of assessment for clinicians via a short questionnaire (see 
Appendix D) 
- time taken to score assessment and draft the reports 
 
Demographics (age, ethnicity, gender, education, marital status) and clinical history (e.g., 
medical problems, mental health diagnosis, length of illness, time on the ward, medication) 
information was collected from clinical records. 
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3.4. Results 
3.4.1. Completion rates 
 
Overall, 15 patients of the Fitzmary II ward were invited to complete the assessment.  Of these 
15 patients, all but two patients accepted the invitation, resulting in a 90% acceptance rate.  
The reasons for not approaching other patients included: current risk issues, communication 
difficulties and being too symptomatic to consent and/or engage in the assessment. The two 
people who declined the invitation to participate said that they were uncomfortable with the 
idea of an assessment.  The demographics of the thirteen participants are shown in Table 1.  
 
All but three of the participants completed the full assessment battery (i.e., the TOPF, RBANS 
and TMT), which represents a completion rate of 77%.  The reasons for non-completion were 
varied.  Of the three who did not complete the full assessment battery, one participant 
completed everything except the TMT trial B – saying she simply did not want to continue, 
another participant became distressed by the Coding task in the RBANs and declined to 
continue with the assessment saying ‘I wish to quit. You know too much about me already. You 
can get what you need from that [coding sample]’, and the remaining participant repeatedly 
appeared to fall asleep and said ‘I don’t really want to do this – can I stop?.’ Most participants 
completed the assessment without taking breaks.  One participant left the testing session on 
three occasions, but returned each time and eventually completed the assessment battery.  
The remaining nine participants who completed the assessment did not take any breaks. 
 
3.4.2. Time taken to complete the assessment 
 
The average length of time taken to complete the assessment (excluding those who did not 
complete) was 34 minutes, ranging from 29 to 42 minutes.  The average elapsed time for those 
who completed the assessment, including breaks/walkouts was 39 minutes ranging from 29 to 
63 minutes.  For the three participants who did not complete the assessment, the elapsed time 
taken before leaving the assessment was 23, 35 and 22 minutes respectively. 
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Table 1: Demographics of the sample 
Variable Categories N=13 
Age (years; mean (range)) 
 
 40 (24-58) 
Age at first presentation to mental health 
services (mean (range)) 
 21 (9-29) 
Length of admission (months; mean (range)). 
 
 4 (0.25 – 14) 
Marital status (% single)  80 
Highest education level n(%) No qualification  3 
 GSCE 4  
 A-levels 3 
 Degree 2 
 Missing/unknown 1 
Diagnosis Schizophrenia  5 
 Schizoaffective Disorder 4 
 Treatment Resistant 
Schizophrenia 
4 
Comorbid physical health problems* Diabetes 2 
 Hydrocephalus 1 
 Hepatitis C 1 
 Cancer 1 
 Neurofibromatosis 1 
 Neuroleptic Malignant Syndrome 1 
 Pulmonary embolism 1 
 Asthma 1 
 None listed 7 
Learning difficulties  1 
Dyslexia  2 
* Some participants had more than one health problem 
 
Scoring the full assessment took approximately 15 minutes.  Writing and drafting the report 
took approximately two hours.  Therefore, the entire time taken to complete the assessment 
including administration of the tests, scoring and report writing was just under three hours per 
participant.   
 
3.4.3. Inpatient views on acceptability of the assessment 
 
The ten participants who completed the full assessment were asked for their opinion on the 
assessment. Participants were asked to rate their experience of the assessment in terms of 
enjoyment, satisfaction, stress, and difficulty. Their responses are shown in Table 2 below. All 
10 participants who completed the assessment said they would be happy to complete a similar 
assessment again.  
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Enjoyable  4.1 5 3-5 
Satisfied 4.2 5 3-5 
Stressful 1.9 1 1-4 
Difficult 2.4 1 1-4 
Note: 5= very enjoyable, very satisfied, very stressful and very difficult 
 
Good things about the process 
Participants were asked for their views on the good things about the assessment.  Seven 
participants provided a response to this question, two of whom said ‘all of it’.  One participant 
said that it ‘killed boredom on the ward’.  Another enjoyed specific aspects and content of the 
assessment saying ‘alphabet, firefighters, drawings, fruit’.  Two participants enjoyed 
performing well and learning new skills.  One participant who was about to be discharged from 
the ward hoped that it would help him get a flat.  
 
Aspects of the assessment that could be improved 
Participants were asked for their view on one thing that could have been improved about the 
assessment. Of the nine participants who provided a response to this question, six said they 
would not change any aspect of the process.  One participant wished he could change aspects 
of his performance and current memory,  
“I just wish I could remember the alphabet and months again.” 
One participant queried whether the particular tests used in the assessment battery would 
adequately capture his perception of his current cognitive difficulties,  
“After having ECT I find that I have a degree of difficulty remembering things from time 
to time and from day to day. If I go shopping I will tend to forget things that previously I 
would have remembered. If the tests have measured that, all well and good, but by 
asking me that and about it might capture the truth more effectively.” 
 
 
3.4.4. Professional views on the acceptability of the assessment 
 
The three psychologists on the ward were asked for their views on the helpfulness of the 
information gleaned from the assessment (rating out of 10 where 10 was extremely helpful 
and 1 was extremely unhelpful).  One psychologist said that the ‘Information has been used to 
inform the care plan and to think about the interventions we are delivering’ and rated the 
helpfulness as 8/10.  The remaining two psychologists rated the helpfulness as 5/10 or 
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‘neutral’ stating concerns about the generalisability of the results. One psychologist said that 
as the medication and presentation of the patients on the ward was constantly changing, it 
was difficult to ascertain how relevant the findings were at any particular time.  Another 
psychologist said that while it was useful to have recommendations for staff and evidence of 
cognitive impairments, the fact that the participants were acutely unwell at the time of testing, 
limited the generalisability of the results.  There was also some concern expressed regarding 
how this information would be used by clinicians in the future – i.e., reading the results as 
‘fact’ without reference to the context of testing and the impact of illness at the point of 
testing.    
 
In terms of the test battery, the psychologists were pleased with the overview of the current 
level of functioning obtained by the RBANS and other measures.  There was an 
acknowledgement of the suitability of the brief nature of the battery for this particular patient 
group.  One psychologist suggested that other aspects would be useful such as gaining more 
information of types of attention deficits (i.e. selective, divided, impulsivity) and having a 
greater focus on tests of frontal lobe functioning.  
 
In terms of recommendations for improvement, three things were suggested:  
- a dedicated person on the ward to complete them;   
- assessments at admission and discharge rather than one point in time;  
- results being translated into real world examples for the report.  
 
The psychologists were asked if they would recommend routine neuropsychological testing on 
the ward and their responses were mixed.  One psychologist said that they were unsure about 
the usefulness of testing on the ward when participants were acutely unwell. Another 
responded that they would ‘definitely’ recommend it.  The remaining psychologist said that 
they would not recommend it due to the time taken to complete the assessment.  
 
 
3.4.5. Cognitive profile of participants.  
 
The RBANs full scale index for the participants is presented in Table 3.  Three participants 
scored between 80 and 90 which would be considered ‘low average range’; three between 70 
and 80 i.e., the ‘borderline’ range; and the remaining five participants score between 42 and 
70 which is considered the ‘extremely low’ range.  Table 4 provides a summary of the groups’ 
functioning. 
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Table 3: Difference between Premorbid IQ and RBANs total scale by individual 
 TOPF estimate of 
premorbid IQ 
RBANS total scale 
index 
Difference 
1 95 69 -26 
2 92 73 -19 
3 75 42 -33 
4 105 87 -18 
5 78 53*** -25 
6 - 51***  
7 - 56***  
8 102 86 -16 
9 114 79 -35 
10 99 72*** -27 
11 94 45 -49 
12 93   
13 95   
*** overall scale score wasn’t reliable due to variations between indices (i.e., differences 
greater than 23) in most cases the visuo-spatial index was significantly higher than other 
indices 
 
Table 3: Overall summary of cognitive functioning  
 N Average Descriptor SD Range 
Premorbid IQ 11 95 Average 11.1 75-114 
RBANS IQ estimate 12 66 Extremely Low 16.4 42-87 
Immediate Memory index 13 62 Extremely low 17.5 40-85 
Delayed Memory Index 10 66 Extremely Low 20.9 40-94 
Visuo-spatial 13 84 Low Average 19 50-109 
Language 13 78 Borderline 12 54-101 
Attention 11 64 Extremely Low 19.5 40-91 
TMT – A 11 48.2  15.9 22-78 
TMT – B 8 118.5  47.1 76-214 
TMT – Ratio - 2.45 unimpaired   
*RBANS IQ estimate was prorated for individuals missing one index score.  
 
In general, participants’ performance on the RBANs indicated a decline in overall functioning 
from the premorbid estimates – see Figure 1.  Areas of particular difficulty were the Immediate 
Memory Index and Attention Index.  Performance on Visuospatial Index and in many cases the 
Language index, were areas of comparative strength for many participants.  In terms of the 
TMT test, only three of the eight who completed the two trials had a ratio greater than 2.5 
which is indicative of impairment. 
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3.5. Discussion  
 
The primary aim of this project was to assess the level of cognitive impairment on the Fitzmary 
II ward.  Thirteen participants completed at least part of the assessment battery. The estimate 
of the premorbid functioning for the overall sample using the TOPF was within average range, 
however the estimate of current functioning for the overall sample using the RBANs was 
significantly below this in the ‘extremely low’ range. The level of current functioning assessed 
by the RBANS is consistent with previous research in similar patient groups [109, 125, 106]. 
However, the discrepancy between the premorbid and current estimates of functioning is larger 
than findings of previous research [106] which is perhaps indicative of the complexity of the 
patients on the Fitzmary II ward.  In line with previous research [109, 126], attention and 
working memory were the areas of most difficulty for participants, while the visuospatial and 
language indices were the areas of least difficulty.  
 
The second aim of the project was to determine the feasibility and acceptability of 
neuropsychological testing on the Fitzmary II ward. Results indicate that the battery of tests 
used in this project were feasible to administer and acceptable to participants.  The 
administration of the tests was successful; the brief nature of the RBANs and the short 
individual tests were useful to maintain the participants’ interest and motivation.  There were 
very few refusals of invitation to participate and very few people did not complete the full 
assessment.  Qualitative responses from service user participants were positive (the most 
frequent responses were 5/5 for enjoyable and 1/5 for stressful).  Participants appeared to 
enjoy the novelty of the assessment and enjoyed being challenged in this manner.  Some 
reported that they enjoyed learning new skills.  The responses from the psychology team were 
more circumspect.  In some instances, reports were used to inform other members of the 
clinical team of current levels of functioning of participants and influenced treatment plans.  
However, some of the psychologists expressed concern regarding the usefulness of the testing 
in the context of rapidly changing clinical presentation of participants, particularly while 
undergoing various intensive treatments on the ward.   
 
In this context, two questions emerge from these data.  Firstly, to what extent is the individual 
snapshot generalisable beyond the context of acute hospitalisations, i.e., would the deficits 
identified in the assessments be relevant once individuals are stabilised sufficiently to be 
discharged?  Secondly, are individual profiles provided by the assessment useful considering the 
amount of time involved in the administration and scoring?  
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3.5.1. Considering the stability of cognitive difficulties 
 
In the past, schizophrenia has been considered a neuro-degenerative condition similar to 
dementia (dementia praecox).  If this were the case, assessment at any point during an 
individuals’ experience of the illness would provide an indication of functioning from which the 
person would likely deteriorate further.  However, few methodologically rigorous longitudinal 
studies have been completed and those that have suggest some decline, but these findings 
need replication. More recently, cognitive interventions such as Cognitive Remediation Therapy 
show promising effects [126] which suggests that rather than an inevitable decline, some 
fluctuations in a person’s cognitive performance are possible. In this context, 
neuropsychological assessments are likely to provide a snapshot of functioning, but need to be 
interpreted with caution and repeated at appropriate intervals to determine evidence for long-
term decline. Studies using the RBANs for individuals diagnosed with schizophrenia (Gold et al, 
1999) suggest good test-retest reliability, however, these findings covered a 12 week period and 
were amongst mostly outpatients.  Gold and colleagues (1999) examined the relationship of 
cognitive performance to symptoms and found that the profiles were relatively independent of 
symptoms, however these analyses were conducted during a period of symptomatic stability. In 
this context, little is known about the longer term reliability of the findings from the RBANs for 
individuals with psychotic diagnoses, and particularly amongst those in the more acute phases 
of the illness.  
 
The assessments in this study were conducted after an average of four months on the Fitzmary 
II ward and participants were subject to changing care plans involving pharmacological and 
psychological interventions.  The report provided for each participant was therefore a snapshot 
of how they were presenting on a given day. In the absence of convincing long-term evidence of 
the stability of cognitive performance assessed by the RBANs in such contexts, we are unable to 
determine the long-term relevance of the findings. On the one hand, as the RBANs tests are not 
particularly difficult as it was originally developed to assess dementia amongst inpatients. 
Considering the consistently poor performance of the sample on these relatively simple tasks, 
we may conclude that this provides evidence of significant impairment at the time of 
assessment, however, without re-testing the sample we cannot conclude that we have evidence 
of longer term decline. It is likely that following optimisation of pharmacological intervention 
and/or response to psychological therapy, their performance on this assessment would 
improve. In this context, the single snapshot provided by this assessment is useful as a baseline, 
but further testing, perhaps at discharge, would be required to establish the stability of the 
findings and provide recommendations for the individual beyond their presentation at an acute 
stage of illness.  
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3.5.2. Similarities in cognitive profile 
 
The overall findings regarding the cognitive profile of residents during the testing period was 
largely consistent with previous research and commonly reported deficits in those diagnosed 
with a psychotic disorder.  Most participants performed lower than would be expected based 
on estimates of premorbid functioning on tests of attention and memory and many had a 
comparative strength in visuospatial processing. Many of the recommendations for tailoring of 
treatment for individuals were common across the reports and included the use of visual 
prompts in therapy sessions, memory aids such as the use of written reminders, calendars and 
verbal repetition of information.   
 
3.5.3. Logistics of neuropsychological assessment  
 
The acceptance and completion rates for the assessment battery were very high, suggesting 
that routine testing would be feasible and acceptable to inpatients.  However, the estimate of 
time taken for the testing and generation of the reports (three hours) did not include the time 
taken by the psychologists in the team in setting up the assessments, feeding back the reports 
to the MDT and the participants themselves. In this context, the time taken overall to 
implement routine neuropsychological testing would be substantially longer than three hours. 
In addition, considering the level of complexity and rapid changes in the clinical presentation of 
the ward, one-off neuropsychological assessments of questionable long-term benefit (see 
above) are unlikely to be prioritised over pressing clinical issues.  For example, on one day when 
testing was due to take place, there was a significant risk issue for one of the inpatients which 
required the use of the office that was booked for testing.  The neuropsychological testing was 
rightly abandoned to enable the clinical risk issue to be appropriately addressed.  Further, the 
number of assessments completed was likely higher than what might be achieved in routine 
practice as there was a person who sole role was to complete the assessments.  Furthermore, 
neuropsychological assessment requires a quiet room with limited distractions – something that 




There a several limitations to these data. Firstly, the acceptability data from the perspective of 
service user participants was limited to their views on the acceptability of the assessment. We 
did not gather data on the number of service users whose psychologist discussed their report 
with them, and amongst those, what the experience was like for service users and whether the 
report was helpful for them.  These data would be important to gauge the relevance and impact 
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of the report for service users. Secondly, we did not collect data from other professionals on the 
ward (e.g., nurses, psychiatrists) regarding the usefulness of the report in their work.  Thirdly, 
we were not able to re-test individuals due to time limitations. These data would be particularly 
important to determine the stability of the difficulties uncovered in the assessment and to 
potentially increase engagement in the findings from the professionals.  Fourthly, a larger 
sample on the ward would provide more information regarding how typical the findings are.  
Finally, we did not measure psychotic, mood or anxiety symptoms at the time of the 
assessment, nor the impact of any co-morbid physical health problems.  In this context, we are 
unable to determine how the individual’s performance was influenced by such co-morbidity, 
and therefore the findings regarding the cognitive profile of the patients must be interpreted 




- At this stage, it is recommended not to continue with testing on the ward in the manner 
trialled in this study, particularly considering the ambiguity regarding the usefulness of a 
single assessment, the amount of time taken and the similarity in recommendations 
between reports. 
 
- However, benefits from neuropsychological testing (participant enjoyment; 
individualised plans; evidence for the effectiveness of treatment) could be harnessed if 
a different approach was taken to the administration.  To enhance the value of 
neuropsychological assessment on the ward, there are four main recommendations:   
1. Conducting paired/repeat assessments: Adding neuropsychological 
assessments to the battery of assessments conducted on admission to the ward 
and repeating this assessment at discharge from the ward (at a minimum).  
Such paired assessments could: 
 be used as evidence of the effectiveness of the intervention 
 provide useful information regarding the profile of individual patients 
on admission 
 provide evidence for stability of cognitive difficulties over the course of 
treatment  
2. Conducting ecologically valid assessments:  Assessments relevant to aspects of 
treatment and life on the ward would enhance the relevance of the assessment 
findings for clinicians. 
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3. Assessing the acceptability and impact of the report findings for service users: 
Understanding how service users understood and appraised the findings from 
the reports would be useful. For example, discovering one has cognitive deficits 
may be additionally stigmatising for some individuals leading to a sense of 
hopelessness.  Others may find the strategies suggested in reports useful and 
empowering.   
4. Having a dedicated professional to conduct assessments: A part-time 
neuropsychologist on the ward could: 
 Ensure the accurate interpretation and application of findings from 
assessment, including training staff in main concepts and overseeing 
the application of recommendations 
 Gather data on psychological and physical symptom at the time of 
assessment to provide a nuanced account of the individual’s 
performance. 
 Prioritise neuropsychological assessment on the ward 
 Be known by the patients on the ward, decreasing the time involved for 
lead clinicians (i.e., be able to directly approach patients, report back to 
MDT, facilitate feedback to patients with lead clinician) 
 Assist in service planning by providing expertise in the impact of service 
plans on the cognitive profile of the inpatients.  
 
3.5.6.  Dissemination 
 
The individual assessment reports were given to the lead psychologist of the patient who then 
discussed it with the patient and separately with the rest of the ward team during ward rounds.  




The psychology team on the ward were invested in the project and were integral in the delivery 
of the project (i.e., through organising and helping to recruit participants).  The psychology team 
on the ward used the reports to influence care packages and to inform other staff members 
regarding the cognitive functioning of the inpatients on the ward.  However, overall the findings 
of this report suggest that routine testing in the manner applied in this project is of limited 
validity for the psychology team. In this context, this report recommends against routine 
neuropsychological testing unless changes are made (see recommendations).  Nevertheless, the 
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findings of this report may influence service planning and provision on the ward, particularly if 
the recommendations for delivery of neuropsychological testing are implemented.   
 
  
Page 87 of 128 
4. Combined References 
 
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition. http://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596; 
2013. 
2. Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation. A 
systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(1):9-18. doi:10.1007/s00127-
004-0701-4. 
3. Sierra M, Berrios GE. The Cambridge Depersonalization Scale: a new instrument for the 
measurement of depersonalization. Psychiatry Res. 2000;93(2):153-64.  
4. Spiegel D, Loewenstein RJ, Lewis-Fernandez R, Sar V, Simeon D, Vermetten E et al. 
Dissociative disorders in DSM-5. Depression and Anxiety. 2011;28(12):E17-E45. 
doi:http://dx.doi.org/10.1002/da.20923. 
5. Holmes EA, Brown RJ, Mansell W, Fearon RP, Hunter EC, Frasquilho F et al. Are there two 
qualitatively distinct forms of dissociation? A review and some clinical implications. Clin 
Psychol Rev. 2005;25(1):1-23. doi:10.1016/j.cpr.2004.08.006. 
6. Hunter E, Phillips M, Chalder T, Sierra M, David A. Depersonalisation disorder: A cognitive-
behavioural conceptualisation. Behaviour Research and Therapy. 2003;41(12):1451-67. 
doi:http://dx.doi.org/10.1016/S0005-7967%2803%2900066-4. 
7. Simeon D. Depersonalisation Disorder: A Contemporary Overview. CNS Drugs. 
2004;18(6):343-54. doi:http://dx.doi.org/10.2165/00023210-200418060-00002. 
8. Sierra M. Depersonalization disorder: pharmacological approaches. Expert rev. 2008;8(1):19-
26.  
9. Spiegel D, Lewis-Fernandez R, Lanius R, Vermetten E, Simeon D, Friedman M. Dissociative 
Disorders in DSM-5. Annual Review of Clinical Psychology, Vol 9. 2013;9:299-326. 
doi:10.1146/annurev-clinpsy-050212-185531. 
10. Sass LA, Parnas J. Schizophrenia, consciousness, and the self. Schizophr Bull. 2003;29(3):427-
44.  
11. Sass L, Pienkos E, Nelson B. Introspection and schizophrenia: a comparative investigation of 
anomalous self experiences. Conscious Cogn. 2013;22(3):853-67. 
doi:http://dx.doi.org/10.1016/j.concog.2013.05.004. 
12. Sedman G, Kenna J. Depersonalization and mood changes in schizophrenia. The British 
Journal of Psychiatry. 1963;109(Whole No. 462):669-73. 
doi:http://dx.doi.org/10.1192/bjp.109.462.669. 
Page 88 of 128 
13. Longden E, Madill A, Waterman MG. Dissociation, Trauma, and the Role of Lived Experience: 
Toward a New Conceptualization of Voice Hearing. Psychol Bull. 2012;138(1):28-76. 
doi:10.1037/a0025995. 
14. Moskowitz A. Schizophrenia, trauma, dissociation, and scientific revolutions. J Trauma 
Dissociation. 2011;12(4):347-57. doi:10.1080/15299732.2011.573770. 
15. Kilcommons AM, Morrison AP. Relationships between trauma and psychosis: an exploration 
of cognitive and dissociative factors. Acta Psychiatr Scand. 2005;112(5):351-9. 
doi:10.1111/j.1600-0447.2005.00623.x. 
16. Perona-Garcelan S, Carrascoso- Lopez F, Garcia-Montes JM, Ductor-Recuerda MJ, Jimenez 
AML, Vallina-Fernandez O et al. Dissociative experiences as mediators between childhood 
trauma and auditory hallucinations. Journal of Traumatic Stress. 2012;25(3):323-9. 
doi:http://dx.doi.org/10.1002/jts.21693. 
17. Perona-Garcelan S, Cuevas-Yust C, Garcia-Montes JM, Perez-Alvarez M, Ductor-Recuerda 
MJ, Salas-Azcona R et al. Relationship between self-focused attention and dissociation in 
patients with an without auditory hallucinations. Journal of Nervous and Mental Disease. 
2008;196(3):190-7. doi:http://dx.doi.org/10.1097/NMD.0b013e318165c7c1. 
18. Allen JG, Coyne L, Console DA. Dissociative detachment relates to psychotic symptoms and 
personality decompensation. Comprehensive Psychiatry. 1997;38(6):327-34. doi:Doi 
10.1016/S0010-440x(97)90928-7. 
19. Parnas J, Handest P. Phenomenology of anomalous self-experience in early schizophrenia. 
Comprehensive Psychiatry. 2003;44(2):121-34.  
20. Angel Gonzalez-Torres M, Inchausti L, Aristegui M, Ibanez B, Diez L, Fernandez-Rivas A et al. 
Depersonalization in Patients with Schizophrenia Spectrum Disorders, First-Degree Relatives 
and Normal Controls. Psychopathology. 2010;43(3):141-9. doi:10.1159/000288635. 
21. Allen JG, Coyne L, Console DA. Dissociative detachment relates to psychotic symptoms and 
personality decompensation. Compr Psychiatry. 1997;38(6):327-34.  
22. Fowler D, Freeman D, Steel C, Hardy A, Smith B, Hackman C et al. The catastrophic 
interaction hypothesis. How do stres, trauma, emotion and information processing 
abnormalities lead to psychosis? In: Larkin W, Morrison AP, editors. Trauma and Psychosis. 
New Directions for theory and therapy. London: Routledge; 2006. 
23. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive 
symptoms of psychosis. Psychol Med. 2001;31(2):189-95.  
24. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach 
to hallucinations and delusions. Behavioural and Cognitive Psychotherapy. 2001;29(3):257-
76.  
Page 89 of 128 
25. Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a 
review. Soc Psychiatry Psychiatr Epidemiol. 2014;49(8):1179-89. doi:10.1007/s00127-014-
0928-7 [doi]. 
26. Lee WE, Kwok CH, Hunter EC, Richards M, David AS. Prevalence and childhood antecedents 
of depersonalization syndrome in a UK birth cohort. Social Psychiatry & Psychiatric 
Epidemiology. 2012;47(2):253-61. doi:10.1007/s00127-010-0327-7 [doi]. 
27. Freeman D. Improving cognitive treatments for delusions. Schizophr Res. 2011;132(2-3):135-
9. doi:10.1016/j.schres.2011.08.012. 
28. Pilton M, Varese F, Berry K, Bucci S. The relationship between dissociation and voices: A 
systematic literature review and meta-analysis. Clin Psychol Rev. 2015;40:138-55. 
doi:10.1016/j.cpr.2015.06.004. 
29. Carlson EB, Putnam F. An update on the Dissociative Experiences Scale. Dissociation. 
1993;6(1):16-27.  
30. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J 
Nerv Ment Dis. 1986;174(12):727-35.  
31. Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in 
the general population: taxometric and behavior genetic findings. J Abnorm Psychol. 
1997;106(4):499-510.  
32. Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of 
observational studies that examine incidence or prevalence and risk factors for diseases. J 
Clin Epidemiol. 2010;63(10):1061-70. doi:10.1016/j.jclinepi.2010.04.014. 
33. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al. The 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: 
guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. 
doi:10.1371/journal.pmed.0040296. 
34. Groenwold RH, Rovers MM. The Catch-22 of appraisals on the quality of observational 
studies. J Clin Epidemiol. 2010;63(10):1059-60. doi:10.1016/j.jclinepi.2010.04.013. 
35. Shamliyan TA, Kane RL, Ansari MT, Raman G, Berkman ND, Grant M et al. Development 
quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of 
chronic diseases: pilot study of new checklists. J Clin Epidemiol. 2011;64(6):637-57. 
doi:10.1016/j.jclinepi.2010.08.006. 
36. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the 
health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 
1998;19(4):170-6.  
Page 90 of 128 
37. Krueger C, Mace CJ. Psychometric validation of the State Scale of Dissociation (SSD). 
Psychology and Psychotherapy: Theory, Research and Practice. 2002;75(1):33-51. 
doi:http://dx.doi.org/10.1348/147608302169535. 
38. Ross CA, Heber S, Anderson G. The Dissociative Disorders Interview Schedule. Am J 
Psychiatry. 1990;147(12):1698-9.  
39. Brunner R, Parzer P, Schmitt R, Resch F. Dissociative Symptoms in Schizophrenia: A 
Comparative Analysis of Patients with Borderline Personality Disorder and Healthy Controls. 
Psychopathology. 2004;37(6):281-4. doi:http://dx.doi.org/10.1159/000081984. 
40. Cernis E, Dunn G, Startup H, Kingdon D, Wingham G, Pugh K et al. Depersonalization in 
patients with persecutory delusions. Journal of Nervous and Mental Disease. 
2014;202(10):752-8. doi:http://dx.doi.org/10.1097/NMD.0000000000000185. 
41. Fagioli F, Telesforo L, Dell'Erba A, Consolazione M, Migliorini V, Patane M et al. 
Depersonalization: An exploratory factor analysis of the Italian version of the Cambridge 
Depersonalization Scale. Comprehensive Psychiatry. 2015;60:161-7. 
doi:10.1016/j.comppsych.2014.06.007. 
42. Krueger C, Bartel P, Fletcher L. Dissociative Mental States Are Canonically Associated with 
Decreased Temporal Theta Activity on Spectral Analysis of EEG. Journal of Trauma & 
Dissociation. 2013;14(4):473-91. doi:10.1080/15299732.2013.769480. 
43. Luque Luque R, Chauca Chauca G, Alonso Lobato P, Jaen Moreno MJ. Despersonalizacion y 
esquizofrenia: estudio comparativo entre primeros y multiples episodios de esquizofrenia. 
Revista de Psiquiatria y Salud Mental. 2016;in press.  
44. Migliorini V, Dell'Erba A, Fagioli F, Sierra M, Mosticoni S, Telesforo L et al. Italian (cross 
cultural) adaptation and validation of the Cambridge Depersonalization Scale (CDS). 
Epidemiology and Psychiatric Sciences. 2012;21(2):221-6. doi:10.1017/s2045796011000850. 
45. Molina Castillo JJ, Martinez de la Iglesia J, Albert Colomer C, Berrios G, Sierra M, Luque 
Luque R. [Cross-cultural adaptation and validation of the Cambridge Depersonalisation 
Scale]. Actas Espanolas de Psiquiatria. 2006;34(3):185-92.  
46. Perona-Garcelan S, Carrascoso-Lopez F, Garcia-Montes JM, Vallina-Fernandez O, Perez-
Alvarez M, Ductor-Recuerda MJ et al. Depersonalization as a mediator in the relationship 
between self-focused attention and auditory hallucinations. Journal of Trauma & 
Dissociation. 2011;12(5):535-48. doi:http://dx.doi.org/10.1080/15299732.2011.602181. 
47. Perona-Garcelan S, Garcia-Montes JM, Ductor-Recuerda MJ, Vallina-Fernandez O, Cuevas-
Yust C, Perez-Alvarez M et al. Relationship of metacognition, absorption, and 
depersonalization in patients with auditory hallucinations. British Journal of Clinical 
Psychology. 2012;51(1):100-18. doi:http://dx.doi.org/10.1111/j.2044-8260.2011.02015.x. 
Page 91 of 128 
48. Schafer I, Fisher HL, Aderhold V, Huber B, Hoffmann-Langer L, Golks D et al. Dissociative 
symptoms in patients with schizophrenia: Relationships with childhood trauma and psychotic 
symptoms. Comprehensive Psychiatry. 2012;53(4):364-71. 
doi:http://dx.doi.org/10.1016/j.comppsych.2011.05.010. 
49. Spitzer C, Haug HJ, Freyberger HJ. Dissociative symptoms in schizophrenic patients with 
positive and negative symptoms. Psychopathology. 1997;30(2):67-75.  
50. Yargic LI, Sar V, Tutkun H, Alyanak B. Comparison of dissociative identity disorder with other 
diagnostic groups using a structured interview in Turkey. Comprehensive Psychiatry. 
1998;39(6):345-51.  
51. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: 
psychometric properties. J Consult Clin Psychol. 1988;56(6):893-7.  
52. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical 
Psychology. 1959;32(50-55).  
53. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl 
Pharmacopsychiatry. 1974;7(0):151-69.  
54. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in 
psychiatric outpatients. J Pers Assess. 1996;67(3):588-97. 
doi:10.1207/s15327752jpa6703_13. 
55. Kay SR, Fiszbein A, Opler LW. The Positive and Negative Syndrome Scale (PANSS) for 
Schizophrenia. Schizophr Bull. 1987;13(2):261-76.  
56. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? 
Schizophr Res. 2005;79(2-3):231-8. doi:10.1016/j.schres.2005.04.008. 
57. Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for 
depersonalisation disorder: an open study. Behav Res Ther. 2005;43(9):1121-30. 
doi:10.1016/j.brat.2004.08.003. 
58. Jaen Moreno MJ, Chauca Chauca G, Alonso Lobato P, Guiote Malpartida M. 
Depersonalization and schizophrenia. European Neuropsychopharmacology. 2015;25:S545-S.  
59. Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for 
depersonalisation disorder: an open study. Behav Res Ther. 2005;43(9):1121-30.  
60. Kirkbride JB, Errazuriz A, Croudace TJ, Morgan C, Jackson D, McCrone P et al. Systematic 
review of the incidence and prevalence of schizophrenia and other psychoses in England. 
http://www.psychiatry.cam.ac.uk/files/2014/05/Final-report-v1.05-Jan-12.pdf: Department 
of Health, Policy Research Programme2012. 
61. Kessler RC, Birnbaum H, Demler O, Falloon IR, Gagnon E, Guyer M et al. The prevalence and 
correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). 
Biol Psychiatry. 2005;58(8):668-76. doi:10.1016/j.biopsych.2005.04.034. 
Page 92 of 128 
62. Knapp M, Andrew A, McDaid D, Iemmi V, McCrone P, Park A-L et al. Investing in recovery: 
making the business case for effective interventions for people with schizophrenia and 
psychosis. London: PSSRU, The London School of Economics and Political Science, and Centre 
for Mental Health.2014. 
63. Bracken P, Thomas P, Timimi S, Asen E, Behr G, Beuster C et al. Psychiatry beyond the 
current paradigm. Br J Psychiatry. 2012;201(6):430-4. doi:10.1192/bjp.bp.112.109447. 
64. The Schizophrenia Commission. The abondoned illness: a report by the Schizophrenia 
Commission. London, 2012. 
65. National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in 
adults: prevention and management [CG178]. London: NICE; 2014. 
66. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy 
for the symptoms of schizophrenia: systematic review and meta-analysis with examination of 
potential bias. Br J Psychiatry. 2014;204(1):20-9. doi:10.1192/bjp.bp.112.116285. 
67. Peters E. An oversimplification of psychosis, its treatment, and its outcomes? Br J Psychiatry. 
2014;205(2):159-60. doi:10.1192/bjp.205.2.159a. 
68. Thomas N. What's really wrong with cognitive behavioral therapy for psychosis? Front 
Psychol. 2015;6:323. doi:10.3389/fpsyg.2015.00323. 
69. Freeman D. Improving cognitive treatments for delusions. Schizophrenia Research. 
2011;132:135-9.  
70. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive 
symptoms of psychosis. Psychol Med. 2001;31(2):189-95.  
71. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach 
to hallucinations and delusions. Behavioural and Cognitive Psychotherapy. 2001;29:257-76.  
72. Freeman D, Dunn G, Startup H, Pugh K, Cordwell J, Mander H et al. Effects of cognitive 
behaviour therapy for worry on persectory delusions in patients with psychosis (WIT): a 
parallel, single-blind, randomised controlled trial with a mediation analysis. Lancet 
Psychiatry. 2016;2(4):305-13.  
73. Parnas J, Handest P. Phenomenology of anomalous self-experience in early schizophrenia. 
Compr Psychiatry. 2003;44(2):121-34. doi:10.1053/comp.2003.50017. 
74. Baker D, Hunter E, Lawrence E, Medford N, Patel M, Senior C et al. Depersonalisation 
disorder: clinical features of 204 cases. Br J Psychiatry. 2003;182:428-33.  
75. Cernis E, Dunn G, Startup H, Kingdon D, Wingham G, Pugh K et al. Depersonalisation in 
patients with persectory delusions. Journal of Nervous and Mental Disease. 2014;202(10). 
doi:10.1097/NMD.0000000000000185. 
Page 93 of 128 
76. Longden E, Madill A, Waterman MG. Dissociation, trauma, and the role of lived experience: 
toward a new conceptualization of voice hearing. Psychol Bull. 2012;138(1):28-76. doi:2011-
25889-001 [pii];10.1037/a0025995 [doi]. 
77. Freeman D, Fowler D. Routes to psychotic symptoms: trauma, anxiety and psychosis-like 
experiences. Psychiatry Res. 2009;169(2):107-12. doi:S0165-1781(08)00229-1 
[pii];10.1016/j.psychres.2008.07.009 [doi]. 
78. Grubaugh AL, Zinzow HM, Paul L, Egede LE, Frueh BC. Trauma exposure and posttraumatic 
stress disorder in adults with severe mental illness: a critical review. Clin Psychol Rev. 
2011;31(6):883-99. doi:10.1016/j.cpr.2011.04.003. 
79. Kilcommons AM, Morrison AP. Relationship between trauma and psychosis: an exploration 
of cognitive and dissociative factors. Acta Psychiatrica Scandinavica. 2005;112:351-9.  
80. Mueser KT, Lu W, Rosenberg SD, Wolfe R. The trauma of psychosis: posttraumatic stress 
disorder and recent onset psychosis. Schizophr Res. 2010;116(2-3):217-27. 
doi:10.1016/j.schres.2009.10.025. 
81. Shevlin M, Dorahy MT, Adamson G. Trauma and Psychosis: An analysis of the National 
Comorbidity Survey. American Journal of Psychiatry. 2007;164:166-9.  
82. Hunter EC, Salkovskis PM, David AS. Attributions, appraisals and attention for symptoms in 
depersonalisation disorder. Behav Res Ther. 2014;53:20-9. doi:S0005-7967(13)00196-4 
[pii];10.1016/j.brat.2013.11.005 [doi]. 
83. Sass L, Pienkos E, Nelson B, Medford N. Anomalous self-experience in depersonalization and 
schizophrenia: A comparative investigation. Consciousness and Cognition: An International 
Journal. 2013;22(2):430-41. doi:http://dx.doi.org/10.1016/j.concog.2013.01.009. 
84. Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for 
depersonalisation disorder: an open study. Behaviour Research and Therapy. 2005;43:1121-
30.  
85. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of 
hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological 
Medicine. 1999;29:879-89.  
86. Sierra M, Berrios GE. The Cambridge Depersonalisation Scale: a new instrument for the 
measurement of depersonalisation. Psychiatry Research. 2000;93:153-64.  
87. Hunter EC, Phillips ML, Chalder T, Sierra M, David AS. Depersonalisation disorder: a 
cognitive-behavioural conceptualisation. Behav Res Ther. 2003;41(12):1451-67. 
doi:S0005796703000664 [pii]. 
88. Department of Health. The Care Programme Approach. London: Department of Health1991. 
Page 94 of 128 
89. Blackburn I-M, James IA, Milne DL, Baker C, Standart S, Garland A et al. The revised cognitive 
therapy scale (CTS-R): Psychometric properties. Behavioural and Cognitive Psychotherapy. 
2001;29:431-46.  
90. Beck AT, Wright FD, Newman CE, Liese BS. Cognitive Therapy of Substance Abuse. New York: 
Guildford Press; 1993. 
91. Miles H, Peters E, Kuipers E. Service-user satisfaction with CBT for Psychosis. Behavioural 
and Cognitive Psychotherapy. 2007;35:109-16.  
92. Sierra M, Baker D, Medford N, David AS. Unpacking the depersonalization syndrome: an 
exploratory factor analysis on the Cambridge Depersonalization Scale. Psychological 
Medicine. 2005;35(10):1523-32. doi:10.1017/S0033291705005325. 
93. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring 
depression. Archives of General Psychiatry. 1961;4:561-71.  
94. Beck AT, Epstien N, Brown G, Steer RA. An inventory for measuring clinical anxiety: 
psychometric properties. Journal of Consulting and Clinical Psychology. 1988;56:893-7.  
95. Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of 
posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological Assessment. 
1997;9(4):445-51.  
96. Steinberg M. Structured clinical interview for DSM-IV dissociative disorders (SCID-D). 
Washington, DC1993 1993. 
97. Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review 
of current practice and editorial policy. BMC Medical Research Methodology. 2014;10:67.  
98. Brown RH. On the use of a pilot sample for sample size determination. Statistics in Medicine. 
1995;14(1933):1940.  
99. Peters E, Crombie T, Agbedjro D, Johns LC, Shahl D, Greenwood K et al. The long-term 
effectiveness of cognitive behavior therapy for psychosis within a routine psychological 
therapies service. Frontiers in Psychology. 2015;6(1658). doi:doi: 10.3389/fpsyg.2015.01658. 
100. Gonzales-Torres MA, Inchausti L, Aristegui M, Ibanez B, Diez L, Fernandez-Rivas A et al. 
Depersonalisation in patients with schizophrenia spectrum disorders, first-degree relatives 
and normal controls. Psychopathology. 2010;43:141-9.  
101. Schafer I, Aderhold V, Freyberger HJ, Spitzer C. Dissociative symptoms in schizophrenia. In: 
Moskowitz A, Schafer I, Dorahy MJ, editors. Psychosis, Trauma and Dissociation: Emerging 
perspectives on severe psychopathology. Chichester, West Sussex: Wiley-Blackwell; 2008. p. 
151-64. 
102. Hazell CM, Hayward M, Cavanagh K, Strauss C. A systematic review and meta-analysis of 
low intensity CBT for psychosis. Clin Psychol Rev. 2016. doi:10.1016/j.cpr.2016.03.004. 
Page 95 of 128 
103. Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK et al. 
Neuropsychological function and dysfunction in schizophrenia and psychotic affective 
disorders. Schizophr Bull. 2009;35(5):1022-9. doi:sbn044 [pii];10.1093/schbul/sbn044 [doi]. 
104. Keefe RS, Harvey PD. Cognitive impairment in schizophrenia. Handbook of Experimental 
Pharmacology. 2012;213:11-37.  
105. Watson A, Cella M, Wykes T. Cognitive therapies for refractory schizophrenia. In: Buckley 
PF, Gaughran F, editors. Treatment-refractory schizophrenia: a clinical conundrum. London: 
Springer; 2014. p. 121-38. 
106. Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive 
assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment 
of Neuropsychological Status. Schizophr Res. 2004;70(2-3):175-86. 
doi:10.1016/j.schres.2003.10.009 [doi];S0920996403003517 [pii]. 
107. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Cognitive functioning 
in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery 
for the Assessment of Neuropsychological Status. Psychiatry Res. 2004;129(1):45-53. 
doi:S0165-1781(04)00176-3 [pii];10.1016/j.psychres.2004.07.002 [doi]. 
108. Wood H, Cupitt C, Lavender T. The experience of cognitive impairment in people with 
psychosis. Clinical Psychology and Psychotherapy. 2013. doi:10.1002/cpp.1878. 
109. Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of 
neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and 
validity. Am J Psychiatry. 1999;156(12):1944-50.  
110. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and 
neurobiological perspective. Biological Psychiatry. 1999;46(6):729-39.  
111. Leeson VC, Sharma P, Harrison M, Ron MA, Barnes TR, Joyce EM. IQ trajectory, cognitive 
reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal 
study. Schizophrenia Bulletin. 2011;37(4):768-77. doi:sbp143 [pii];10.1093/schbul/sbp143 
[doi]. 
112. Leeson VC, Barnes TRE, Hutton SB, Ron MA, Joyce EM. IQ as a predictor of functional 
outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. 
Schizophrenia Research. 2009;107(1):55-60.  
113. Oie M, Sundet K, Rund BR. Neurocognitive decline in early-onset schizophrenia compared 
with ADHD and normal controls: evidence from a 13-year follow-up study. Schizophrenia 
Bulletin. 2010;36(3):557-65.  
114. Morrison G, O'Carroll R, McCreadie R. Long-term course of cognitive impairment in 
schizophrenia. British Journal of Psychiatry. 2006;189:556-7.  
Page 96 of 128 
115. Miller BJ, Buckley PF. Medical and psychiatric comorbidities: complicating treatment 
expectations. In: Buckley PF, Gaughran F, editors. Treatment-refractory schizophrenia: a 
clinical conundrum. London: Springer; 2014. p. 45-63. 
116. Sundermann O, Onwumere J, Kane F, Morgan C, Kuipers E. Social networks and support in 
first-episode psychosis: exploring the role of loneliness and anxiety. Social Psychiatry and 
Psychiatric Epidemiology. 2014;49(3):359-66.  
117. Cacioppo JT, Hawkley LC. Perceived social isolation and cognition. Trends in Cognition 
Science. 2009;13(10):447-54. doi:10.1016/j.tics.2009.06.005. 
118. Randolph C. Repeatable battery for the assessment of neuropsychological status (RBANS). 
San Antonio, TX.: Psychological Corporation; 1998. 
119. Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M et al. Test-retest stability of 
the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. 
Am J Psychiatry. 2002;159(5):838-44.  
120. Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of 
neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant 
validity and diagnostic group comparisons. Am J Psychiatry. 1999;156(12):1951-7.  
121. Chianetta JM, Lefebvre M, LeBlanc R, Grignon S. Comparative psychometric properties of 
the BACS and RBANS in patients with schizophrenia and schizoaffective disorder. Schizophr 
Res. 2008;105(1-3):86-94. doi:S0920-9964(08)00276-4 [pii];10.1016/j.schres.2008.05.024 
[doi]. 
122. Weschsler D. Test of Premorbid Functioning - UK Version (TOPF UK). London: Pearson 
Assessment; 2011. 
123. Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. 
Archives of Clinical Neuropsychology. 2003;19:203-14.  
124. Mahurin RK, Velligan DI, Hazleton B, Davis JM, Eckert S, Miller AL. Trail making test errors 
and executive function in schizophrenia and depression. The Clinical Neuropsychologist. 
2006;20(2):271-88.  
125. Loughland CM, Lewin TJ, Carr VJ, Sheedy J, Harris AW. RBANS neuropsychological profiles 
within schizophrenia samples recruited from non-clinical settings. Schizophr Res. 2007;89(1-
3):232-42. doi:S0920-9964(06)00394-X [pii];10.1016/j.schres.2006.08.022 [doi]. 
126. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor PÃ. A meta-analysis of cognitive 
remediation for schizophrenia: methodology and effect sizes. American Journal of Psychiatry. 
2011;168(5):474-85.  
  
Page 97 of 128 
 
5. List of combined Appendices 
 
A: Systematic Review – Quality Tool        99 
B: Empirical Project – Protocol Manuscript      101 
C: Empirical Project Ethics Approval Notification      112 
D: Competence and Fidelity measure       113 
E: Shared Formulation Example #1       115 
F: Shared Formulation Example #2       116 
G: Service Evaluation Project Application for CAG Approval    117 
H: CAG Approval Email         122 
I: Service User Satisfaction with Neuropsychological Assessment Questionnaire  123 
J: Staff Satisfaction with Neuropsychological Assessment Questionnaire   124 





Page 98 of 128 
Appendix A: Systematic Review - Quality tool  
 
Section 1: External validity 
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Section 2: Internal validity 
 
 9. Source of 
psychosis diagnosis 
10. Source of DP 
data 
11. Reliability of 
estimate of DP 
12. Severity of DP 13. Frequency of 
DPD  
14. Frequency of 
DP symptoms 
0 Not reported Not reported Not reported Not reported Not reported Not reported 




measure but not 




with no estimate of 
inter-rater 
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Mean scores and 
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Notes: 
* Loney published rate of ‘acceptable’ 
- Items 2,3, 5, 7, 8 and 9-14 are adapted from Shamliyan and colleagues’ tool [35] 
- Item 6 was from the STROBE [33]tool  
- Items 1 and 4 were author additions  
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Depersonalisation is the experience of being detached or disconnected from one’s experience. 
Studies suggest that clinically significant levels of depersonalisation are common in individuals 
who have psychotic symptoms and are associated with increased impairment. However, to 
date, there have been no studies that have investigated an intervention designed to target 
clinically significant depersonalisation in such patient groups. This study aims to determine the 
feasibility and acceptability of a brief intervention targeting clinically significant 
depersonalisation in those who also have current psychotic symptoms. 
Methods/Design 
The feasibility of delivering six sessions of Cognitive Behavioural Therapy for depersonalisation 
in psychosis patients will be evaluated using a single blinded randomised controlled trial with a 
treatment as usual control condition. Participants will be assessed at baseline and then 
randomised to either the treatment or control arm. Participants randomised to the treatment 
arm will be offered six sessions of individual Cognitive Behavioural Therapy delivered over a 
maximum of 10 weeks. Therapy will focus on an individualised shared formulation of 
depersonalisation experiences, and behavioural, cognitive, emotional regulation and thinking 
process strategies to decrease distress associated with depersonalisation. Participants will be 
assessed again at a 10 week (post randomisation) follow-up assessment. The primary outcomes 
of interest will be those assessing the feasibility and acceptability of the intervention including: 
rates of referral, eligibility, and acceptance to participate; attendance at therapy sessions and 
completion of homework tasks; satisfaction with the intervention; maintenance of blinding; and 
therapist competence. Secondary outcomes will be data on clinical outcome measures of 
depersonalisation, positive symptoms of psychosis, anxiety, depression and post-traumatic 
stress. 
Discussion 
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This study will determine the feasibility of delivering six sessions of Cognitive Behavioural 
Therapy for individuals with current psychotic symptoms who also experience clinically 
significant levels of depersonalisation. The results will provide information to inform a larger 
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Psychosis is a general term covering a range of psychiatric diagnoses such as Schizophrenia, 
Schizoaffective disorder and Delusional Disorder[1]. Psychotic symptoms include delusions, 
hallucinations, negative symptoms such as affective flattening, and cognitive disturbances. 
Recent estimates suggest that four in every 1000 people in the UK have a diagnosis of a 
psychotic condition [2]. Alongside medication, current treatment guidelines [1] recommend 
psychological intervention using either Cognitive Behavioural Therapy for psychosis (CBTp) 
and/or Family Interventions.  Recent meta-analyses have shown some efficacy for CBTp[3] , 
however prominent theorists and clinicians have called for further treatment innovations and 
understanding of the most efficacious treatment components [4-6]. One such approach is the 
‘the causal-interventionalist’ approach [4], whereby a single hypothesised maintenance factor is 
targeted with CBT in order to reduce both this problem (e.g. worry , insomnia) with the 
secondary gain of improving psychotic, and other emotional, symptoms. Dissociation, and 
depersonalisation in particular, may be one such maintenance factor. 
 
Defining dissociation and depersonalisation 
Dissociation is defined as  ‘a disruption of and/or discontinuity in the normal integration of 
consciousness, memory, identity, emotion, perception, body representation, motor control and 
behaviour’ [7].  As such it is an umbrella term that incorporates a spectrum of phenomena 
ranging from normal, everyday experiences such as absorption and divided attention, to more 
distressing and functionally impairing experiences of clinical significance such as the psychiatric 
condition of Depersonalisation Disorder (DPD).   
Historically, all types of dissociative phenomena have been viewed as part of a continuum, from 
‘normative’ experiences to more pathological experiences.  However, more recent theoretical 
reviews have suggested that dissociation may be best considered as comprising of two 
categories of phenomena:  detachment and compartmentalisation [8], although these are not 
necessarily mutually exclusive. ‘Detachment’ concerns a person’s sense of separation from 
experience, including from their sense of self (i.e., depersonalisation) or from the external world 
(i.e., derealisation) [8, 9].  ‘Compartmentalisation’ on the other hand, is defined as a disruption 
in normally integrated functions that is not accessible to conscious control and includes 
Dissociative Amnesia and Somatoform Dissociation [8].  This study is primarily interested in the 
‘detachment’ experiences of depersonalisation and derealisation (referred to as 
depersonalisation henceforth) in those with a diagnosis of a psychotic disorder. 
Prevalence estimates of depersonalisation 
Depersonalisation symptoms are common in non-clinical and clinical populations, particularly 
amongst those with anxiety disorders where it is amongst the diagnostic criteria of panic 
disorder and post-traumatic stress disorder (PTSD) [10]. Epidemiological studies suggest lifetime 
prevalence rates of transient depersonalisation symptoms in the general population of between 
26 and 74% [11].Community surveys examining the prevalence of Depersonalisation Disorder 
(DPD) specifically, using standardised diagnostic criteria, suggest one month prevalence rates of 
between 1.2 and 2.4%, and rates as high as 82.6% have been reported comorbid with other 
psychiatric disorders [11].  
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Dissociation and psychosis – common factors or pathway? 
There has been increasing interest in the presence of dissociative experiences in psychotic 
disorders, in part due to common aetiological factors of trauma and anxiety, and the potential 
for dissociation to play a mediating role in psychosis [12-14].  Dissociation has long been 
considered a psychological defence mechanism to protect the individual against intolerable 
events such as trauma (see [14]).  It is also now well established that rates of trauma are high in 
psychosis [15].  Recent population based studies in both the UK and the USA show high rates of 
lifetime experiences of sexual and physical abuse in those diagnosed with a psychotic disorder 
[16, 17].  Further, in a critical review of studies examining trauma in those with severe mental 
illnesses, rates of trauma exposure were between 49-100% [18].  Considering the well-
established link between trauma and dissociation, and the high rates of trauma experiences in 
psychosis, it is therefore not surprising that dissociation is also common in psychosis [19].  
Additionally, the cognitive model of DPD [20] has emphasised the role of anxiety and cognitive 
processes common to anxiety disorders, in the development and maintenance of DPD. 
Experimental research provides support for the influence of cognitive processes of attention, 
catastrophic appraisals and attribution biases in DPD [21].   Further, a longitudinal study of over 
3000 participants in the UK, found that childhood anxiety was a significant predictor of adult 
depersonalisation experiences [22].  Likewise, cognitive models of psychosis [23] emphasise the 
role of emotional processes, particularly anxiety, in the onset and maintenance cycle of 
psychotic symptoms [5, 24]. 
Considering the commonalities in maintenance processes of dissociation and psychosis, it is 
understandable that dissociation is also common in psychosis and indeed, some authors have 
speculated that some psychotic symptoms, in particular auditory hallucinations, may actually be 
better understood as dissociative in nature [14, 12].   
 
Rates of Depersonalisation in psychosis 
Eleven studies were identified by a review of research investigating dissociation in psychosis 
[25]. The reviewers concluded that there was ‘solid empirical evidence’ that individuals with a 
diagnosis of schizophrenia have more frequent, and severe, dissociative experiences than non-
clinical populations, but less frequent and severe than those diagnosed with Borderline 
Personality Disorder, PTSD, or Dissociative Identity Disorder.  Furthermore, they found a 
consistent association between experiences of dissociation and severity of delusions and 
hallucinations.  However, there have been methodological flaws in many of these studies as 
they used a general measure of dissociation that includes aspects of amnesia, detachment and 
more ‘normative’ dissociation such as absorption in the same overall score. In this context, it is 
unclear precisely what aspects of dissociative experience were associated with psychosis.    
More recently, a few studies have specifically investigated depersonalisation experiences in 
psychosis. For example, in a study of 147 inpatients with a diagnosis of schizophrenia, 17% were 
found to meet threshold criteria for DPD   Similarly, studies examining depersonalisation 
symptoms in schizophrenia suggest that depersonalisation may be more  common in those 
experiencing hallucinations, compared to those with delusions only, and when present are 
associated with more severe psychotic symptoms.[26-28].  However, this is still an emerging 
field of enquiry perhaps in part due to the ‘diagnostic overshadowing’ of psychosis.  In this 
context, there is only a limited understanding of both the rates of DPD and the phenomenology 
of depersonalisation in psychosis.     
 
Depersonalisation – an anomalous experience in psychosis? 
One potential understanding of depersonalisation in psychosis is of depersonalisation 
symptoms as an anomalous experience that are interpreted in a distressing manner.  In the 
Cognitive Behavioural Therapy (CBT) model of DPD (Hunter et al., 2003), catastrophic appraisals 
of transient depersonalisation experiences (such as of having damaged one’s brain, or of 
incipient ‘madness’) serve to exacerbate and maintain symptoms. Similarly, in cognitive models 
of psychosis (e.g.[29, 30], appraisals of anomalous experiences as personally relevant, 
threatening and/or attributed to an external cause are proposed to contribute to the 
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development of psychotic symptoms  Depersonalisation symptoms could be considered a type 
of anomalous experience [23, 28], and although to the authors’ knowledge there are no 
empirical studies which have explored the appraisals of depersonalisation symptoms in those 
with psychosis, and in particular whether these symptoms might give rise to psychotic 
explanations in the absence of any alternative explanation for these phenomena, it may be that 
this could be a factor that precipitates, and/or maintains, psychosis.   
A study of CBT for DPD [31] focused on generating less threatening explanations for the 
depersonalisation symptoms and reducing symptom-focused attention, avoidance and safety 
behaviours that were identified as maintaining factors.  This study showed significant 
improvements in experience of depersonalisation symptoms, depression and anxiety, with a 
third of participants no longer meeting threshold for DPD at the end of therapy.  It is proposed 
that a similar approach to depersonalisation symptoms in psychosis might be effective in 
reducing the distress associated depersonalisation and may have a secondary impact of 
psychotic symptoms.  This approach is in line with the ‘causal-interventionist’ approach [4] 
which has been proposed as the way forward for CBT for Psychosis. To the authors’ knowledge 
there are no published studies or trials of interventions for depersonalisation symptoms in 
psychosis. 
Summary and research questions 
Depersonalisation symptoms appear to be prevalent in people diagnosed with psychotic 
disorders and when present, depersonalisation symptoms are linked with more severe 
psychotic symptoms.  It is likely that negative appraisals of these anomalous experiences might 
act to precipitate, maintain and exacerbate psychotic symptoms. CBT has been found to be 
beneficial in patients with chronic DPD and it would be valuable to ascertain if similar 
approaches to target depersonalisation symptoms in psychosis would be effective. This study 
aims to establish the feasibility of a brief CBT-based intervention for depersonalisation 
symptoms in people diagnosed with a psychotic disorder.   The aim of the intervention would be 
to alter negative attributions and distress associated with depersonalisation experiences 
through psycho-education, learning coping strategies such as ‘grounding’, changing attentional 
biases, and cognitive restructuring techniques to modify appraisals.  It is proposed that through 
reducing distress, in particular, the maintenance cycle associated with depersonalisation will be 
altered and thus overall depersonalisation experiences reduced, with a possibility of reducing 
psychotic phenomena in addition.  
In this context there are two main research questions: 
1. Will it be feasible to deliver a brief intervention for depersonalisation symptoms in individuals 
with current psychotic symptoms?  





Method and Design 
This study aims to determine the feasibility and acceptability of a brief intervention for 
depersonalisation symptoms in those with current psychotic symptoms.  
The intervention will be evaluated using a single blinded (researcher blinded) randomised 
controlled trial (RCT) with a treatment as usual control condition. Participants will be assessed 
at baseline (T1) and then randomised to either the treatment or control arm. Participants 
randomised to the treatment arm will be offered six sessions of individual therapy delivered 
over a maximum of 10 weeks (to allow for non-attendance).  All participants will be assessed 
again at a 10 week post-randomisation follow-up assessment.  
Aims and objectives 
The specific aims of the study are to establish: 
- the feasibility of:  
o Recruitment, including eligibility rates and acceptance rates and the 
randomisation process. 
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o delivering a brief CBT intervention for DPD, including attendance and completion 
rates 
- the acceptability of the intervention for participants including estimates of satisfaction 
and treatment adherence 
A secondary aim is to establish estimates of standard deviations for outcomes of 
depersonalisation symptoms to inform sample size calculations for a future trial. 
 
Participants 
We will seek to recruit 30 adults aged 18-70 with current psychotic symptoms, and whose 
depersonalisation symptoms meet threshold for DPD (i.e., over 75 on the Cambridge 
Depersonalisation Scale (CDS))..  We will exclude those with: insufficient capacity to provide 
informed consent; insufficient proficiency in English (spoken and written) to engage in CBT; a 
primary diagnosis of intellectual disability, head injury, substance misuse or organic cause for 
psychosis; and those currently engaging in CBT or other psychotherapy.  
Power calculation 
As this is a feasibility study and the aim is to provide estimates of key parameters for a future 
trial rather than to power the current study to detect statistically significant differences, an a 
priori power calculation was not conducted [32]. Instead, we aim to recruit sufficient 
participants to provide reasonable estimates of study parameters.   Based on the feasibility of 
recruitment, we aim to recruit 30 participants.   Two pieces of work enable estimation of the 
number of patients we would need to screen in order to obtain 30 participants.  Published 
research with a similar sample [28] suggests that approximately 94% of individuals diagnosed 
with a current psychotic disorder will report at least one depersonalisation symptom, and 60% 
will experience at least 10 depersonalisation symptoms often.  A recently completed research 
study (Emma Davies, unpublished thesis, 2015) recruiting people with psychosis from the same 
pools as proposed for this trial suggests that approximately 50% of participants reporting 
depersonalisation symptoms met criteria for DPD.  In this context we are likely to need to 
screen 60 participants (assuming most individuals will report at least one symptom and 50% will 
score above our threshold) to obtain our target sample.  As it is unlikely that all those contacted 
via initial letter will respond and/or agree to be screened, we anticipate attempting to contact 
approximately 100 individuals to be able to screen 60. 
 
Intervention 
The intervention is based on the protocol developed for CBT for DPD [31]. The intervention aims 
to reduce distress associated with depersonalisation symptoms by altering catastrophic 
attributions through psychoeducation, developing a shared understanding linking 
depersonalisation symptoms to anxiety and/or past traumas, enhancing coping strategies 
(including grounding) and cognitive restructuring techniques to modify unhelpful appraisals.  It 
is hypothesized that through reducing distress, in particular, the maintenance cycle associated 
with depersonalisation will be altered and thus overall depersonalisation symptoms reduced.   
The intervention will be delivered, in addition to treatment as usual (see below)over six, 60 
minute sessions, covering the areas outlined in Figure 1, as appropriate and determined by the 
individual needs of the participant.  Sessions will be conducted at outpatient consulting rooms 
closest to the participant or their home, depending on participant preference and needs.  
The therapy will be delivered by SF, a clinical psychologist in training under the supervision of 
EH, a consultant clinical psychologist and developer of the cognitive model of DPD [20].  In order 
to ensure the best delivery of the intervention, the therapist (SF) will be trained by EH.  Regular 
supervision through the intervention period of the study will be provided by EH.  In addition, to 
ensure the competence in CBT and fidelity of the intervention a random selection of 10% audio 
recordings of intervention sessions will be rated by EH using a well-established adherence 
measure of CBT [33] and a measure designed at the start of the study to capture fidelity to the 
depersonalisation protocol.   
Treatment as usual control condition 
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For most participants, the treatment as usual will involve regular contact with a care 
coordinator, medication and regular reviews with a psychiatrist as provided for under the Care 
Programme Approach (CPA –[34]).  
 
[Figure 1 – Components of the intervention – about here] 
 
Procedure 
Eligible participants will be recruited from a secondary care mental health trust in South London 
(SLaM), and will include community mental health teams, psychological therapies services and 
research registers.  
Potential participants identified from the sources above will be sent a letter of invitation and 
study information in the post. .The letter will provide detail of how to contact the researcher 
should they be interested.  If after one week, there has been no contact from the participant, 
the first author will telephone them, answer any questions they may have about the study, and 
offer an opportunity to be screened for eligibility.  This screening interview ask questions about 
current experiences of hallucinations and paranoia or other delusions and will determine 
whether they are likely to meet criteria for diagnosis of DPD using the Cambridge 
Depersonalisation Scale [35].   Participants passing this initial screen will then be invited to a 
face to face interview with a researcher and be invited to provide informed consent to 
participate in the study before participating in the baseline assessment 
All assessments will be conducted by an independent research assistant, trained in the 
administration of measures and who will remain blind to treatment allocation; maintenance of 
blinding will be collected at outcome assessment.  After the completion of the follow-up 
interview, researchers will be unblinded and will re-contact those who received the intervention 
to assess satisfaction with and acceptability of the intervention.  See Figure 2 for the trial flow-
chart. 
Randomisation 
An online randomisation service will be used to allocate participants to either the intervention 
group or control.  Randomisation will use randomly permuted blocks to ensure equal allocation 
to each group. After the baseline interview, the first author will enter the participant's details 
into the online service and will receive an automatic email which details the allocation of the 
participant. The first author will then contact the participant to alert them of their allocation 
and if the CBT/active intervention group, will arrange first therapy session.  The RA will be kept 
blinded to the allocation to reduce bias. 
 
[Figure 2: Trial Flowchart – about here] 
 
Data collection 
The primary outcomes of this trial are the estimates of feasibility and acceptability.  
To establish the feasibility of conducting a future trial, the following data will be collected 
throughout the recruitment and intervention process: 
- Referral (number of participants referred to the study)  
- Eligibility rates (number of referred and approached participants who meet study 
entrance criteria). 
- Acceptance rates (number of participants consenting to the study) and reasons for 
study refusals.   
- Participant attendance rates at sessions and duration of intervention (i.e., number of 
weeks taken to attend six sessions)  
- Data attrition (proportion of outcome data obtained)   
- Feasibility of randomisation process and (maintenance of researcher blindness to 
treatment allocation.)  
- Therapist competence, CBT fidelity, and CBT for DPD.  
To establish the acceptability of the intervention, in addition to the data above, attrition rates 
(number of treatment sessions completed by participants, number of therapy drop outs (i.e., 
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completing two or fewer sessions) and percent of homework tasks completed) will be collected 
throughout the intervention 
After the follow-up interview is completed and scored, researchers will be unblinded and all 
intervention participants will be interviewed about their impressions of the intervention.  The 
interview will collect data on their impressions of and satisfaction with the intervention using 
questions based on the Satisfaction of Therapy Questionnaire [36], altered to capture aspects of 
improvement/satisfaction related to depersonalisation symptoms. Participants will be asked to 
rate on a five point likert scales:  
o their expectations and actual progress made on dealing with depersonalisation 
o their level of satisfaction with the therapy, therapist, tasks between therapy 
o the extent to which they gained new skills and knowledge during the intervention 
o their relationship to the therapist including therapist competence, sympathy, caring 
nature, supportiveness.  
There will be four additional open questions to determine the aspects of the intervention the 
participants found most and least helpful, their views on whether the intervention met their 
expectations overall, and an opportunity to make any other comments 
 
Clinical data 
Clinical and demographic data will be collected at baseline interview and will include sex, age, 
ethnicity, marital status, education, employment status, medication use, age of onset of both 
DP/DR and psychotic symptoms, current clinical diagnosis, and past experience of cognitive 
behavioural therapy or other psychotherapeutic approaches.   Data will be collected at baseline 
assessment and at an outcome interview at ten weeks.   
Secondary, clinical outcome data will be collected to estimate key parameters to inform future 
trial design. Outcomes include depersonalisation, psychotic, depression and anxiety symptoms, 
as well as screening for post-traumatic stress disorder.  .  
- Cambridge Depersonalisation Scale (CDS; [35].  The CDS is a 29 item scale that measures 
the severity of trait depersonalisation symptoms over the preceding six months.  For each item, 
frequency (likert scale 0=never to 4=all the time) and duration (likert scale 1=few seconds to 
6=more than a week) are collected; each item maximum is therefore 10. A total scale score is 
the sum of each item, with a maximum of 290.  Scores greater than 70 have been shown to 
reliably predict a clinical diagnosis of DPD using DSM criteria. . In order to measure change, the 
wording of the trait CDS will be changed to measure the severity of DP/DR symptoms over the 
preceding month.  The level of distress, preoccupation, impairment and understanding of 
depersonalisation symptoms will also be collected.   
- The Psychotic Symptom Rating Scale (PSYRATS; [37].  The PSYRATS will be used to 
monitor changes in psychotic symptomatology between baseline assessment and outcome 
interview.  The PSYRATS consists of two subscales measuring the presence and typology, 
beliefs/conviction, distress and disruption associated with auditory hallucinations and 
delusions.  The auditory hallucination (AH) subscale has 11 items and the delusions (DELS) 
subscale has six items.  All items are scored between 0 and 4. For example, for item 1 in the AH 
scale 0=voices are not present to 4 voices are present continuously…  The maximum score for 
the AH and DELs subscales are 44 and 24 respectively. 
- Beck Depression Inventory (BDI; [38]). The BDI-II is a 21 item self-report scale, rated on 
a 4 point Likert scale (0= symptom not present to 3 = symptom present with significant 
distress/impairment) measuring common symptoms of depression.  Total scores range from 0 
to 63.  Total scores of less than 13 indicate minimal depression, scores 14-19 indicate mild 
depression, scores 20-28 indicated moderate depression and scores above 29 indicate severe 
depression.   
- Beck Anxiety Inventory (BAI; [39]). The BAI is a 21 item self-report scale with the same 
scoring.  Total scores are interpreted as follows: 0-9 indicates minimal anxiety; 10-16 indicates 
mild anxiety; 17-29 indicates moderate anxiety; and 30-63 indicates severe anxiety. 
- Post-traumatic Diagnosis Scale (PDS ; [40]. The PDS has 49 items including a checklist of 
potentially traumatising events and an indication of the distress, intrusive thoughts, avoidance 
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and hyperarousal in the last month.   There is a total score ranging from 0 to 51 with 1-10 
considered ‘mild’, 11-20 ‘moderate, 21-35 moderate to severe and greater than 36 severe.  
- Structured clinical interview for DSM-IV dissociative disorders (SCID-D)[41]. It includes 
nine items addressing the presence and frequency of common depersonalisation symptoms, the 
duration and frequency of the most severe instance of depersonalisation, functional 
impairment, distress and exclusionary criteria such as: not the result of drugs, organic issues 
and does not occur exclusively in the context of other psychiatric condition such as psychosis. 
 
Analyses 
As this is a feasibility study, the analyses will be primarily descriptive aiming to provide 
estimates of feasibility parameters and to inform power calculations for a future trial.  
Descriptions of continuous data, including clinical data and sample characteristics, will be 
provided using mean, SD, median and IQR. Frequencies and proportions will be used to analyse 
categorical variables.  
Feasibility of trial procedures will be assessed using proportions and their estimated 95% 
confidence intervals (CIs) for rates of: referral (number of referrals divided by total 
approached); eligibility (number of eligible participants divided by number screened and 
number approached); acceptance (number screened divided by number approached and 
number consented divided by number approached); attendance (average number of treatment 
sessions attended and average number of weeks taken to complete intervention); data attrition 
(proportion of outcome data obtained); and maintenance of blinding (incidences of unblinding 
of researcher divided by number of follow-up assessments). Therapist competence will be 
presented as proportion with estimated 95% confidence intervals for the total score divided by 
applicable items on the CTRS and DPD fidelity measure. Acceptability of trial procedures will be 
assessed using proportions and their estimated 95% confidence intervals for rates of: attrition 
(proportion of treatment sessions completed and of homework tasks completed), expectations 
and actual progress (proportion rating at each point on likert scale) and satisfaction with 
therapy, therapist and tasks (proportion rating at each point on likert scale).  
Population variances will be determined using the upper 80th nonparametric bootstrap 
percentile of confidence intervals around the estimates [42]. 
Adverse events 
We do not anticipate any serious adverse events as a result of this psychological intervention, 
but all adverse events will be collected, discussed in supervision and reported to regulatory 
authorities as required.  
Ethical approval and oversight 
The trial has received approval from the Camberwell and St Giles Research and Ethics 
Committee (ref: 15/L0/0081) and is registered with ClinicalTrials.gov (ClinicalTrials.gov 
Identifier: NCT02427542). 
Good Clinical Practice Guidelines for research trials (such as data storage and administrative 
functions) and CONSORT guidelines [43]for reporting will be fully adhered to.  As this is a small-
scale feasibility study, formal trial steering and data monitoring committees will not be 
convened. Rather, academic supervisors will ensure the running of the trial adheres to Good 
Clinical Practice Guidelines and local policies.  
 
Discussion 
This paper presents the protocol for a study to assess the feasibility and acceptability of a brief 
Cognitive Behavioural Therapy intervention for individuals who have depersonalisation 
symptoms in the context of psychotic symptoms.  The intervention, based on that developed for 
DPD, will focus on providing an individual cognitive formulation and explanation of 
depersonalisation experiences and developing behavioural, cognitive, emotional regulation and 
thinking processing changes or strategies to decrease the associated distress.  The findings from 
this study will help estimate the key parameters for a future trial.  
 
Trial Status 
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Recruitment to the trial is underway and is due to be completed in March 2016. The first 
participant was randomised in June 2015. 
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Appendix C: Ethics Approval 
 
 
Page 112 of 128 
Appendix D: Competence and Fidelity measure 
 
Patient ID  
Session number  
Session Date  
Rating Date:  
 
CBT skills assessed using CTS-R 
Scoring 0-6 
N/A – Absent, but not necessary at this stage 
0  absence of feature, or highly inappropriate performance  
1  inappropriate performance, with major problems evident  
2  evidence of competence, but numerous problems and lack of consistency  
3  competent, but some problems and/or inconsistencies  
4  good features, but minor problems and/or inconsistencies  
5  very good features, minimal problems and/or inconsistencies  





1. Agenda  
2. Feedback  
3. Understanding  
4. Interpersonal effectiveness  
5. Collaboration  
6. Pacing and efficient use of time  
7. Guided discovery  
8. Focusing on key behaviours and cognitions  
9. Strategy for change  
10. Application of cognitive behavioural techniques  
11. Homework  
Overall Sum  
Average (of applicable items)  
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DP protocol fidelity 
Scoring 0-6 
N/A – Absent, but not necessary at this stage 
0 absence of feature, or highly inappropriate performance  
1 inappropriate performance, with major problems evident  
2  evidence of competence, but numerous problems and lack of consistency  
3 competent, but some problems and/or inconsistencies  
4  good features, but minor problems and/or inconsistencies  
5  very good features, minimal problems and/or inconsistencies  




Specific elements Rating 
Psycho-education / 
shared formulation  
Psycho-education about DP/DR  
individualised CBT shared formulations for current pattern of DP/DR 
(including assessing factors which influence fluctuations in severity ) 
 
Behavioural  Diary use  - analysing what makes it better and worse  
Planning  environmental / behavioural changes to manipulate and 
manage DP/DR symptoms 
 
Emotion regulation Examining the role of emotions associated with DP/DR  
Identifying anxiety/ distress management strategies.  
Psycho-education about grounding strategies and practice of these  
Cognitive  Identifying unhelpful thoughts about DP/DR  
Cognitive restructuring  - Reviewing the evidence for and against 
unhelpful DP/DR related thoughts 
 
Thinking processing  Psycho-education about role of attention in maintaining DP/DR  
Reducing hyper-vigilance / symptom monitoring / checking 
behaviours 
 
Acceptance and mindfulness approaches to DP/DR  
Review and relapse 
prevention 
Summary of what has been learnt from the sessions  
DP/DR Action plan  
Overall Sum  
Average (of applicable items)  
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What is the first thing I notice about DP? 
Don’t know where I am  
Don’t know how to do basic things 
Don’t understand time, can’t feel emotions/body/legs 
 
Situation/triggers 
Interactions with people in authority 
Critical voices 
Hallucinations of distressing images 
Reminders of childhood abuse 
emotions and fears from when I was abused – feeling 
no control/bullied, lack of privacy, 
shame/humiliation/lack of respect 
 
Historical context 
Onset of DP during childhood sexual, emotional and physical abuse and neglect.  
“Zoning out was the thing that protected me in the past [during abuse]”. 
Core beliefs about self as not-deserving, shame, disgust at self and body. 
What do I think? 
I’m going to lose it,  
There’s no respite  
It’s some sort of hell 
I’m stuck, not equipped for life 
I’m imprisoned  
 











How I think? 
Worry  
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Appendix F: Anonymised Shared Formulation #2 (Showing original and ‘Action Plan’) 
 
  
What is the first thing I notice about DP? 
Everything seems distant 
Feeling numb detached. 
Situation/triggers 
Worrying/stressful situations 
Uncontained and unpredictable social 
situations 
Heightened anxiety 
Not knowing what the ‘rules’ are 
Feeling embarrassed/alienated 
Arguments 
What do I think? 
I don’t understand things 
Is there anything in my head 
I’m a canary down a mind 
I could get lost forever and never be 
lucid 
I’m going crazy/dementia 
I’m not a good person/friend 
No one likes me 
I shouldn’t be this way 
How I think? 
Worry about trying to find a 
path through that doesn’t 
make it worse 
Festering 
What I do… 
Pacing, listen to music for 
distraction 






like there is hole)  
Vicious cycle 
Wider context 
Starting to accept myself where I am now and to build up my 
sense of self-worth 
New thoughts 
Maybe everyone is as lost as 
I am. 
Depersonalisation is 
common when people feel 
anxious 
It hasn’t stopped, but I can 
stop it – its challengeable 
I can feel emotion and not 
be overwhelmed 
I am a worthy person 
New thinking style 
Starting to take control 
of my thought processes 




Deliberate decision to engage ‘outside 
of my head’ 
Manage my anxiety by breathing and 






The difficulty I had in my late teenage years, ending up in hospital, 
feeling suicidal. Having a low sense of self 
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Appendix G: Service Evaluation Project-  Application for CAG approvals 
 
 
Audit & Service Evaluation Project Proposal Form (PPF) 
Should you require any assistance with completing this proforma, please contact your Local 
Clinical Audit Project Officer or for Trustwide audits the Clinical Audit & Effectiveness Team 
(details are available on the SLaM Clinical Audit & Effectiveness Internet Site).  For local team 
based, directorate or CAG- wide projects please send your completed PPF to your local CG 
Project Manager/Officer, for ethical approval. For Trust wide projects please send your 
completed PPF to the Corporate Audit Dept (All relevant contact details are on the SLaM 
Clinical Audit & Effectiveness Team Intranet site).  
1(a)  Project lead details: Dr Juliana Onwumere 
Name: Juliana  Job title: Consultant Clinical Psychologist 
Work Address: Fitzmary II Ward  
Telephone:  0203 228 4274/5 E-mail:Juliana.onwumere@slam.nhs.uk 
1(b) Project Title: What are the levels of cognitive functioning difficulties in patients with refractory psychosis 
admitted to the Fitzmary II ward 
Project start date: November 2013 Project end date: November 2014 
1(c) Please tick  one box: Is this project a: 
Clinical Audit (e.g. Measures a standard)         A Service Evaluation (e.g. Patient Survey)                                          
1(d) Which CQC Standards does this audit relate to: Please tick  relevant boxes: 
Involvement and Information                                                           Personalised Care, Treatment and Support                         
Safeguarding and Safety                                                            Suitability of Staffing                                         
Quality Management                                                 Suitability of Management                                                                              
2 (a) Overall project aim, e.g., purpose of the audit, are changes achievable etc. 
The main aim of the project is to document the number of inpatients with cognitive functioning difficulties on 
Fitzmary II and to use this data to inform service planning decisions about the delivery of ward based group 
interventions to support patients to cope with the impact on their day to day functioning.   
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2(b) Specific objectives. What are the audit guidelines or standards?   The definition of a clinical audit is that it 
compares practice to agreed standards such as those defined in NICE guidelines and clinical policies, protocols 
and procedures.  Please state the source of your standards or criteria 
Cognitive functioning comprises a broad range of processes including memory, executive functioning,  attention 
and processing speed. Disturbances in any one of these domains are likely to impact on an individual’s day-to -
day functioning.  Cognitive functioning difficulties in service users with psychosis (e.g. problems with executive 
functions) are positively associated with poorer outcomes such as reduced levels of occupational and social 
functioning, and quality of life. These difficulties can also negatively impact on a patient’s ability to engage in 
treatment programmes and progress with their individual recovery.  
The purpose of the current service related project  is to document  the proportion of inpatients on FM2 
exhibiting cognitive impairments  and for this data to inform future service planning.  
Using assessment measures routinely available within the Fitzmary II ward, a patient’s level of cognitive 
functioning will be recorded as part of the broad assessments that patients undergo on the unit.  Data will also 
be collected on the length of assessment and patient engagement and satisfaction in the overall assessment 
process.  
 
2 (c) In which ways do you think the project will improve patient care / outcomes? 
The project should provide valuable data in characterising the nature of cognitive difficulties in our inpatient 
group and determining the approximate level of need for providing ward based interventions that specifically 
target cognitive problems. 
 
3 (a) Type of project     Please Tick   where appropriate – more than one might apply 
(A) National  Re-audit  High risk  
(B) Trust-wide  Interface  High volume  
(C) Directorate/CAG  X Multidisciplinary  Issue of local concern  
(D) Team based  Uni-disciplinary  
Wide variation in 
practice 
 
Other (please state): 
 
3 (b) Does your project criteria apply to any of the following?  If so Please Tick   where appropriate 
NHS Litigation Authority 
(NHSLA) 
 Risk Register (high risk)  Complaints  
Trust Policy  
CQC   Patient Survey  
NICE Guidance  Business Plan  
DOH Policy Implementation 
Guidance 
 
National Audit  Improving working lives  Issue of local concern   X 
Any Other (please state) 
 
4(a) Who will be on the audit steering group?  
Elizabeth Mott (Ward Manager); Dr Fiona Gaughran (Lead Consultant Psychiatrist); Tanya Greenland (Clinical 
Service Lead); Lidia Yaguez (Clinical Neuropsychologist, Kings College Hospital; Academic Director; Doctorate in 
Clinical Psychology, KCL, Alison McGourty (Senior Psychologist); Juliana Onwumere (Clinical Psychologist) 
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4(b) What consideration has been given to the involvement of patients, carers or the public? 
 Full user involvement at all stages of the audit   
 Partial user involvement : please state what stages _______________________________ 
X  No user involvement (please state why not) ______Not required at this 
stage_______________________________ 
 
5. Information Governance Requirements:   When planning an audit, each project should be evaluated whether 
Personal Identifiable Information (PII) needs to be used. Unless there is genuine justification, all PII should be 
taken out to effectively anonymise the data for audit and research purposes. If you are unsure or need guidance 
and advice, please contact:  dataprotectionoffice@slam.nhs.uk Personal identifiable information (PII) is any 
piece of information which can potentially be used to uniquely identify, contact, or locate an individual including 
name, address, full post code, date of birth, gender, ethnicity, NHS number, photographs, videos, audio-tapes 
etc. 
 
5(a) Source of 
data 
 Patient    Staff Other (please specify) 
5(b) Method of 
collection 
 Direct from subjects 
(interview or 
questionnaire) 
The data will be collated 
from routine assessment 
measures.   
 From an information 
system (e.g. ePJS) 
 
 
 Other (please specify) 
 
5(c) Will the 
data be fully 
anonymised? 
 Yes   No  
If yes, how: 
 
 
If no, why not: 
If no, which personal identifiers will be used 
If no, have you made arrangements to gain 
consent from data subjects?         Yes          No 
5(d) Where will 
the data be 
recorded? 
 Manual forms                            
 Electronic forms  
 Electronic spreadsheet       
 Electronic database     
In accordance with patient data 
collected in the service, all assessment 
data will be kept in patient hard files on 
the ward and the electronic note system 
(epjs)                  
 Other (please specify) 
                                                                                         
5(e) Where will 
it be stored? 
x In a locked cabinet 
x In a locked office 
x On shared folder on SLaM network 
 On secure network outside SLaM  





x Password protected 
x Encrypted 
x Login required 
 Other (please specify) 




x Yes, in an anonymised format                     No  
 Yes, with identifiers   You must contact dataprotectionoffice@slam.nhs.uk to register any 
transfer of personal identifiable information in advance. 
If yes, how  
 Physically in person                                             Physically using a secure courier 
 Physically using registered mail services            Electronically using nhs.net email 
 Electronically using encrypted portable media    Other (please specify) 
5(h) Will the 
data leave the 
EU? 
 Yes (Please specify where and why)  x No  
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5(i) Information 
Asset Owner: 
This is the 
person 
responsible for 
the data  
Name: Juliana Onwumere 
Job title: Consultant Clinical Psychologist 
CAG: Psychosis 
Organisation: South London and Maudsley NHS Trust 
 
 
6) Data Collection (please answer ALL of the following questions) 
6(a) Where from?  Audit data can be collected from 
many sources including:  medical records/epjs, nursing 
records, patients, clinicians, and other staff. 
Inpatients 
6(b) How? The data source will obviously influence the 
method used to collect data.  E.g. If data is to be 
collected from patients the most appropriate method 
might be a survey or interview.  If data is to be 
collected from medical records, it will be necessary to 
design a data collection proforma. Questionnaires, 
one-to-one interview, focus groups.   
Cognitive assessments – including pen and paper tests, 
questions. 
6 (c) How much?  As a guide, a sample should include a 
minimum of 30 cases and perhaps as many as 100.  If 
the initial sample proves to be too small to provide 
data necessary, it can be added later. 
Inpatients admitted to the Fitzmary II ward during the 
period November 2012-November 2013. 
 
The ward has 23 beds and patients approximate length 
of stay is 6-9 months.  
6 (d) Who?  Who will be responsible for collecting the 
data? Ensure the person identified understands their 
role. 
Doctorate in Clinical Psychology trainee 
6(e) Timescale?  Over what period is the data to be 
collected? 
Inpatients admitted to the Fitzmary II ward during the 
period November 2012-November 2013 
6 (f) Pilot Audit? Y/N In most cases it will be advisable 
to carry out a pilot to check quality of questionnaire, 
length of interview, etc.  In light of the pilot audit 
findings, modifications to any of the above may need 
to be made. 
Not applicable 
 
7(a) Who will be affected by the outcomes of this project? 
The inpatients from Fiztmary II ward 
7(b) With whom and where will the final report be shared? i.e. Local CG Committees, CAEC? 
The results will be presented as part of a service related report for the Doctorate in Clinical Psychology trainee 
and submitted in part fulfilment of their course.  
The report will also be shared with ward staff and the local CG committee. 
 
7(c) Who will take responsibility for disseminating the results of the project and following through 
recommendations? And how and when will the recommendations be evaluated, monitored and reviewed? 
Doctorate in Clinical Psychology trainee will prepare a report. Juliana Onwumere will lead on disseminating the 
results and the monitoring, review and evaluation of recommendations. 
 
All completed projects must be followed up with a completed recommendations monitoring form, available 
on the SLaM Clinical Audit & Effectiveness Intranet sitehttp://sites.intranet.slam.nhs.uk/cg/default.aspx 
 
 
8) Audit Approval 
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8(a) Information Governance Approval: 
  IG Audit approval given by: 
_________________________________ 
Date Audit IG 
approved:_________________________ 
 
8(b) Clinical Audit Ethical approval given by: 
Clinical Audit Ethical approval given by: 
__________________________________ 
Date of Clinical Audit Committee 
approval:_______________________________ 
 Clinical Effectiveness and Audit Committee 
 Drugs and Therapeutics Committee 
 Directorate Clinical Governance/Audit Committee 
 
 
9. Audit Timeframe Planning Table (Optional) 
Activity  Start Date End Date  Responsible Date Achieved 
Literature Search     
Standard Setting     
Project Design (methodology)     
Information Governance      
Pilot     
Data Collection     
Data Input and Analysis     
Report Writing     
Agree Recommendations     
Implementation of 
recommendations 
    
Monitoring of 
recommendations  
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Appendix H: CAG approval email 
 
From: Obi, Lucky <Lucky.Obi@slam.nhs.uk> 
Sent: 08 October 2013 18:20 
To: Onwumere, Juliana 
Cc: McKenzie, Sandra 
Subject: NEW PPF FOR APPROVAL  
  
Dear Juliana, 
Your proposed project has been approved; you may wish to start now. 
Please remember to send this department a copy of your report and recommendation on 
completion. 




Governance Project Officer 
Inpatient & Complex Care Pathway 
Psychosis CAG  
South London and Maudsley NHS Foundation Trust 
Felix Post Unit | Maudsley Hospital |Denmark Hill | London | SE5 8RG |   
Telephone: 020 3228 6389 Internal: 86389  
Fax: 020 3228 2643 
  
  
Visit our website http://www.slam.nhs.uk/ 
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Appendix I: Service Evaluation Project - Service user questionnaire  
Participant views on the acceptability of the assessment session 
 
Name   _____________________________________________________ 
 
ID number  _____________________________________________________ 
 
Date of assessment _____________________________________________________ 
 
 
How enjoyable did you find the assessment session?  Please circle one response. 
1 2 3 4 5 
Not at all 
enjoyable 
 Neutral  Very enjoyable 
 
 
How satisfied are you with the assessment session?  Please circle one response. 
1 2 3 4 5 
Not at all 
satisfied 
 Neutral  Very satisfied 
 
 
How stressful did you find the session? Please circle one response. 
1 2 3 4 5 
Not at all 
stressful 
 Neutral  Very stressful 
 
 
How difficult did you find it? Please circle one response. 
1 2 3 4 5 
Not at all 
difficult 
 Neutral  Very difficult 
 
 
Would you be happy to do a similar assessment session again? 
Yes / No / Don’t Know 
 
 
What was one good thing about the session?  
 
 
What was one thing that could have been improved 
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Appendix J: Service Evaluation Project - Professionals questionnaire 
 
 
As part of the service related project to evaluate the cognitive functioning needs of inpatients on 
Fitzmary II Ward, I would be grateful if you could answer the following questions about the 
neuropsychological assessments on the ward. There are not right or wrong answers. Thanking 
you in advance for your time.  
 






2. How helpful was the information gleaned from the assessments?  




   Neutral     
Extremely 
helpful 
1 2 3 4 5 6 7 8 9 10 







3. The assessment battery included the Test of Premorbid Functioning, the RBANs and a test of 
executive functioning (Trial Making Test).  How helpful did you find the assessment battery? 




   Neutral     
Extremely 
helpful 
1 2 3 4 5 6 7 8 9 10 
          
 










Please explain your response 
 
Clinical/counselling psychologist’s views on usefulness of 
neuropsychological testing on Fitzmary II ward 
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Overall impressions 
5. How helpful for your work do you think neuropsychological testing can be?  




   Neutral     
Extremely 
helpful 
1 2 3 4 5 6 7 8 9 10 









6. Would you recommend routine neuropsychological testing for inpatients on FM2?  










7. Are there any recommendations you would make to improving process of 













































Thank-you for taking the time to complete this survey! 
Page 125 of 128 
Appendix K: Service Evaluation -  Example report  
 
 
PRIVATE AND CONFIDENTIAL 
National Psychosis Unit 
Bethlem Royal Hospital 















DATE OF ADMISSION: XXX  
DIAGNOSIS: Schizophrenia 





XXX was admitted to the National Psychosis Unit, under a Section 3 of the Mental Health Act to 
ascertain optimal pharmacological interventions.  XXX was admitted with a previous history of 
periods of decreased responsiveness that were increasing in frequency, occasional collapse, 
bizarre behaviour and irritability. These periods had been described as possible fits or catatonia 
and no underlying physical causes or triggers had been identified. 
 
In terms of educational and social history, XXX previous records report that he performed well 
at school and achieved eight GCSEs at secondary school (3 As and 5 Cs). However, shortly after 
his GSCEs XXX began to struggle academically. He left school at 16 years of age. He attended a 
local college for a brief period to study for A levels, and subsequently dropped out of college 
and all formal education. XXX worked briefly in restaurants up until the age of 18/19. His first 
presentation to mental health services was at age 19 years.  
 
ASSESSMENT MEASURES 
- Test of Premorbid Functioning (TOPF) – provides an estimate of premorbid IQ 
- Repeatable Battery for the Assessment of Neurological Status (RBANs) which includes 
immediate and delayed memory, attention, language, visuo-spatial perception and an 
overall estimate of functioning.  
- Trail Making Test – a test of processing speed, rule detection and set shifting.  
 




Name:  XXX 
Dob:   XXX  
Age:   33 
Date of testing: 30/01/2014 
Location:  Fitzmary II Ward 
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XXX speech was slurred and his words were often not well articulated. However as he seemed 
to relax into the assessment session his speech slowed down a little and his words were more 
clearly enunciated. His hands were noticeably shaky, which affected his ability to complete tasks 
with fine motor skills components. However, he applied himself to all of the tasks and appeared 
to enjoy aspects of the testing situation. When the assessment was complete, he left the room 
quite quickly and did not engage in any non-essential conversation.  XXX said that he did not 
want to find out his results on the tests.   
 
PREMORBID INTELLECTUAL FUNCTIONING 
The Test of Premorbid Functioning (TOPF) estimated XXX optimal intellectual functioning at 92 – 
which is within the normal range.   
 
RBANS 
Immediate memory index 
The tasks involved in this index are a measure of learning complex and simple verbal 
information.  XXX scored 65 which placed him in the 1st percentile, indicating significant 
impairment in learning new verbal information.   XXX did show improvement in recalling 
both the list of unrelated words (from 3 on first trial to 8 on final trial) and story (from 4 
in Trial 1 to 8 in Trial 2) indicating improved recollection and learning after verbal 
repetition.  
Visuospatial/constructional 
The tasks involved in this index measure basic visuospatial perception and the ability to 
copy a design from a model. XXX performed well on this index (score 84), suggesting a 
relative strength in processing and using visuospatial information.  While he was able to 
correctly perceive and copy the figure, he lost points by not attending to the finer 
details (for example joining lines); however this may have been affected by the shaking 
in his hands.  
Language 
This index is a measure of expressive language function and it involves the ability to 
name objects presented visually and to retrieve and express verbally the names of as 
many fruit and vegetables as possible in a 60 second period.  Overall, XXX performed 
well on this index: he scored 85, which places him in the 16th percentile. XXX correctly 
identified all the pictures on the Picture Naming task, placing him in the 51-75th 
percentile on this subtest. On the Verbal Fluency task, he was able to name 16 fruits or 
vegetables in the 60 seconds allowed, achieving a scaled score of 4. At times, it was 
difficult to understand his pronunciation of the words as the task required him to speak 
quickly.  
Attention 
This index is a measure of auditory registration, visual scanning and processing speed.  XXX 
scored 75 on this index (5th percentile). On the Digit Span task, XXX was able to successfully 
remember and repeat six numbers, achieving a scaled score of 8. He was able to recall the next 
trial of 7 numbers but not in the correct order.  XXX also performed well on the Coding task, 
which requires drawing symbols associated with a specific number, however his lack of fine 
motor skills hindered his speed in this task.  
Delayed memory 
The tasks in this index are a measure of delayed recall and recognition of verbal and 
visual information.  XXX scored 85 which placed him in 16th percentile indicating some 
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difficulty retrieving information from long term memory stores.  He had difficulty 
drawing the complex figure, in part due to his fine motor skill deficits, and recalling the 
unrelated list of words.  He performed particularly well on the list recognition task, 
correctly recognising all of both target and distracter words. 
Overall estimate of current functioning 
The RBANs total scale score estimate of current functioning is 73, which is in borderline range 
and below Mr Rollinson’s predicted optimal level of functioning. 
 
EXECUTIVE FUNCTIONS 
XXX completed both trials of the Trail Making Test.  He took 59 seconds to complete the first 
task, involving drawing a line between consecutive numbers. This time placed him lower than 
the 10th percentile, indicating deficits in processing speed.  The second trial involves switching 
between numbers and letters, and therefore requires an ability to inhibit responses and switch 
attention; durations of greater than 2.5 times the first trial indicate significant impairment. XXX 
took 112 seconds, indicating no significant impairment in this task.  
 
CONCLUSIONS 
XXX is a 33 year old man with 15 year history of severe mental health problems.  He is currently 
functioning below his estimated optimal level. There was a fairly consistent performance across 
domains with the exception of immediate verbal memory which appears to be a particular 
difficulty for him. There was, however, evidence of learning in subsequent trials of verbal 
memory and indeed he had a strong ability to recognise verbal information when prompted 
after a delay.  Furthermore, he performed well on visual based tasks. 
 
Recommendations: 
- Due to his difficulties with immediate verbal memory, XXX may benefit from strategies 
that decrease the load on his verbal working memory, such as: 
o Written reminders of information such as keeping a notebook, a calendar with 
reminders or using post-it notes. 
- XXX’s superior performance on tests of delayed recognition compared to recall suggests 
that he would benefit from some strategies designed to improve his encoding of verbal 
material, such as: 
o Repetition of verbal information after appropriate intervals. 
o Asking him to repeat back verbal information to ensure understanding and 
creating opportunities for learning. 
o Practicing ‘chunking’ of units of information. 
o Attaching meaning to the information that he is trying to remember – such as 
creating a story or relating it to something that he knows. 
- XXX may benefit from more time being allowed for tasks involving fine motor skills. 
- As this assessment was conducted during a period of changing treatment, we 
recommend re-testing once XXX is stabilised or upon discharge from the ward. 
 
Dr Simone Farrelly, Ph.D. 
Trainee Clinical Psychologist 
Supervised by 
Dr. Lidia Yágüez, Ph.D.  
C.Psychol and Clinical Neuropsychologist 
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Neuropsychological Scores Summary 
 
Name:   XXX    Dob:   XXX 
Age:    33    Date of testing:
 30/01/2014 
Assessed by:  Dr Simone Farrelly  
 
 
General Intellectual Functioning 
 
TOPF 
Raw score: 30, Predicted IQ (for WAIS IV): 92 
 
RBANS 
Sub-Scale    Index   Percentile 
Immediate Memory    65   1st 
 
Subtests    Age Scaled Scores 
List learning    4 
Story memory   4 
 
Visuospatial/constructional  84  9-16th 
 
Subtests    Age Scaled Scores/percentiles 
Figure copy    1 
Line Orientation   >75th 
 
Language    85  16th 
Subtests    Age Scaled Scores/Percentile 
Picture Naming   51-75th 
Semantic Fluency   4 
 
Attention    75  5th 
Subtests    Age Scaled Scores 
Digit Span    8 
Coding    4 
 
 
Delayed memory   85  16th 
Subtests    Age Scaled Scores 
List recall    26-50th 
List recognition   51-75th 
Story Recall    7 
Figure recall    6 
 




TRAIL MAKING TEST 
Trails A 59 sec (less than 10th percentile) 
Trails B 112 sec (10-25th percentile) 
 
